Rural disadvantage in breast cancer health-care service use and outcomes: quantifying the effects of individual risk factors and health service risk factors by Leung, Janni King-Yi
  
 
 
 
 
 
Rural disadvantage in breast cancer health-care service use and outcomes: 
Quantifying the effects of individual risk factors and health service risk factors 
Janni King-Yi Leung 
BArts (Psyc), BHlthSc (Hons I) 
 
 
 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy at 
The University of Queensland in 2014 
School of Population Health 
 
  
 
 
3 
 
Abstract 
Background: Breast cancer is the most prevalent cancer worldwide. Fortunately, survival rates are 
high. However, inequalities in survival rates have been observed in sub-populations. Existing 
evidence indicates that women with breast cancer living in rural areas have a lower survival rate 
than their urban counterparts. However, the reason behind the rural disadvantage in breast cancer 
survival remains unclear. Health service provision in rural and urban areas differ across countries, 
therefore results based on observations from other countries may not be used for the basis of health 
policy and decision making in the Australian setting. While a significant proportion of Australia 
consists of rural areas, existing studies on breast cancer health-care service use and outcomes are 
largely based on an urban sample. The thesis provides an epidemiological investigation to address 
the lack of research on rural and urban differences in risk factors that can affect breast cancer 
health-care service use and outcomes in Australia.  
 
Methods: This thesis is comprised of systematic review studies and secondary analysis research 
studies. Systematic reviews studies were conducted based on the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Secondary analysis studies were 
conducted drawing data from the Australian Longitudinal Study on Women’s Health (ALSWH). 
Analysis was based on longitudinal data with a 14-year follow-up with 13,715 women aged 45 to 
50 years in 1996. Linked data from the cancer registries were used in order to obtain information on 
the cancer characteristics of the participants. Area of residence was defined in accordance with the 
Accessibility Remoteness Index of Australia Plus. 
 
Results: Findings from a systematic review study conducted as part of this thesis revealed that, 
internationally, the rural populations were less likely to have mammography breast screening. It 
was found that all studies were cross-sectional, and most of the studies were based in the United 
States or Canada, with only one Australian study that compared mammography in 1995. From this, 
it was evident that research based on more recent data was needed to compare the rural and urban 
populations on long-term engagement in breast screening behaviour in Australia. Using the 
ALSWH data, breast screening patterns over time were compared between women living in rural 
and urban Australia. Somewhat surprisingly, despite poorer access to mammography services, 
women residing in rural areas had similar mammography screening rates to their urban counterparts. 
Another systematic review study in this thesis revealed that people residing in rural areas were more 
likely to be diagnosed with more advanced breast cancer. As existing Australian studies used cancer 
registry data, factors that may act as a possible confound in the relationship between rurality of 
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residence and the late stage of diagnosis were not available for statistical analysis. From this, it was 
evident that research was needed to compare rural and urban differences in stage of diagnosis, 
taking into consideration other individual characteristic factors. In a data linkage study that 
incorporated information on cancer characteristics from cancer registries, it was found that 
advanced breast cancer was diagnosed in 36% of women residing in urban areas and in 40% of 
women residing in rural areas. Obesity was found to be the strongest risk factor of an advanced 
stage at diagnosis, after adjusting for individual and socio-demographic variables including survey 
year, menopausal status, and country of birth, education, marital status, and rurality of residence. 
Lastly, using the ALSWH data, this thesis showed that physical and mental health-related quality of 
life (HRQOL) did not differ between women living in rural and urban samples, indicating no rural 
disadvantage in HRQOL after a breast cancer diagnosis.  
 
Conclusions: The thesis forms the first Australian epidemiological examination of rural and urban 
differences in area-level and individual-level factors that can affect breast cancer health-care service 
use and outcomes. The finding that there were no rural disadvantages in mammography rates 
implies that the breast screening service provision to rural areas in Australia has been successful. 
Finally, the thesis showed that despite common belief, rural women were not disadvantaged in 
terms of social support received, and there was no rural disadvantage in quality of life in breast 
cancer survivors living in rural areas. The work is significant because it contributes to an 
understanding of why rural women have worse breast cancer outcomes, and can thus help direct 
planning and allocation of breast cancer resources. 
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Glossary 
Terms Definition 
Asymptomatic Presenting no symptoms of disease. 
Biopsy The removal and examination of tissue, cells, or fluids from the 
living body to determine the presence or extent of a disease. 
Breast 
conserving 
surgery 
Surgery that involves the removal of part of the breast to treat 
breast cancer. 
Breast self-
examination 
Self-examination of the breast to physically check for breast 
cancer. 
Burden of 
disease 
Impact of a health problem measured by morbidity, mortality, 
and financial costs.  
Cancer A malignant tumour of potentially unlimited growth that expands 
locally by invasion and systemically by metastasis. 
Chemotherapy A breast cancer treatment that involves the use of drugs to treat 
cancer.  
Clinical breast 
examination 
Examination of the breast by a clinician to physically check for 
breast cancer. 
Degree of spread A measure of the progression of the cancer. 
Diagnosis The identification of disease.  
Health-related 
quality of life 
Quality of life assessed by emotional, social, and physical well-
being. 
High caseload 
surgeons 
A surgeon who has handled a high number of cases in a given 
period, which is usually an indicator of higher success rates.  
Intervention The act or fact or a method of interfering with the outcome or 
course, especially of a condition or process (as to prevent harm 
or improve functioning). 
Lesion An abnormal change in structure of an organ or part due to injury 
or disease. 
Longitudinal 
study 
Observational study that is repeated over time. 
Lumpectomy Surgery to remove a small part of the breast to treat breast 
cancer. 
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Mammography X-ray examination of the breasts for early detection of cancer. 
Mastectomy Surgery that involves the removal of the whole breast to treat 
breast cancer. 
Metastasis The spread of cancer from one organ or part of the body to 
another.  
Meta-analysis Analysis that combines the effects of existing studies that address 
a common research question. 
Neoplasm an abnormal mass of tissue from abnormal growth that can be 
pre-cancer or cancer 
Non-
communicable 
disease 
A disease which is not transmissible by direct contact. 
Prognosis The prediction of the outcome of disease. 
Psychosocial 
factors 
Combination and interaction of psychological and social factors. 
Risk factor Something which increases risk or susceptibility. 
Screening To test or examine for the presence of a disease. 
Social support Perception of care and support received from other people. 
Stage of cancer The description of spread and advance of cancer. 
Symptomatic Presenting symptoms of disease. 
Systematic 
review 
A review of the literature using a systematic method for the 
synthesis of all high quality scientific evidence. 
Tumour An abnormal benign or malignant new growth of tissue that 
possesses no physiological function and arises from uncontrolled, 
usually rapid cellular proliferation. 
Definitions were selected and adapted from American Cancer Society, Cancer 
Council New South Wales, MedlinePlus Webster’s medical dictionary, and National 
Cancer Institute at the National Institutes of Health. 
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List of abbreviations 
ABS Australian Bureau of Statistics 
AIHW Australian Institute of Health and Welfare 
ALSWH  Australian Longitudinal Study on Women's Health 
ARIA+ Accessibility/Remoteness Index of Australia Plus  
ASGC Australian Standard Geographic Classification 
BMI  Body mass index 
BSE Breast self-examination 
CBE Clinical breast examination 
CI Confidence intervals 
HRQOL Health-related quality of life 
NSW New South Wales 
OR Odds ratio 
QLD Queensland 
TNM TNM Classification of Malignant Tumours 
VIC Victoria 
WA Western Australia 
WHO  World Health Organization 
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 Introduction  Chapter 1.
There is a ‘can’ in CANcer because we CAN beat it! 
Breast cancer is the most common cancer in women, accounting for 23% of all cancer cases; also, it 
is responsible for most cancer deaths in women globally, accounting for 14% of all cancer deaths in 
2008 [1, 2]. However, thanks to advances in breast cancer detection and treatment, five-year 
survival rates are now at a very high rate of over 85% [2, 3]. Nevertheless, there are inequalities in 
breast cancer outcomes, and this high survival rate is not shared across population groups [4].  
 
One factor known to be associated with inequalities in breast cancer outcomes is rurality of 
residence. For women diagnosed with breast cancer, studies in several developed countries around 
the world have shown that rurality is associated with lower survival rate and worse health-related 
quality of life (HRQOL) in survivors [5-9]. This apparent health disparity in breast cancer outcomes 
between rural and urban populations is a public health concern.  
 
Globally, there is increasing evidence of inequalities in health related to place of residence, with 
rural populations being disadvantaged when compared to urban populations [10]. Epidemiological 
research on breast cancer outcomes have largely been derived from urban samples. 
Recommendations based on such research cannot be generalised to the rural population. This is 
because the rural and urban population is likely to be different in accessibility to breast cancer 
health services, and in individual characteristics that can affect breast cancer outcomes. Research on 
factors that affect breast cancer outcomes that includes the rural population for comparison is 
lacking, despite the importance of such research in countries that include a large proportion of rural 
areas, such as Australia [11]. Epidemiological studies are thus needed to identify factors that may 
explain rural and urban factors affecting breast cancer outcomes, and subsequently to guide public 
health policies that aim to reduce rural–urban disparities [10].  
 
The aim of this thesis is to compare rural and urban differences in health services, and individual 
risk factors that can affect breast cancer outcomes in Australia, using a large representative sample 
of women residing in rural and urban areas of Australia. The thesis will advance knowledge relating 
to factors that affect breast cancer outcomes in the Australian rural and urban population, by 
comparing individual-level and area-level factors. Quantifying the contributions to rural–urban 
health differences into individual-level and area-level causes is crucial for public health resource 
allocation decisions.  
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The thesis is comprised of nine chapters, and incorporates five individual research studies. Chapter 
2 provides a literature review into the epidemiology of breast cancer and rural health. In addition, it 
provides a comprehensive review and critical evaluation of evidence on rural and urban disparities 
in breast cancer risk factors. The chapter concludes with a conceptual model illustrating the gaps in 
literature and the potential relationships between rural and urban differences in risk factors that may 
affect breast cancer outcomes. Chapter 3 describes the overall methods, and provides details of the 
sample and dataset used in the current research. Chapters 4 to 8 were research studies that focused 
on specific research questions. In these study chapters, the published article has been inserted 
retaining the content and format requirements of the corresponding journals. A brief contextual 
introduction and conclusion bracket each of these publications to integrate them into the thesis 
document. This includes the specific aims of the chapter, and a summary of the chapter findings 
corresponding to the aims. Chapter 9 summarises the thesis as a whole, and discusses the 
implications of the findings from all the research studies. Possible directions for future research and 
the thesis’ contribution to public health conclude the thesis. 
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 Literature review Chapter 2.
This literature review provides background on the epidemiology of breast cancer and its public 
health impact. An outline of the journey of women with a new diagnosis of breast cancer is 
described, starting with screening and detection, and continuing through cancer staging, treatment 
and management, to outcomes. This is followed by an introduction to the concept of ‘rural health’ 
as a public health issue. Next, this chapter presents current knowledge about how living in a rural 
area affects breast cancer outcomes. Finally, the rationale for the thesis is presented.  
 
2.1. Epidemiology of breast cancer 
Public health impact 
Breast cancer (International classification of disease code ICD10 C50) is a type of cancer that forms 
in breast tissues; it is also known as malignant breast neoplasm or tumour [12]. Globally, it is the 
most common type of cancer in women [1]. This is also the case in Australia, with 13,567 breast 
cancer cases in 2008 (age-standardised incidence 115.4 per 100,000 population) [13]. In 2008, the 
age-standardised mortality rate from breast cancer in Australia was 22.1 per 100,000 population, 
and it was responsible for 4% (n=2680) of all deaths, and 15.5% of all cancer deaths in women. The 
risk of diagnosis before 85 years has been estimated to be 13%, and the 5-year survival rate 89% 
[14]. Breast cancer is likely to be a prominent disease in mid-aged women with highest risk in 
women aged 50–69 years [14]. 
 
Primary risk factors for breast cancer in women include older age, having a family history of breast 
cancer, poor dietary patterns, high hormone levels, and the absence of giving birth or breastfeeding 
[15-17]. Other risk factors include overweight or obesity, physical inactivity, menopause status, 
high levels of alcohol consumption and smoking. Survivors of breast cancer have poorer health 
status and higher levels of psychological distress than women who have no cancer experience [18, 
19].  
 
Screening and detection 
Breast cancer is generally detected early and has a good prognosis in developed countries. In 
Australia, detection and diagnosis of breast cancer usually involves a number of procedures, such as 
physical examinations, mammograms, ultrasounds and biopsies. In 1991, The National Program for 
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Early Detection of Breast Cancer, known as BreastScreen Australia, was established by the 
Australian Government to provide cost-free screening mammography services for Australian 
women aged 40 years and older [20]. Screening mammograms are used to regularly check for breast 
cancer in symptom-free women. This thesis focuses on screening mammography in the Chapters 
that examined mammography below. The recommended guideline for screening is every two years 
for women aged 50 years and older, in order to detect cancer before the symptoms are present. 
Permanent clinics are available in urban areas, and mobile services are available regularly in rural 
areas [21].  
 
Cancer staging 
At diagnosis, the stage of cancer is determined, in order to assess the spread, size and severity of the 
cancer. In Australia, staging is carried out by following the TNM (tumour, nodes, metastasis) 
Classification of Malignant Tumours, which is the gold standard cancer classification tool used 
across the world [22], and takes into consideration the size and spread of tumour. Stages are rated 
from 0 to IV, with the higher stages being indicative of more severe cancer (see Table 1) [23]. 
Staging of cancer is important because it assists in the determination of the most appropriate 
treatment options. However, sometimes, the stage is not determined at diagnosis. Unstaged cancer 
may be an indication of poor medical service quality, and may lead to less than optimal treatments. 
Early stage cancer has a better prognosis than later stage cancer. A higher five-year survival after 
diagnosis is an indicator that a good prognosis is likely.  
 
Table 1. Stages of breast cancer according to the TNM classification of malignant tumours, 
with the corresponding 5-year survival rate 
TNM stage Description (5-year survival rate) 
0 Carcinoma in situ – tumour is in its pre-cancerous condition and has 
not spread to the lymph nodes (93%).  
I Cancer is within the breast area in its early stage, tumour is <2 cm*, 
and may be within the breast or lymph nodes (88%). 
II Cancer is within the breast area in its moderate stage, tumour is 2–
5 cm and has spread to the lymph nodes (78%). 
III Cancer is within the breast area in its advanced stage, tumour is >5 cm 
and has spread to the lymph nodes (52%). 
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IV Metastatic cancer – cancer is in its advanced stage and has spread to 
other parts of the body, such as the bone, lung, liver and brain (15%).  
*Diameter at its widest point [23] 
Treatment and management 
Treatment for breast cancer can include lumpectomy and mastectomy surgery, radiotherapy, 
chemotherapy and hormone therapy, and usually involves a combination of treatments. The best 
treatment for breast cancer varies, depending on patients’ preference, cancer stage and 
characteristics, and patient characteristics such as age and health status [24-27]. Generally, 
lumpectomy and radiation are used to treat less severe cancers, and mastectomy and chemotherapy 
to treat more severe cancers.  
 
Most large Australian hospitals have specialised cancer-care nurses who provide patients with 
health information, resources and support throughout the treatment process [12]. Women who live 
in rural or remote areas may need to travel to a major metropolitan city to access cancer specialists, 
services and treatments. In Australia, some supporting programs are offered for rural women with 
cancer; for example, the Supporting Women in Rural Areas Diagnosed with Breast Cancer program, 
which holds networking forums in regional areas to provide information on breast cancer and 
treatment, and promotes support for women [28].  
 
Breast cancer outcomes 
This thesis examined several outcomes variables related to breast cancer. Specific outcomes 
examined in each of the Chapters are defined in the corresponding Chapters below. In general, 
assessing the outcomes of breast cancer, it is important to consider both physical and psychological 
outcomes. In terms of physical outcomes, after a breast cancer diagnosis, the strongest focus is on 
survival time. Overall, survival rates are high – currently 89% for five-year survival as briefly 
mentioned above [2] – and the prognosis generally improves with each additional year of survival 
since diagnosis [29]. Given the high incidence and high survival rate for breast cancer, there is an 
increasing group of breast cancer survivors in the population [30]. Therefore, another important 
breast cancer outcome to consider is good health-related quality of life (HRQOL). The mental and 
physical stress of living with the chronic disease may compromise HRQOL, and survivors of breast 
cancer have been found to have poorer health status and higher levels of psychological distress than 
women who have no cancer experience [18].  
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The availability and use of health-care services may affect breast cancer outcomes. For example, the 
purpose of breast screening is for the early detection of the disease [31]. Cancer that is detected 
early is likely to be at a less advanced and invasive stage, than cancer that is detected late, which are 
likely to be at a more advanced and invasive stage. [31]. A screening mammogram used for the 
detection of breast cancer involves a breast X-ray test for women without any symptoms of breast 
cancer. Many developed countries have established population-based breast cancer screening 
programs (e.g. BreastScreen Australia, mentioned above). In urban areas of Australia, permanent 
clinics are available, and eligible women can book an appointment to undertake a mammogram at 
any time of the year [32]. In contrast, in rural areas, mobile screening services visit rural and remote 
towns every two years, and eligible women can book an appointment to undertake a mammogram 
when the mobile service stops in their area [21]. Difficulties in accessing breast screening for early 
detection of cancer can result in more advanced breast cancer at diagnosis. Clearly, the provision of 
breast cancer screening services, a critical factor in the early detection of disease, differs for rural 
and urban women.  
 
The high overall breast cancer survival rates mean that it is important to ensure that women living 
with breast cancer have a good level of HRQOL [33]. HRQOL is a multidimensional construct that 
includes a person’s overall level of physical and mental wellbeing [34]. As public health advances 
have resulted in better survival, HRQOL has become an increasingly important outcome of interest, 
in addition to measuring morbidity and mortality [35]. A diagnosis of breast cancer is a distressing 
event that affects HRQOL. Breast cancer survivors have to deal with general psychological distress 
and anxiety about the recurrence of cancer [36]. The stress may be increased in women with breast 
cancer living in rural areas, where breast cancer is associated with a greater level of stigma in the 
rural culture [36]; they are also likely to face additional stress due to the time and financial costs of 
travelling a greater distance to access health services [36]. Further, the lack of mental health 
services available to women with breast cancer living in rural areas is another rural disadvantage 
that could lead to poorer HRQOL [37].  
 
2.2. Rural health as a public health concern 
Impact of rurality on health 
Research in rural health involves the study of health status, health outcomes, and health-care service 
access and provision to rural populations. From the 1990s, ‘rural health’ has received increasing 
research attention globally in developed countries, because of rural disadvantage [10]. For example, 
Chapter 2 – Literature review 
33 
 
in Australia, the rural population has a lower life expectancy [38]: the average life expectancy for 
Australian women is 83.8 years in major cities but only 77.6 years in very remote Australia. Further, 
there is growing evidence of rural and urban disparities in health-care access, with such access 
being more difficult or lacking in rural areas [10].  
 
A review of the literature on rural and urban differences in health was conducted, examining 
evidence from Australia, Canada, New Zealand, the United Kingdom and other western European 
nations, and the United States [10]. Globally, people who live in rural areas were found to have 
lower levels of health service access than people who lived in urban areas. However, the lack of 
health service access was not consistently associated with worsened health. Rather, it seems that 
rurality combined with socio-demographic disadvantage, individual lifestyle and health service 
access contribute to the rural disadvantage in health. The review also highlighted how different 
health-care policies across different countries can affect whether a rural population is disadvantaged 
in health.  
 
Area of residence is now recognised as a social determinant of health, and research is urgently 
needed to provide information on the rural health disadvantage [39]. However, ‘rural health’ is 
relatively new in the research setting, and there is little epidemiological research in this field. The 
rural and urban disparities in health may be due to differences in environmental factors, 
demographic factors, socio-economic factors and personal health factors, and it is unclear how each 
of these factors plays a role in determining specific health outcomes. Given the lack of research, 
epidemiological research on rural health is required to provide evidence on which to base policies 
aimed at reducing rural–urban disparities in health [10]. 
 
The importance of research in rural health 
Research is required to identify disparities in health-care needs and outcomes of the rural population, 
to guide public health policies [11]. Health inequalities are often preventable, differences in the 
health of certain populations, which can largely be affected by public policies. Research on rural–
urban disparities in breast cancer outcomes may help to close the gap, and bring us closer to rural–
urban health equality. In recognition of the importance of rural health research, rural health specific 
policies, such as The National Strategic Framework for Rural and Remote Health, have been 
implemented to address the rural–urban disadvantages in health [38, 40]. However, information is 
still lacking, as highlighted by the following quote by the Australian Institute of Health and Welfare 
in a report on the impact of rurality on health status: 
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“However, it is not currently possible to apportion the generally poorer health outcomes outside 
major cities to access, environment or risk factor issues. It is likely that each of these three play a 
part.” [41] 
 
Common issues with rural health research include data quality and the unavailability of datasets that 
include both an urban and a rural sample. Most epidemiological research studies are based on an 
urban sample. However, research findings using a sample from the urban population cannot be 
generalised to the rural population, and rural-specific research is needed to provide information 
relevant to the needs of the rural population [11]. Rural health studies need to include both rural and 
urban samples for comparison; those that focus solely on a rural sample have been criticised for the 
lack of an urban comparison group [10]. An urban and rural comparison is critical to allow 
comparisons of epidemiological information; to determine whether a health problem is rural-
specific; and to identify health inequalities, and thus guide interventions. Research studies are 
important because they inform the evidence base for health-care policies and decisions by 
individuals in the general public, health-care professionals and public health policy makers.  
 
Research on rural health can contribute to public health in a number of ways. Through 
dissemination of findings, the information can be used to: 
 enable individuals to make better decisions on health-care, treatment and lifestyle 
behaviours, so that they can improve their health and reduce their health risks 
 guide interventions and programs to address rural inequalities in health 
 help health-care professionals in a clinical setting to address the needs of the rural 
community 
 guide public health policies to address access issues, and thus improve rural health 
outcomes 
 allocate public health resources and develop public health programs 
 address the rural-specific needs of rural population.  
 
Rural health in the Australian setting 
Rural disadvantage in breast cancer outcomes has been researched extensively in the United States, 
but a similar level of evidence has not yet been established in Australia. Results from the United 
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States cannot simply be generalised onto the Australian population, owing to the large differences 
in health services, demographics and geography between the countries.  
 
Rural areas are often characterised by a low population density with poor access to health care [42]. 
Rural areas are often referred to as ‘the country’, ‘countryside’ or ‘remote areas’, whereas urban 
areas are often referred to as ‘metropolitan areas’, ‘urbanised areas’, ‘major cities’ or ‘cities’. As 
shown in Figure 1, the proportion of Australia classified as rural makes up a significant amount of 
the country’s geographical area. New South Wales has the largest population and includes a mix of 
urban and rural areas. Victoria has the second highest population and the highest proportion of 
major cities and inner regional areas; no areas are classified as very remote. Queensland and 
Western Australia also have high population sizes, and include variations of rural and urban areas. 
Approximately one-third of the Australian population (6.5 million people) live outside major cities 
[5, 43]. The rural population has poorer health than those living in urban areas [38, 44-46]. For 
example, death rates in rural areas are 1.1–1.7 times higher than those in urban areas [5, 47, 48]. 
People who live in rural areas also have higher morbidity than their counterparts in urban areas, and 
experience a greater frequency of chronic conditions such as asthma, arthritis and lung disease [38, 
47]. Clearly, rural health is an important public health concern in the Australian setting.  
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Figure 1. Remoteness area map of Australia according to Accessibility/Remoteness Index of 
Australia (ARIA+) classification with the population size (‘000) of each state in 2011 (adapted 
from Australian Bureau of Statistics) 
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2.3. Review of breast cancer and rurality 
Rural disadvantage in breast cancer outcomes 
Breast cancer is an important public health concern in Australia. In terms of burden of disease, 
breast cancer is the leading cancer in Australian women [14]. As illustrated in Figure 2, breast 
cancer is responsible for the largest proportion of all cancer incidences in women in Australia [13].  
 
Figure 2. Cancer incidences in Australian women in 2008. 
 
Breast cancer is of particular importance to mid-aged women in Australia. Over 69% of breast 
cancers were diagnosed in women age 40-69, the age group with the greatest risk, with only 1.9% 
of breast cancer being diagnosed in women under the age of 35 years [13, 30]. Research studies 
investigating breast cancer outcomes and associated risk factors among mid-aged women are 
warranted because of the high incidence of the cancer among this group.  
 
Women diagnosed with breast cancer living in rural, regional and remote Australia have been 
identified as a particular focus for increased support, information and services, as part of the 
government’s goal to improve high-priority health issues [11]. Although the incidence of breast 
cancer is lower in women residing in rural areas than those living in urban areas, higher mortality 
rates have been observed among rural women diagnosed with breast cancer [7, 8, 49-53]. In 
Australia, studies using data from 1977 to 2006 have consistently shown a rural disadvantage in 
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breast cancer mortality [6, 7, 53, 54]. In addition, HRQOL in breast cancer survivors has been 
observed to be poorer in women living in rural areas than in women living in urban areas [55]. 
However, the causal factors for the rural disadvantage in breast cancer outcomes remain unclear. 
Therefore, epidemiological research into the rural–urban difference in risk factors that can lead to 
poor breast cancer outcomes is required, especially for women who are in the high-prevalence mid-
aged group.  
 
Researchers investigating rural disadvantage in breast cancer outcomes in survival and HRQOL 
have focused on a number of potential explanatory factors. Poor access to health services and 
urban–rural differences in a number of individual variables have been proposed as contributory 
factors. Michell et al. [7] used records from the Western Australia Cancer Registry to demonstrate 
that rural women with invasive breast cancer had 1.62 times higher 5-year mortality rate later than 
their urban counterparts. While age of patients and characteristics of the cancer was adjusted for in 
that study, other key determinants of breast cancer survival, such as socio-economic status and 
lifestyle factors, were not adjusted for due to the unavailability of this information in the dataset 
used. Therefore, further research in Australia is required to examine how much of the rural–urban 
difference in breast cancer outcome can be explained by health service accessibility or individual 
factors, or both.  
 
In conclusion, breast cancer is the most prevalent cancer in mid-aged women. Breast cancer is one 
cancer in which a rural disadvantage in outcomes in survival and HRQOL has been observed. The 
rural disadvantage in breast cancer outcomes may be explained in part by lower access to health 
services. However, it remains unclear to what extent rural disadvantage in breast cancer outcomes is 
associated with health service access versus individual risk factors. From a public health perspective, 
the distinction between health service risks and individual risks is crucial, so that appropriate 
interventions can be implemented.  
 
Individual-level rural risk factors 
This section provides a literature review of individual characteristics of the Australian rural 
population that are possible explanations for the rural disadvantage in breast cancer outcomes. 
 
The age distribution in rural populations is generally older than that of the urban population [38]. In 
Australia, in 2006, it was observed that 76% of women aged 18–23 years lived in the city, 
compared to 72% and 70% of women aged 45–50 and 70–75 years, respectively [56]. Adults aged 
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20 to 40 years are more likely to live in major cities than regional areas, but adults 40 years and 
older are more likely to in regional areas compared to major cities, as shown in Figure 3.  
 
 
Figure 3. Age structure of Australians in 2006; adapted from ABS 2006 Census of Population 
and Housing 
 
Older age is commonly associated with higher incidence of chronic conditions and greater mortality 
[13]. Importantly, cancer prognoses worsen with increased age at diagnosis [13, 14]. Evidence from 
a Canadian study found that breast cancer patients aged 70 years or older had poorer survival rates 
than those aged 40–69 years [57]. Similar results were found in a study of an Australian community 
sample of 14,048 women with breast cancer aged 50 years or older, identified from the Eastern 
Cancer Registration and Information Centre [57]. Compared to women aged 50–69 years, women 
aged 70 years and over were at 1.88–3.81 times higher risk of mortality. However, other research 
indicates that discrepancies remain in cancer mortality after adjusting for age [58-61], suggesting 
that individual differences in age are only partly responsible for the rural–urban differences in 
cancer outcomes. 
 
Another individual characteristic that may explain the rural breast cancer survival disadvantage is 
socio-economic status (SES). People residing in rural areas are more socio-economically 
disadvantaged than those living in urban areas [47], and lower SES is associated with poorer health 
[62]. Therefore, breast cancer patients with lower SES are expected to have poorer prognoses 
compared with their higher SES counterparts [63]. Furthermore, SES may influence how breast 
cancer patients access and use health services. Compared to urban women, rural women with lower 
SES are less likely to access breast cancer screening services [64]. As previously discussed, this is 
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likely to lead to a more advanced stage at diagnosis, and poorer survival. Breast cancer patients with 
lower SES may also experience other forms of health service disadvantage. In England, it was 
found that cancer patients with lower SES were less likely to receive state-of-the art treatments than 
those from higher SES backgrounds [65]. In summary, low SES in rural women is an individual 
risk factor that may contribute to a disadvantage in health service use and access, which may lead to 
poorer breast cancer survival. Therefore, SES will be taken into consideration in the studies in this 
thesis.  
 
Cancer survival is affected by lifestyle factors [66]; therefore, rural–urban differences in individual 
lifestyle factors may be associated with the rural disadvantage in breast cancer survival. Unhealthy 
lifestyle behaviours, such as smoking, are major risk factors for mortality that differ between urban 
and rural areas [67]. Rural populations are more likely to engage in risky lifestyle behaviours. For 
example, Miller et al. [68] found a higher rate of risky alcohol consumption in the rural population 
in Australia. Also in Australia, Dobson et al. [69] reported that rural women have a higher 
prevalence of obesity and lower levels of physical activity than urban women. Obesity is a risk 
factor for breast cancer mortality [70, 71]. However, based on current research, it remains 
inconclusive how much of the urban–rural discrepancy in breast cancer survival can be explained 
by unhealthy lifestyle factors. 
 
Health service disadvantage in the rural population 
As a result of the physical isolation in rural areas, poorer access to health services is likely in the 
rural population. This section provides a literature review of health service related factors in the 
Australian setting that are possible explanations of the rural disadvantage in breast cancer outcomes. 
 
Access to and use of breast cancer screening services, namely mammography, is a factor that affects 
breast cancer survival [72]. Regular mammography can help in the early detection of breast cancer 
and better individual prognoses for women with breast cancer [72-74]. If rural women have poorer 
access to breast screening services, then it is possible that the rural disadvantage in breast cancer is 
due to health service provision discrepancies. 
 
Differences in the use of breast cancer screening services between rural and urban women were 
examined in an Australian study [75]. The 1995 National Health Survey, which included 10,179 
women, found a rural disadvantage in the use of breast cancer screening services. The prevalence of 
women who had never had a mammogram was significantly higher in rural (47%) than in urban 
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women (40%). Compared to urban women, rural women were more likely to have not had a 
mammogram or clinical breast examinations in the past two years or ever (odds ratio 
[OR]=1.22, 95% confidence interval [CI] 1.07–1.39 to OR=1.42, 95%CI=1.25–1.62), after 
adjusting for age and medical doctor service use. In addition, the authors compared rural and urban 
differences in breast self-examination, and found that breast self-examination was significantly 
more common in rural than in urban women. It is possible that rural women who were less likely to 
access formal examinations may be attempting to compensate by conducting more self-
examinations, or that urban women may be less likely to conduct self-examinations because they 
have already undergone formal examinations. However, several research questions remain. In this 
study, data were taken at one time point, and information on whether the screening was conducted 
consistently in the long term has not yet been investigated. The three types of breast screening 
methods promoted were mammography, clinical breast examination and breast self-examinations, 
but no studies have examined how women used the three screening methods in combination. 
Further, the measurements in the above study were taken in 1995; since this time, improvements in 
providing health-care services in rural Australia may have closed this gap in the rural disadvantage 
in breast screening service use. Therefore, the use of breast cancer screening services among 
Australian women in rural and urban areas requires additional research. 
 
Given that screening is a crucial factor for early detection of cancer, rural–urban differences in the 
use of breast cancer screening service use may lead to discrepancies in the stage of cancer at 
diagnosis. As discussed above, patients in whom cancer is detected early have a better prognosis 
than those for whom it is detected later. Consistent later cancer diagnosis in a population suggests 
that there may be a lack of breast cancer screening service use within the population [76]. Therefore, 
stage of cancer at diagnosis may be an indicator of health services use in the population. There is 
evidence that breast cancer patients residing in rural areas are more likely to have a later stage at 
breast cancer diagnosis. This was observed in an Australian study in a population sample of women 
aged 30–80 years [64], in which rural residency was defined by the standard Australian measure, 
Accessibility/Remoteness Index of Australia Plus (ARIA+) [43]. Over 50% of women living in 
inner regional, outer regional, remote and very remote areas were found to have advanced breast 
cancer at diagnosis, compared to 46% of urban women. This rural discrepancy remained even after 
adjusting for SES, year of diagnosis, age, Indigenous status, occupation and marital status. The 
results are unlikely to be due to screening service access alone, because similar observations have 
been found in other studies that adjusted for mammography and service access [77, 78]. The study 
by Baade et al. [64] was the first Australian study to provide evidence that rural women were likely 
to be at a more advanced stage at breast cancer diagnosis. However, the cancer registry data 
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provided a limited number of individual factors for analysis. For instance, obesity is a characteristic 
of the rural population [69], which is associated with a more advanced stage of breast cancer at 
diagnosis [79-81], but information on obesity was not available in the cancer registry dataset used 
for the above research. Further research that investigates a wider spectrum of individual-level 
factors is required to evaluate the risk of an advanced stage of breast cancer diagnosis.  
 
In using HRQOL as a breast cancer outcome, a disparity across rural and urban breast cancer 
patients has been observed [9, 82]. An Australian study compared rural and urban differences in 
quality of life (measured by Functional Assessment of Cancer Therapy questionnaire) after a breast 
cancer diagnosis [55]. Quality of life in urban breast cancer survivors was found to be higher than 
that in rural counterparts. One possible explanation is the lack of mental health support services in 
rural areas [83]. In addition, women with breast cancer living in rural areas are more susceptible to 
physical isolation [36], which may be associated with poorer HRQOL. Although there is evidence 
of poorer quality of life as a rural disadvantage in women living with breast cancer, further research 
is warranted to examine factors that can promote quality of life in breast cancer patients in rural and 
urban areas, as well as causal factors in the rural disadvantage in breast cancer outcome in terms of 
quality of life in women living with breast cancer.  
 
In summary, the literature shows some urban–rural differences in breast cancer outcomes. People 
living in rural areas have poorer access to mammography breast screening, are more likely to have a 
later stage at cancer diagnosis, and have limited mental health support services. However, as 
discussed above, unanswered research questions on the rural disadvantage in breast cancer 
outcomes exist, particularly information about factors known to be associated with poor breast 
cancer outcomes. Specifically, it remains unclear how much of the observed effect can be explained 
by area of residence alone, or specific individual risk factors, such as obesity. Hence, further 
research is warranted to investigate what are the casual factors for the rural disadvantage in breast 
cancer outcomes.  
 
2.4. Gaps in existing literature 
In Australia, studies using hospital records, cancer and death registry data have shown that breast 
cancer patients residing in rural areas have poorer survival rates than their urban counterparts [53, 
84]. Basic demographic factors such as age and ethnicity were adjusted for in these studies, but 
details on individual lifestyle factors were not measured. To date, no research has been able to 
clearly attribute how much of the poorer breast cancer survival in the rural population is attributable 
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to location of residence, or individual characteristics and lifestyle factors. To establish the effects of 
rural breast cancer patients’ individual characteristics and lifestyle factors on breast cancer 
outcomes, further research using data drawn from administrative sources linked with data that 
include detailed information on the women’s individual lifestyle factors is required.  
 
In summary, it has already been established that breast cancer patients who reside in rural areas are 
at higher mortality risk and have poorer quality of life than those who reside in urban areas. A 
possible explanation is that the rural population may experience lower levels of health service 
access and use. This explanation is supported by studies that show lower rates of mammography 
screening attendance, and presentation with more advanced breast cancer in the rural population. In 
addition, this explanation is also supported by studies which showed that mental health support 
services in rural areas are lacking and that poorer HRQOL was observed in women with breast 
cancer living in rural areas. Women with breast cancer living in rural areas may be more susceptible 
to social isolation and loneliness due to the limited community support and mental health services 
available, which is related to poorer quality of life in breast cancer survivors. An alternative 
explanation is that the rural population may have individual risk factors that contribute to the 
increased risk of breast cancer mortality or poorer quality of life. Compared to women residing in 
urban areas, women residing in rural areas are likely to be older, more socio-economically 
disadvantaged, and more likely to engage in unhealthy lifestyle factors. These individual factors are 
related to poorer breast cancer survival outcomes. However, researchers have not been able to 
examine how health service factors and individual risk factors together can affect the breast cancer 
outcomes in women living in urban and rural Australia. Although routinely collected administrative 
data, such as the cancer registry data, provide an objective measure of disease characteristics, 
detailed individual factors (e.g., education, smoking, mental health) on outcome factors such as 
screening behavior and health-related quality of life are not measured. Individual factors may be 
measured by population health surveys, but they often lack objective measures of information on 
cancer characteristics, such as date of diagnosis or disease severity at diagnosis. Due to the 
unavailability of both types of measures within one dataset, it remains unclear how the rural 
disadvantage in breast cancer outcome can be caused by individual factors, health service factors, or 
the two combined. Data linkage studies provide a solution to sharing information across different 
datasets so that relevant information can be used together to answer important research questions.  
 
The specific areas requiring further research are shown in the framework presented in Figure 4. 
Overall there is a need to examine the reasons for the rural-urban difference in outcomes and the 
effect of individual characteristics that are possible confounding factors. This thesis examines to 
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what extent the rural disadvantage in breast cancer outcomes can be explained by health service 
factors and individual factors. It will make important contributions to public health, because 
disadvantages in breast cancer outcomes in the rural population have been identified as a critical 
public health concern in a number of countries, including Australia. To understand the 
epidemiological factors for the rural disadvantage in breast cancer outcomes, country-specific 
research is required, because of differences in countries’ health services and systems, as well as 
geographic distribution of populations. Therefore, epidemiological research is required to address 
these gaps in the literature.  
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Figure 4. Framework of research areas that require investigation that can explain the rural 
disadvantage in breast cancer outcomes. Solid lines represent established associations, dashed 
lines represent unestablished associations that require research. 
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2.5. Thesis research directions and aims 
The research questions addressed in this thesis are: 1) What are the rural and urban differences in 
health service use; 2) What are the individual characteristic risk factors for breast cancer outcomes; 
and 3) How do these differ between rural and urban population? For original research studies, data 
were drawn from the Australian Longitudinal Study on Women’s Health (ALSWH), which 
provides detailed, individual variables on demographic characteristics, health and wellbeing, and 
lifestyle factors. A linked cancer registry dataset provided information on the cancer diagnosis and 
characteristics of women in the ALSWH. This linked dataset provided a rich source of longitudinal 
individual variables as well as cancer characteristics variables for the women living in rural and 
urban areas.  
 
Specific hypotheses and methods for each study incorporated in the current thesis are presented in 
the relevant chapters below. The research findings of this thesis will be disseminated through 
presentation of findings at conferences, publication in journals, media releases, the internet and a 
newsletter distributed to participants of the survey. Findings and publication of these data can be 
used to identify subpopulations that are experiencing health inequality and are in need of health-
care resources, provide directions for public health policies and health-care strategies, and evaluate 
the effects of public health interventions and health service provision between the urban and rural 
population in Australia. 
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 Research methodology Chapter 3.
This chapter provides a definition of urban and rural areas in the Australian setting employed in 
studies that comprised the thesis. This is followed by an overview of datasets used for original 
research in the thesis and the description of procedures involved in obtaining the datasets.  
 
3.1. Definition of rurality in the Australian setting 
The rural and urban definitions that are used in the current thesis are based on the 
Accessibility/Remoteness Index of Australia Plus (ARIA+) [43]. The ARIA+ is a component of the 
Australian Standard Geographic Classification (ASGC). It is a classification of geographic areas 
based on the remoteness of the area, used by the Australian Bureau of Statistics (ABS). The ARIA+ 
was derived based on an area’s distance to service centres, and is the standard measure of 
remoteness used by the Australian Government. Service centres are defined as localities with more 
than 1,000 persons in the population and containing basic level of services such as health, education, 
and retail. It does not take into consideration access to health-care specialists or specialised 
treatment centres. There are 738 service centres that have been identified in Australia for the 
calculation of ARIA+. Geographic areas are scored from 0 to 15 according to the road distance to 
service towns. The five categories of the ARIA+ are: major cities (scored up to 0.20), inner regional 
(scored over 0.20 to 2.40), outer regional (scored over 2.40 to 5.92), remote (scored over 5.92 to 
10.53), and very remote (scored over 10.53) [43].  
 
3.2. Secondary data analysis research design 
The research design of the thesis is based on secondary data analysis. Secondary data analysis is a 
well-established method that involves drawing upon existing datasets to answer research questions 
[85]. For the systematic review studies in the thesis, data were drawn from existing peer-reviewed 
research articles extracted from relevant databases. For the original research studies of this thesis, 
two of the studies were based on data drawn from the Australian Longitudinal Study on Women’s 
Health (ALSWH), and one study was based on linkage of ALSWH survey data with cancer registry 
datasets for participants in the ALSWH. The ALSWH provided longitudinal information on the 
women’s demographic characteristics, health and well-being, and lifestyle factors. The linked 
cancer registry data provided information on date of diagnosis, cancer type, and characteristics and 
severity of cancer. By drawing on these secondary datasets for analysis, a rich dataset consisting of 
Chapter 3 – Research methodology 
48 
 
a comprehensive collection of variables can be utilised for answering the research questions in this 
thesis. Furthermore, this method enabled a very large sample size as well as longitudinal data that 
have been collected since the start of the ALSWH in 1996. By linking the cancer registry data to the 
ALSWH data, detailed and longitudinal information on both the individual factors and health 
service factors of the women can be analysed. This provided an opportunity for the first Australian-
wide linked data epidemiological study examining rural and urban differences in breast cancer 
outcomes. A description of the secondary datasets employed in this thesis is provided below.  
 
3.3. Australian Longitudinal Study on Women’s Health (ALSWH) 
The ALSWH is a longitudinal population-based survey that examines the health of over 40,000 
Australian women. The prospective study is the largest project of its kind in Australia and explores 
factors that influence health and well-being, such as physical and emotional health, use of health 
services, health behaviours and risk factors, and socio-demographic factors. The ALSWH is funded 
by the Australian Government Department of Health. It is a collaborative project between The 
University of Newcastle and The University of Queensland. The ethics committees of The 
University of Queensland and the University of Newcastle approved the research protocol at every 
stage. 
 
The three cohorts of women in ALSWH were aged 18–23 years (‘1973–78 cohort’), 45–50 years 
(‘1946–51 cohort’) and 70–75 years (‘1921–26 cohort’) at the time of Survey 1 in 1996. The 
ALSWH participants are broadly representative of the Australian population of women in the target 
age groups [86]. The study sample was selected randomly from the Medicare Australia database, 
which contains the name and address details of all Australian citizens and permanent residentsIn 
terms of response rates, an estimated 41%–42% of the younger women (n = 14,247), 53%–56% of 
the mid-age women (n = 13,716), and 37%–40% of the older women (n = 12,432) agreed to 
participate in the longitudinal study [86]. Due to uncertainties about the accuracy of the Medicare 
database, response rates cannot be exactly specified. 
 
The sampling methods of the ALSWH involved intentional over-sampling of women living in rural 
and remote areas [87]. Specifically, women from rural and remote areas were sampled at twice the 
rate of women in urban areas. As mentioned previously, a common shortfall of research in rural 
health is the inadequate number of participants from rural areas for statistical analysis. The 
sampling method of the ALSWH allowed an adequate number of women living in rural areas for 
statistical comparisons against women living in urban areas. The ALSWH is the largest study on 
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health issues in rural and remote Australia and thus is an ideal data source for research on rural 
health.  
 
The ALSWH was not designed as, and should not be used as, a source of data about Indigenous 
health. Also due to the nature of the sampling frame, research methods and respondent bias, the data 
provided by Indigenous women in the ALSWH are unlikely to be representative of the experiences 
and health status of Indigenous women in Australia more generally. Therefore, the ALSWH is 
essentially a study on the non-Indigenous Australian population, and results from this thesis should 
not be generalised to the Indigenous population.  
 
In this thesis, the ALSWH data from the 1946–51 cohort (N=13,715 in 1996) were used, when the 
women were aged 45–50 years at Survey 1. The reason for using this age group was because breast 
cancer is likely to be a prominent disease in mid-aged women with highest risk in women aged 50–
69 years [14]. Specific sub-sample and surveys used for each of the individual studies in the thesis 
are detailed in the relevant methods sections of the studies in the corresponding chapters. Access to 
ALSWH data is overseen by the Publication, Substudies and Analyses (PSA) Committee and 
details of the process are available at: http://www.alswh.org.au/how-to-access-the-data/alswh-data. 
Each proposed project is initially discussed with an ALSWH Liaison person who has experience in 
the field of research. This is followed by the submission of an Expression of Interest (EOI), which 
outlines the proposed research aims and methods. The EOI is reviewed by the PSA and based on the 
comments and feedback received, the Expression of Interest may be revised and resubmitted for 
review, before approval to access the ALSWH data is granted. The process used for this thesis 
followed this format and a data disc that included the survey data was obtained within one month of 
application.  
 
Data have been collected for six waves in the 1946–51 birth cohort from 1996–2010 (see Table 2). 
Retention rate was very high: 91% in Survey 2, 84% in Survey 3, 84% in Survey 4, 84% in Survey 
5, and 82% in Survey 6 [88]. The main reason for non-response was that the participant was unable 
to be contacted. Non-respondents from this cohort were more likely to be separated, divorced or 
widowed, be from non-English speaking countries, or report difficulties in managing their income 
[89]. Demographic comparisons against census data showed that the sample had lower proportions 
of women from non-English speaking countries, and women who were separated or divorced. 
Therefore, our sample is likely to be an under-representation of women fitting these profiles. 
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Table 2. Participation and retention of the 1946–51 cohort sample from the ALSWH 
  
Survey 
2 
Survey 
3 
Survey 
4 
Survey 
5 
Survey 
6 
Age in years 47–52 50–55 53–58 56–61 59–64 
Eligible at previous survey 13715 13605 13310 12979 12694 
Ineligible           
Deceased between surveys 50 65 88 99 119 
Frailty (e.g. dementia, stroke) 7 14 14 19 28 
Withdrawn before mail out 
survey date 
53 216 229 167 277 
Total ineligible 110 295 331 285 424 
Eligible at current survey 13605 13310 12978 12694 12270 
Non-respondents           
Withdrawn from the project 155 155 136 226 201 
Contacted but did not return 
survey 
254 998 886 995 1153 
Unable to contact participant 858 931 1052 935 905 
Total non-respondents 1268 2084 2074 2056 2259 
Respondents           
Completed survey 12338 11226 10905 10638 10011 
Retention rate as % eligible 90.70% 84.30% 84.00% 83.80% 81.60% 
 
The distribution of ALSWH participants by ARIA+ classification is shown in Table 3. There were 
no substantial changes in the overall proportion of women residing in each of the areas across time. 
The sample sizes and percentages for the outer regional, remote, and very remote groups were small, 
therefore these groups would be combined for further analyses.  
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Table 3. Percentage distribution of ALSWH participants in the 1946–51 cohort by area of 
residence 
  Number and % of women in the 1946–51cohort residing in each ARIA+ 
 
Major cities Inner regional Outer regional Remote 
Very 
remote 
Survey 1 5000 36% 5214 38% 2798 20% 544 4% 156 1% 
Survey 2 4082 33% 4959 40% 2611 21% 491 4% 131 1% 
Survey 3 3807 34% 4539 41% 2322 21% 387 3% 98 1% 
Survey 4 4106 38% 4255 39% 2124 19% 324 3% 84 1% 
Survey 5 3989 38% 4150 39% 2072 20% 313 3% 85 1% 
Survey 6 3778 38% 3994 40% 1881 19% 264 3% 86 1% 
 
 
Migrations across area of residence from each survey to each of the corresponding survey are 
presented in Table 4. As shown, migrations were uncommon in these women. From Survey 1 to 
Survey 2, 0.4% of women residing in major cities moved to outer regional/remote/very remote areas, 
and 0.9% of women from outer regional/remote/very remote areas moved to major cities. Most 
women (90%-97%) did not move across area of residence. Mobility increased over time, however, 
the percentages of women who moved remained very low (see Table 4). Therefore, mobility across 
area of residence is unlikely to be a major concern in this thesis. However, as there is some mobility, 
analyses cannot simply be conducted using the women’s area of residence at Survey 1. Instead, the 
areas of residence of the women at each survey corresponding to the breast cancer measures were 
analyzed. Specific methods in regards to the analysis of area of residence longitudinally are 
described in each of the research study chapters.   
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Table 4. Migration across area of residence in the 1946–51 cohort ALSWH participants  
    Area of residence at next survey 
  
Major cities Inner regional Outer 
regional/remote/very 
remote 
Area of residence at survey  n % n % n % 
Survey 1 to Survey 2 
       Major cities 3993 90.0% 427 9.6% 18 .4% 
 Inner regional 62 1.3% 4456 94.6% 190 4.0% 
 Outer regional/remote/very remote 27 .9% 76 2.4% 3025 96.7% 
Survey 2 to Survey 3 
      
 Major cities 3358 96.1% 107 3.1% 28 .8% 
 Inner regional 173 3.9% 4141 94.1% 86 2.0% 
 Outer regional/remote/very remote 101 3.6% 139 4.9% 2591 91.5% 
Survey 3 to Survey 4 
      
 Major cities 3274 95.7% 115 3.4% 31 .9% 
 Inner regional 439 10.6% 3605 86.9% 104 2.5% 
 Outer regional/remote/very remote 88 3.5% 234 9.2% 2215 87.3% 
Survey 5 to Survey 5 
      
 Major cities 3456 92.4% 231 6.2% 52 1.4% 
 Inner regional 159 4.1% 3560 91.5% 171 4.4% 
 Outer regional/remote/very remote 64 2.8% 133 5.8% 2095 91.4% 
Survey 5 to Survey 6 
      
 Major cities 3338 95.1% 135 3.8% 37 1.1% 
 Inner regional 162 4.4% 3436 93.2% 88 2.4% 
  Outer regional/remote/very remote 56 2.6% 258 12.0% 1834 85.4% 
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Each survey of the ALSWH has about 350 items covering: tobacco and alcohol consumption; 
weight and height; physical activity and time spent sitting; access to GPs, medical specialists and 
hospitals; use of complementary and alternative medicines; diagnoses, symptoms, psychological 
scales and general health measures. All data are self-reported. Some of the measures are the same 
for every cohort and over time, while others are cohort-specific; for example, for the 1946–51 birth 
cohort there are questions about menopause and retirement. Wherever possible, standard well-
validated measures are used for which population normative data are available. Detailed description 
of the variables used for each specific study of this thesis is provided within the methods section of 
the corresponding study chapters. 
 
3.4. Obtaining linked cancer registry data 
As part of the process for obtaining data, applications were made for the ALSWH data to be linked 
with state-based, routinely collected administrative health data. Data linkage is a valuable source of 
existing data that can be used for public health research. Specifically, for the purpose of the thesis 
linkages were made with cancer registry data from New South Wales, Queensland, Western 
Australia, and Victoria. These states were chosen because of the high population, covering 84% of 
the participants in the ALSWH.  
 
The first step in obtaining cancer registry datasets was to gain university ethics approval for this 
data linkage project. The applications were made to and approved by The University of Queensland 
Medical Research Ethics Committee (approval ID: 2012000132), and The University of Newcastle 
Human Research Ethics Committee (approval ID: H-2011-0371). University ethics approval was 
obtained within two months from application.  
 
Data linkage applications were made to each of the four states separately. These linkages formed 
part of a broader data linkage project that included a number of datasets in each state. The data 
linkage application processes vary slightly among the Australian states. Generically, the initial step 
involved planning the details of the study and identifying specific datasets and variables required to 
answer the research questions for the data linkage application. The applications included an 
expression of interest for data linkage, an ethical application, a tailored National Ethics Application 
Form (NEAF) for some states, a research protocol, and a list of datasets and variables of interest 
identified from the Data Custodian’s data dictionary with justifications of their use. The process to 
apply for data linkages is illustrated in Figure 5.The applications were submitted to the data linkage 
units of each state. The data linkage units committee discussed the data linkage application with the 
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data custodians and provided feedback and comments on the data linkage applications to clarify 
specific details and to provide more information about the details of the study. The applications 
were then amended incorporating feedback and resubmitted to the data linkage units for review with 
the data custodians. After gaining the data custodians’ approval, the final applications were 
submitted to the relevant ethics committee of each state for approval. Once these approvals were 
obtained, the data custodians provided a final sign-off and final approval for the data linkage 
application. At this stage, the data linkage processes were initiated. Using identifying information 
for the ALSWH participants (e.g. name and address) provided by the Data Manager (Cohorts) of 
the ALSWH study at University of Newcastle, the data linkage units of each state identified the 
study population. The data linkage unit provided project specific linkage keys, which are computer 
generated random numbers and letters to replace the sample’s identifying information, to the data 
custodians. Using the linkage keys, the data custodians provided the de-identified datasets with the 
variables required for the proposed project to the ALSWH Data Manager at The University of 
Queensland The time-frame of the data linkage applications was 21 months, from initial application 
in February 2011 to obtaining the data in November 2012.  
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Figure 5. Data linkage application process for data linkage between the Australian 
Longitudinal Study on Women’s Health with state-based administrative data sources 
 
In this study, after the administrative data of each state had been received, the ALSWH Data 
Manager provided the separate administrative datasets of each state with the linkage keys for each 
participant. A separate dataset with the corresponding linkage keys was provided with the requested 
variables from the ALSWH. For the thesis, the separate administrative datasets of each state were 
combined, and then merged with the ALSWH variables using the linkage keys to create the dataset 
for statistical analysis. This linked data were used to conduct the original research study in Chapter 
7. The details of the variables used in each study are described in the methods section within the 
corresponding chapter.   
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 Study 1 – Rural disadvantage in mammography service use  Chapter 4.
This chapter presents the first systematic review examining existing international evidence on 
mammogram breast screening between the rural and urban population. The study has been 
published in a peer-reviewed journal (Citation 1) [90]. In addition, the findings of the study were 
published in a newsletter, and presented in a guest lecture for an introduction to epidemiology 
university course. A brief introduction and conclusion in relation to the research questions of this 
chapter are included to bracket the publication.  
 
4.1. Chapter aims 
Poorer access to screening mammography is a possible factor that can explain the rural 
disadvantage in breast cancer survival. This is because screening mammography is useful in the 
early detection of breast cancer, and earlier detected cancer can be treated more successfully,  
resulting in higher five-year survival rate after breast cancer diagnosis [72-74, 91]. Due to the 
limited access to mammography in rural areas, it is possible that mammography uptake is lower in 
the rural population. While the service provision of mammography to rural areas differs across 
countries, no systematic review has compared the effects of rurality on the uptake of mammography 
across different countries with different levels of health service provision to rural areas. A 
systematic review is useful for the evaluation of existing evidence on rural disadvantages in 
mammography uptake. It can also be used to monitor changes in patterns of mammography uptake 
between the rural and urban population. From a public health perspective, this review is important 
because such evaluations can help to judge whether mammography service provision to rural areas 
is adequate, and thus help guide public health policies for better delivery of mammography services 
across urban and rural areas.  
 
The aim of this chapter is to conduct a systematic review and meta-analysis to evaluate existing 
evidence and compare rural and urban differences on mammography uptake. The research questions 
of this chapter are:  
1) Is there a rural disadvantage in mammography breast screening service use based on 
existing literature? If yes, is this observed on an international level or is the observation 
country specific? 
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2) Has the discrepancy of mammography rate between the rural and urban population 
changed over time? 
3) What are the limitations of existing evidence on research that examined rural and urban 
disparities in mammography uptake in the Australian setting?   
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4.2. Publication  
Leung J, McKenzie S, Martin J, and McLaughlin D. Effect of rurality on screening for breast cancer: 
a systematic review and meta-analysis comparing mammography. Rural and Remote Health. 2014. 
14 (2): p. 2730 
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Abstract 
Background: The lower breast cancer survival rate observed among rural women may be related to 
differences in screening access and utilization. We evaluated existing evidence for rural and urban 
differences in mammography service use in adult women.  
 
Methods: A systematic search was conducted on November 1, 2012, which yielded 28 studies for 
inclusion. Quality and risk of bias of each study was assessed by adapting the Newcastle-Ottawa 
Scale (NOS) for quality assessment of non-randomized studies in meta-analyses. 
 
Results: The rural population was less likely to have mammographic breast screening, and this 
difference was consistent in various areas of the United States as well as across a number of other 
countries. Meta-analyses using random effects models showed that women residing in rural areas 
were less likely than urban women to have ever had a mammogram (OR = 0.74, 95% CI = 0.62-
0.89) or to have an up-to-date mammogram (OR = 0.59, 95%CI = 0.49-0.70).  
 
Conclusion: Mammography is currently the best tool for the early detection and diagnosis of breast 
cancer. The rural disadvantage this review has identified may contribute to the lower breast cancer 
survival among women living outside urban areas. 
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Background 
Breast cancer is the most prevalent cancer in women and disparities in prognosis based on area of 
residence have been observed [6-8]. Rural areas are characterized by a low population density and 
often have poorer access to health care than urban areas [42]. While the incidence of breast cancer 
has been observed to be lower in women residing in rural areas, in those diagnosed with breast 
cancer, death rates are higher [8]. 
 
Rural-urban differences in the breast cancer experience of women have been systematically 
reviewed [36]. Across the 41 studies reviewed, rural women were likely to report difficulties in 
breast cancer health service access, such as a greater distance to breast cancer specialists and 
treatments. In addition, treatment procedures also differed, with a rural disadvantage noted in access 
to, and use of, breast cancer services after diagnosis. However, this review did not consider pre-
diagnosis screening differences between women residing in rural and urban areas.  
 
Despite recent evidence questioning the efficacy of mammograms across all age groups [92], 
current guidelines suggest that women over the age of 50 years should have a mammogram every 
two years as this is currently the best tool available for the early detection of breast cancer [31]. 
Most developed countries do have population-based breast screening programs in place, where 
women over 50 years of age are encouraged to have a mammogram every two years [31]. However, 
it remains unclear in which countries the urban-rural differences in the use of mammograms are 
observed. The aim of this systematic review is to compare all existing evidence on the prevalence of 
mammograms between women residing in rural and urban areas. 
 
Methods 
Search terms and databases  
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were 
used to perform the systematic review[93]. A review protocol for search and inclusion criteria was 
determined in advance and its completion was documented. The search strategy was developed by 
JL and SM and was implemented by JL. 
 
The literature search was carried out on April 4th 2012, and updated on November 1st 2012. The 
databases searched (from earliest available date) were Pubmed (from 1951), CINAHL (from 1982), 
Embase (from 1966), Sociological Abstracts (from 1952), Cochrane (from 1996), Web of Science 
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(from 1898), and RURAL (from 1966). Search terms were (“breast cancer” or “breast neoplasms” 
or “breast tumor” or “breast tumour”) and (“rural” or “rural population” or “rural health” or “rural 
health services” or “rural health care” or “urban rural differences”) and (“mammography” or 
“mammogram” or “breast examination” or “physical examination” or “early detection of cancer” or 
“cancer detection”). Limits were applied on the search to include peer-reviewed publications in 
English in adult women, with no restrictions on the date of publication. Lists of references from 
retained articles were screened for additional material. Where full text articles could not be 
retrieved through databases, authors were contacted and the articles requested.  
 
Eligibility criteria and study selection  
Studies to be included underwent assessment by two independent reviewers (JL and SM). Where 
discrepancies existed between the reviewers, papers were referred to a third reviewer (DM). Studies 
were included in the systematic review if they met the following eligibility criteria:  
 1) The population included adult women; 
 2) The outcome measure was clinic record or self-report of mammography;  
 3) Quantitative statistics of rural versus urban comparisons were present;  
 4) The study included an observation on the screening rates in a non-intervention sample;  
 5) Quality was 6/10 or higher, based on the assessment described below.  
 
Cross-sectional studies were included. Baseline cross-sectional observations from intervention 
studies before the intervention had been carried out are included. Studies were included in the meta-
analysis if required statistics were available.  
 
Quality assessment 
Quality and risk of bias of each study was assessed by adapting the Newcastle-Ottawa Scale (NOS) 
for quality assessment of non-randomized studies in meta-analyses [94]. The development of the 
NOS involved panel review and critical review by experts. The NOS has strong face validity and is 
endorsed by the Cochrane Collaboration. Ratings were made on a dichotomous scale on whether the 
study met the criteria on the selection of study groups, comparability of groups, and the assessment 
of outcomes. The total quality score ranged from 0 to 10, with higher scores indicative of higher 
quality. The 10-criteria assessed in the current systematic review included:  
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1) Representativeness of the rural and urban sample;  
2) Selection of the rural and urban sample;  
3) Definition and ascertainment of rural and urban areas;  
4) Report of the rural and urban sample sizes;  
5) Comparability of the rural and urban sample;  
6) Report of mammography events;  
7) Effect size described;  
8) Assessment of mammography;  
9) Definition of an up-to-date mammography; and  
10) Adequacy of time-frame period  
 
Data extraction and analysis  
Data extraction was performed on studies that met eligibility criteria. The parameters that were 
assessed included study country, sample size, sample age, rural-urban definition employed, 
outcome measure, control variables, and mammography rates across rural and urban areas. For the 
meta-analysis, data extracted on screening rates included the number of participants who had 
mammograms in the rural and urban sample out of the total number of participants in the rural and 
urban sample. In studies that included more than two classifications of the rurality of area, data on 
the most urban and most rural area were extracted and analysed. In the case where these data were 
not presented in the article, the data were obtained by contacting the study authors. The individual 
studies were weighted by their sample size. 
 
Results of whether women had ever had a mammogram and whether women had an up-to-date or 
recent mammogram were reviewed separately. The overall effects of residing in rural areas on 
mammogram rates from the studies were pooled and estimated using the Cochrane Collaboration 
Review Manager software, RevMan 4.1. The Mantel-Haenszel method was employed. 
Heterogeneity of studies was assessed by calculation of the χ2 and I2 statistics. A random effects 
model was used when the test of heterogeneity was significant. Risk of publication bias across 
studies was assessed by examination of funnel plots. A funnel plot presents study sample size on the 
y-axis and study results on the x-axis. A plot with all data-points clustered together indicates 
publication bias. Results were presented as odds ratios (OR) and 95% confidence intervals (CI). 
Where an adequate number of studies were present (n>2), sub-analyses were conducted stratified by 
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country, age of sample, year of data (separate analysis for studies with data from 1990 to 1999 and 
2000 to 2009), and definition of the outcome measures.  
 
Results 
Study selection  
Figure 6 shows the flow chart of included papers. The search resulted in 745 articles, of which 119 
met the eligibility criteria from screening the titles and abstracts. From the full text examinations of 
these articles, 28 studies were found to meet the inclusion criteria for the systematic review. This 
resulted in a total of 1,308,126 observations across the studies. Of these, a total of 20 studies (17 
provided the data, 3 were requested from authors) had data available for, and were included in, the 
meta-analysis.  
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Figure 6. Flow chart of included papers identified in the review of rural-urban comparisons 
on breast cancer mammogram screening 
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Study characteristics 
Characteristics of the 28 included studies are shown in Table 5. Sample sizes of each study ranged 
from 238 to 409,675. Most studies used data from population based administrative data sources, 
such as cancer registry databases. Other data collection methods included questionnaires and 
interviews [95-100].  
 
Most studies used a standardized definition of rural and urban areas, such as the United States 
Department of Agriculture Rural and Urban Classification codes. Other definitions included 
specific city as urban areas and other specific towns or suburbs as rural areas. Four studies defined 
rural and urban areas based on population density, or distance to services.  
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Table 5. Characteristics of included studies that examined rural and urban differences in mammography (n = 28) 
Study Author(s),  
Year [ref] 
N Data source Rural urban definition 
Adib et al., 2009 [101] 1,600 Statistics Lebanon, a private survey 
company in Beirut 
Beirut city and suburbs were urban, Akkar, Batroun, Chouf, Sour, 
and Zahleh districts were rural 
Bennett et al., 2012 [102] 128,607 Behavioral Risk Factor Surveillance 
System 
US Department of Agriculture Economic Research Service's 
Urban Influence Codes 
Bryant et al., 1992 [103] 1,270 Alberta Knowledge, Attitude, and 
Behavior Study 
Edmonton and Calgary were urban, locations 1 to 3 hours away 
from mammography facilities were rural 
Calle et al., 1993 [104] 12,252 National Health Interview Survey 
Cancer Control Supplement 
Metropolitan statistical area classification 
Coughlin et al., 2008 [105] 91,492 Behavioral Risk Factor Surveillance 
System and Area Resource File 
US Department of Agriculture classification 
Coughlin et al., 2002a [106] 108,326 Behavioral Risk Factor Surveillance 
System 
US Department of Agriculture classification 
Coughlin et al., 2002b [107] 5,840 Behavioural Risk Factor 
Surveillance System 
US Department of Agriculture Rural Urban Continuum Codes 
Doescher et al., 2009 [58] 409,675 Behavioral Risk Factor Surveillance 
System 
US country Federal Information Processing Standard codes. 
Fleming et al., 2011 [95] 698 Telephone interview Appalachian county was rural 
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Study Author(s),  
Year [ref] 
N Data source Rural urban definition 
Henderson et al., 2001 [108] 388,707 North Carolina Medicare 
mammography claims and 
enrolment files 
Population density <190 residents per square mile was rural 
Husaini et al., 2005 [96] 326 Intervention study Nashville was urban, West Tennessee was rural 
Inoue et al., 2009 [97] 521 Black Rural and Urban Caregivers 
Mental Health and Functioning 
Study 
Metropolitan St Lousis was urban, Butler, Dunklin, Cap 
Girardeau, New Madrid, Mississippi, Pemiscot, Scott, and 
Stoddard Counties (<10 000 population) were rural 
Jackson et al., 2009 [109] 33,938 California Health Interview Survey 
and Food and Drug Administration 
Centre for Devices and 
Radiological Health data 
California Medical Service Study Area classification 
Kakefuda et al., 2006 [110] 1,255 Colorado Behavioral Risk Factor 
Surveillance System and Colorado 
Farm Family Health and Hazard 
Survey 
US Department of Agriculture classification 
Kinnear et al., 2011 [111] 25,128 National Breast Screening System 
and Northern Ireland Longitudinal 
Study  
UK official classification of settlement bands 
Larson et al., 2006 [112] 9,358 Medical Expenditure Panel Survey 
and Area Resource File 
Urban Influence Code 
Lee et al., 2010 [113] 2,583 Korea National Health and Unclear 
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Study Author(s),  
Year [ref] 
N Data source Rural urban definition 
Nutrition Examination Survey 
Mah et al., 1997 [98] 1,211 Telephone interview Rural areas were 1 to 3 hours from mammographic facility 
Maxwell et al., 2001 [114] 8,602 National Population Health Survey Unclear 
McDonald et al., 2010 [115] 37,794 Canadian Community Health 
Survey 
Metropolitan influenced zone classification. 
Michielutte et al. 1999 [99] 719 Interview Open country was rural, town or city were urban 
Park et al., 2011 [116] 4,139 Korea National Cancer Screening 
Survey 
Classified as metropolitan, urban, or rural 
Polasek et al., 2007 [117] 9,070 Croatian Adult Health Survey Central Bureau of Statistics classification 
Schootman et al., 1999 
[118] 
7,200 Iowa Behavioral Risk Factor 
Surveillance System and Iowa's 
Surveillance, Epidemiology, and 
End Results 
Counties with ≥100 residents per square mile were urban 
Schumacher et al., 2008 
[119] 
4,957 The Education and Research 
Towards Health Study 
US Census definition of urbanized area 
Siahpush et al., 2002 [75] 10,179 National Health Survey Classified as metropolitan and non-metropolitan 
Stamenic et al., 2011 [100] 924 The Mamma population-based 
screening program 
Croatian Rural Development Strategy Classification 
Tekkel et al., 2007 [120] 1,755 Health Behavior Study Tallinn was urban 
Chapter 4 – Rural disadvantage in mammography 
69 
 
 
There were 20 studies that were conducted in either the United States (n = 16) [58, 95-97, 99, 102, 
104-110, 112, 118, 119] or Canada (n = 4) [98, 103, 114, 115]. Other countries which were 
represented included two studies from Korea [113, 116], two from Croatia [100, 117], and one 
study each from Australia [75], Estonia [120], Lebanon [101], and Northern Ireland [111].  
 
Ten of the studies included women who were 40 years of age or older and seven studies were 
conducted on women in a specific age range from 40 years (such as 40 to 75 and 40 to 80). 
Participants’ age in the remaining studies varied from >18 years to 60 or older. 
 
Quality was high, with a mean study quality evaluation score of 7.74 (SD = 1.13). Overall, the 
studies employed a population representative sample for the rural and urban groups. Most studies 
controlled for key factors, such as age and year of data, and the studies controlled for a range of 
socio-economic variables when such data were available. Most studies clearly stated the use of a 
standard rural-urban classification method. One study from the United States used data from 1987 
[104]. There were eight studies that used data from 1991 to 1999, and 19 studies that used data from 
2000 to 2009. Funnel plots were examined and indicated that publication bias was unlikely, because 
data points were balanced on either side of the plots (see Figure 7).  
 
 
Figure 7. Funnel plot of the 6 studies included for the outcome of ever had a mammogram 
and the 16 studies included for the outcome of an up-to-date mammogram 
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Ever had a mammogram 
There were eight studies that compared urban and rural women on whether they had ever had a 
mammogram (see Table 6). Five studies, which were from the United States, Canada, and Australia, 
found that the proportion of women who had ever obtained a mammogram was greater in the urban 
population than the rural population [75, 103, 104, 108, 114]. One study from the United States 
observed no rural and urban differences in women aged 60 years or older [99]. Contrastingly, two 
studies, one from Northern Ireland [111] and one from Korea [116], found that women residing in 
more rural areas were more likely to have ever had a mammogram than women residing in more 
urban areas. 
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Table 6. Studies comparing whether the women had ever had a mammogram between the rural and urban population 
Study  
Year [ref] 
Country Age Data 
year 
Control variables Conclusion Quality 
(/10) 
Bryant et al., 
1992 [103] 
Canada, 
Alberta 
40-74 1991 - *U>R 7.5 
Calle et al., 1993 
[104] 
US ≥18 1987 Age, race, income, education, marital status, region, employment 
status 
*U>R 6 
Henderson et al., 
2001 [108] 
US, North 
Carolina 
≥65 1994-
1997 
Age, race, and insurance *U>R 7.5 
Kinnear et al., 
2011 [111] 
Northern 
Ireland 
53-64 2001 Age, marital status, health status, socio-economic status *R>U 7.5 
Maxwell et al., 
2001 [114] 
Canada 50-69 1996-
1997 
Age, household income, education, country of birth, presence of 
regular physician, medical consultations, blood pressure check, 
hormone drug use, smoking, and physical activity 
*U>R 7 
Michielutte et al. 
1999 [99] 
US ≥60 <1999 Age, race, education, marital status, insurance, knowledge of breast 
cancer and screening, medical factors, attitudes towards screening, 
and transport and cost barriers. 
R=U 9.5 
Park et al., 2011 
[116] 
Korea 40-74 2005-
2009 
Age, marital status, education, household income, and private health 
insurance 
R>U 7 
Siahpush et al., 
2002 [75] 
Australia ≥40  1995 Doctor consultation, age, marital status, country of birth, area level 
socioeconomic status, and education 
*U>R 7 
*p < 0.05, U>R: urban prevalence greater than rural prevalence, R>U: rural prevalence greater than urban prevalence. 
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There were six studies that had data for inclusion in the meta-analysis (see Figure 8) [103, 104, 108, 
116, 121, 122]. This resulted in a total number of 225,447 rural and 189,416 urban observations. 
Heterogeneity tests showed that the studies were heterogeneous, Tau
2 = 0.05, χ2 (5) = 109.28, p < 
0.001, I
2 
= 95%. Therefore, a random effects model was fitted. The test for overall effect was 
significant, Z = 3.29, p < 0.001. Pooled effects results showed that the rural population had 
significantly lower odds of ever having a mammogram than the urban population (odds ratio (OR) = 
0.74, 95% confidence interval (CI) = 0.62-0.89). For sensitivity analyses, separately analyses were 
conducted stratified by country to test whether results differ by country.  Only the US and Canada 
had an adequate number of included studies for a separate analysis. The effect was stronger when 
only including studies from the US [104, 108] and Canada [103, 121] (OR = 0.65, 95%CI = 0.49-
0.86). 
 
 
Figure 8. Meta-analysis results of the ever use of mammogram between the rural and urban 
population 
 
Up-to-date mammography 
Twenty-three studies compared rural and urban differences in the prevalence of up-to-date 
mammography service use (see Table 7). Most of the studies defined up-to-date as having a 
mammogram in the past 1 or 2 years. One study compared women who had a mammogram in the 
past 3 years [102]. All studies observed that women residing in more urban areas were more likely 
to have an up-to-date mammogram than women residing in more rural areas.  
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Table 7. Studies comparing the prevalence of up-to-date mammogram between the rural and urban population 
Study Author(s),  
Year [ref] 
Country Age Data year Outcome measure of 
up-to-date 
mammogram 
Control variables Conclusion Quality 
(/10) 
Adib et al., 2009 
[101] 
Lebanon ≥40 2000-2005 Past 1 year - *U>R 6 
Bennett et al., 2012 
[102] 
US 40-75  2008 Past 3 years Age, education, employment status, insurance, 
marital status, language, income, medical care 
service use and supply, and region 
 8 
Bryant et al., 1992 
[103] 
Canada, 
Alberta  
40-74 1991 Past 2 years Age, education, income, and marital status *U>R 7.5 
Calle et al., 1993 
[104] 
US ≥18 1987 Past 1 year Age, race, income, education, marital status, 
region, employment status 
*U>R 6 
Coughlin et al., 
2008 [105] 
US ≥40  2002 Past 2 years Age, race, marital status, education, income, 
number of persons in household, insurance, 
number of health centres 
*U>R 8 
Coughlin et al., 
2002a [106] 
US ≥40 1998-1999 Past 2 years Year, age, race, marital status, education, 
household, employment status, smoking, physician 
consultation, and health insurance 
*U>R 9 
Coughlin et al., 
2002b [107] 
US ≥18 1998-2000 Past 2 years  Age, year *U>R 10 
Doescher et al., 
2009 [58] 
US ≥40 1994-2000, 
2002, 2004 
Past 2 years Age, race, education, income, employment status, 
region, self-reported health, health insurance  
*U>R 8 
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Study Author(s),  
Year [ref] 
Country Age Data year Outcome measure of 
up-to-date 
mammogram 
Control variables Conclusion Quality 
(/10) 
Fleming et al., 2011 
[95] 
US, 
Kentucky 
≥42 2008 Past 2 years Age, race, and education U>R 9 
Husaini et al., 2005 
[96] 
US, 
Nashville 
and West 
Tennessee 
≥40  1998-2000 Past 1 year - *U>R 6.5 
Inoue et al., 2009 
[97] 
US ≥40 1999-2002 Past 2 years - *U>R 9.5 
Jackson et al., 2009 
[109] 
US, 
California 
40-84 2003, 2005 Past 2 years Year, age, race, marital status, income, language, 
breast cancer history, health insurance, source of 
care, census level 
*U>R 8 
Kakefuda et al., 
2006 [110] 
US, 
Colorado 
≥24 1993, 1997 Past 2 years Age, race, education, marital status, general health, 
insurance, financial barriers, and primary source of 
medical care 
*U>R 8.5 
Larson et al., 2006 
[112] 
US ≥40 2000 Past 1 and 2 years Age, marital status, race, income, health status, 
usual source of care, physicians per capita, 
education, and insurance 
*U>R 7.5 
Lee et al., 2010 
[113] 
Korea ≥40 2005 Past 2 years - U>R 8.5 
Mah et al., 1997 
[98] 
Canada, 
Alberta 
40-75 Unclear, 
<1997 
Past 2 years Belief that symptoms are needed for 
mammograms, ability to encourage a friend to 
have a mammogram, belief that few women are 
being screened 
*U>R 8.5 
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Study Author(s),  
Year [ref] 
Country Age Data year Outcome measure of 
up-to-date 
mammogram 
Control variables Conclusion Quality 
(/10) 
McDonald et al., 
2010 [115] 
Canada 40-69 2002-2005 Past 2 years Age, marital status, immigrant, ethnicity, language, 
income, education 
*U>R 8.5 
Polasek et al., 2007 
[117] 
Croatia 40-80 2003 Past 1 year Age, education, occupation, access, and income *U>R 7 
Schootman et al., 
1999 [118] 
US, Iowa ≥18  1996-1997 Past 1-2 years Age, education, income, and insurance *U>R 7 
Schumacher et al., 
2008 [119] 
US, 
Southwest 
US and 
Alaska 
≥40  2004-2007 Past 2 years Age, location, education, tobacco use, medical 
conditions, income 
*U>R 7 
Siahpush et al., 
2002 [75] 
Australia ≥40  Past 2 years for 
women over 40 
years, past 1 year for 
women aged over 50 
years 
Doctor consultation, age, marital status, country of 
birth, area level socioeconomic status, and 
education 
*U>R  7 
Stamenic et al., 
2011 [100] 
Croatia 50-69 2007-2009 Past 1 year - *U>R 9 
Tekkel et al., 2007 
[120] 
Estonia 16-64 2004 Past 2 years - *U>R 6 
*p < 0.05, U>R: urban prevalence greater than rural prevalence, R>U: rural prevalence greater than urban prevalence.  
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There were 16 studies that had data for the meta-analysis, which included 367,845 rural and 
341,341 urban observations (see Figure 9) [95-98, 100-105, 109, 110, 113, 117, 119, 122]. The 
studies were heterogeneous (Tau
2 = 0.11, χ2 (15) = 1169.65, p < 0.001, I2 = 99%), justifying a 
random effects model. Pooled effects results showed that rural women had significantly lower odds 
of having an up-to-date mammogram when compared to urban women (OR = 0.59, 95%CI = 0.49-
0.70). Sensitivity analyses were conducted by time frame of the outcome measure. Results were 
consistent across studies that defined an up-to-date mammogram as within the past year [96, 100, 
101, 104, 117] (OR = 0.49, 95%CI = 0.40-0.59) and studies that defined it as within the past 2 years 
[95, 97, 98, 103, 105, 109, 110, 113, 119] (OR = 0.60, 95%CI = 0.51-0.72), though the effect was 
weaker in the latter.  
 
Sensitivity analyses were conducted by country. Only the US and Canada had an adequate number 
of included studies for a separate analysis. When only including studies from the US [95-97, 102, 
104, 105, 109, 110, 119]and Canada [98, 103], rural women had 0.62 lower odds (95%CI = 0.55-
0.69) of having a recent mammogram. These results were consistent when only including studies on 
women aged 40 years or older (OR = 0.60, 95%CI = 0.53-0.67) [95-98, 101-103, 105, 109, 113, 
117, 119, 122] . In addition, conducting the analysis stratified by data year showed consistent 
results (data year 1991-1999 [96, 103, 110] OR = 0.58, 95%CI = 0.34-1.00, data year 2000-2009 
OR = 0.59, 95%CI = 0.48-0.74). 
  
Chapter 4 – Rural disadvantage in mammography 
77 
 
 
Figure 9. Meta-analysis results of up-to-date mammogram between the rural and urban 
population 
 
Discussion 
The aim of the current study was to review the existing literature on rural and urban differences in 
mammogram use. Our analyses indicate that there is strong and consistent evidence of differences 
in mammogram uptake between women residing in rural and urban areas in a number of developed 
countries. These differences remained consistent even when the mammographic services offered in 
each country may not be directly comparable in terms of cost and availability. The rural 
disadvantage on the ever use of a mammogram was only observed in the US, Canada, and Australia. 
However, the observation that women residing in rural areas were less likely than their urban 
counterparts to have had a recent mammogram was found across all the included studies. These 
findings are consistent with a previous review showing urban-rural disparities in breast cancer 
treatment and experience [36]. Although the focus of the current paper was on comparisons of rural 
and urban women across many different systems, it is important to note that countries differ in the 
preventive public health services that are available. The importance of this work is that within a 
country, differences in mammogram use are likely to play a key role in differential rates of early 
detection and diagnosis of breast cancer [31, 123]. The data in this study therefore provide evidence 
for policy makers when deciding on allocation of screening resources. 
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There are a number of limitations that should be considered when interpreting the findings of this 
paper. Firstly there is heterogeneity among studies, although this is to be expected because of the 
diversity of study settings. However, the meta-analysis results were consistent with the systematic 
review findings, and so the observed heterogeneity was unlikely to change the interpretation of the 
findings. While there are criticisms of wide variation of the definition of “rurality” in previous 
research [36], in the current review, most studies employed a national level standard definition. 
Internationally, the standard classification methods of rurality were similar and were commonly 
based on distance to major service areas and population density. 
 
Another discrepancy in the reviewed studies was the age of the sample. Some studies included 
women who were 18 years and over, while others examined only women who were 60 years and 
over. Nevertheless, the urban and rural differences in mammogram use were generally consistent 
across studies of different age groups. Most studies examined breast screening service use in 
women from 40 years of age onwards, as population health breast screening programs are often 
targeted to women of this age group. Our meta-analysis on studies that include women from 40 
years revealed a rural disadvantage in mammography use. Studies that focused on particular age 
groups have merit over studies that simply include women across all ages, as the guidelines and 
public health recommendations and services available to women in different age groups are 
different [31, 123]. Our search strategy was limited to English language publications thus we may 
have overlooked studies which were indexed in other languages, or which appeared in electronic 
databases that were not accessed. Possible differences in factors associated with screening (such as 
attitudes) between sub-populations of different cultural groups could affect results.  
 
A strength of the included studies was that many employed national level data sources with large 
sample sizes, which allowed for adequate power. In addition, many of the reviewed studies 
controlled for socio-demographic variables, a potentially important factor as rural populations are 
often characterized by lower socio-economic status [48]. While there are numerous studies on rural 
and urban differences in breast screening conducted in the US and Canada, research in other 
countries is rare, although our review showed that the rural disadvantage in mammogram screening 
is likely to be an issue across several countries. 
 
Research comparing rural and urban differences in breast screening rates in the population has only 
received research attention in recent years. To date, there have been no studies that have followed 
rural and urban women to ascertain if they consistently follow breast screening guidelines over time. 
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As long-term adherence to breast screening guidelines is recommended, longitudinal studies to 
examine how urban and rural women engage in mammographic screening are warranted. 
 
Conclusion 
This review showed a difference in the use of mammograms in rural compared to urban women 
across several countries. Although there were limitations in terms of different healthcare systems in 
which the work was undertaken, a rural disadvantage in up to date mammogram use was observed 
internationally. However, it is clear from the analysis that more studies on rural and urban 
comparisons on breast screening are needed in countries other than the United States and Canada. 
Mammographic screening is an important step in the early detection and diagnosis of breast cancer, 
and future studies could also explore influences, such as physical or psychosocial factors, which 
may affect mammogram use in rural areas. 
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4.3. Chapter summary 
This chapter described a systematic review and meta-analysis of the existing literature on rural and 
urban differences in mammography use to address the research questions of this chapter. Firstly, the 
study examined whether there was a rural disadvantage in mammography breast screening, and if 
yes, whether this is country specific. Findings from this chapter revealed that breast screening by 
mammography was observed to be lower in the rural population across a number of countries, 
including the United States, Canada, and Australia. While most studies were based on analyses 
using data from the United States and Canada, the observation that rural–urban discrepancy was 
also observed in other countries suggests that the inequality in mammography in the rural 
population is an issue for several countries across the world. As access to services plays a large role 
in the use of preventive health-care services [10], a possible explanation of the rural disadvantage in 
mammography uptake is that the rural population may have poorer access to mammography 
services to rural areas. Another possible explanation is that there may be cultural or attitudinal 
differences between the urban and rural population that could affect their health service use 
behaviour. Indeed, research on a number of rural communities has found that breast cancer and 
breast cancer screening were perceived negatively [103, 124-126]. Lack of education about 
mammography in the rural population can also play a role in their lower mammography rates [127]. 
Further research is required to examine the roles of other factors that may be responsible for the 
rural disadvantage in mammography in order to inform interventions to reduce this health-care 
inequality.  
 
Secondly, the study examined whether the gaps in mammography screening rates between the rural 
and urban populations have changed over time according to cross-sectional data. Findings from this 
chapter suggested that the rural and urban difference in mammography is consistent over time, with 
studies showing consistent results after stratifying the findings by year of data examined. It should 
be noted that while mammography is recommended regularly, the studies reviewed in this chapter 
employed a cross-sectional design to describe mammography at one time-point. No existing study 
that compared rural and urban differences in mammography examined whether the women had 
consistently attended mammography screening over time, thus this question remains unanswered.  
 
Thirdly, this study examined limitations of existing research on rural and urban comparisons on 
mammographic breast screening in Australia. Findings revealed that conclusive evidence on the 
topic has not yet been achieved based on Australian data, with only one existing study identified to 
date. While rural disadvantage in mammography screening rates has been researched extensively in 
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the United States, a similar level of evidence has not yet been established in Australia. Results from 
the United States cannot simply be generalised onto the Australian population, owing to the large 
differences in health services, demographics and geography between the countries. Further, the 
Australian study was conducted using data from 1995 [75], when the national breast screening 
program, which was launched in 1991, was relatively new [32]. No studies using more recent data 
have replicated the findings of that one study to show a rural disadvantage in mammography. 
Further research using updated data is required for the evaluation of how changes in health policies 
may affect mammography screening behaviour in the population.  
 
This chapter highlighted several unanswered questions in research comparing rural and urban 
differences in breast screening service use. It is evident that research comparing rural and urban 
differences in Australian women in their use of mammography is neither current nor explored in the 
context of changes to women’s health policy. In addition, no Australian research comparing 
mammography by area of residence has taken into consideration both area of residence as well as 
individual level risk factors. Further research is required to address these unanswered questions for 
the purpose of identifying specifically what factors are responsible for the urban and rural 
difference in mammography uptake across the Australian rural and urban populations. These gaps 
in the literature are addressed in the next chapter comparing long-term breast screening patterns in 
the Australian urban and rural populations, drawing data from the Australian Longitudinal Study on 
Women’s Health.  
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 Study 2 – Breast screening patterns in urban and rural Australia Chapter 5.
This chapter presents the long-term patterns of breast screening methods used by women residing in 
rural and urban Australia. Specifically, the study examined how women residing in rural and urban 
areas use mammography, clinical breast examinations, and breast self-examinations together. 
Secondary analyses were conducted using data drawn from the 2001 to 2010 surveys of the 
Australian Longitudinal Study on Women’s Health. This study has been published in a peer-
reviewed journal (  
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Citation 2) [128]. In addition, findings were disseminated through conference presentations and 
seminars, and published in a newsletter. A brief introduction and conclusion in relation to the 
research questions of this chapter are included to bracket the publication.  
  
5.1. Chapter aims 
In the previous chapter, it was revealed that a health service disadvantage in terms of breast 
screening mammography was observed in the rural population in a number of countries across the 
world, posing the lack of mammography as a possible risk factor for the higher breast cancer 
mortality in the rural population. As discussed previously, the goal of breast screening is for the 
early detection of breast cancer in symptom-free populations so that the cancer can be treated early 
for lower rates of breast cancer mortality [129]. Most existing studies focus on mammography 
breast screening, because evidence indicate that screening mammography is effective in the early 
detection of cancer [130]. While clinical breast examinations (CBE) and breast self-examinations 
(BSE) are other widely-used breast screening methods that are promoted by health care service 
providers or public health organizations [23, 123], epidemiological research is lacking in these two 
types of breast screening methods. Given the estimation that up to half of breast cancers are 
detected from CBE or BSE [131], research on breast screening should include mammography as 
well as CBE and BSE.  
 
Clinical breast examination is a physical examination of the breast conducted by a health-care 
professional, such as a doctor or nurse [123]. It involves the health-care professional examining the 
breast and underarm physically and visually for signs of breast cancer. In a Canada-based 13-year 
longitudinal study, it was found that the effects of breast screening by CBE on reducing breast 
cancer mortality was the same as the effects of breast screening by mammography [132]. Since 
access to health-care services is poorer in rural areas [41], it is expected that the rural population 
would be less likely to conduct CBE than the urban population. If the rural population is 
disadvantaged in CBE, it would be a contributing factor to their lower breast cancer survival after 
dianogisis.  
 
A literature review was conducted as part of this thesis to examine evidence on rural disadvantages 
in CBE (see Table 8). This confirmed that the topic of rural and urban differences in CBE is 
currently under-researched. There were six existing studies that compared urban and rural use of 
CBE [97, 99, 103, 106, 112, 122]. Four of these studies (from the United States, Canada, and 
Australia) found that women residing in urban areas were more likely to have CBE [75, 103, 106, 
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112]. Two studies from the United States reported no rural and urban differences [97, 99]. The only 
Australian study was conducted using data from 1995, which was over 19 years ago [75]. No 
research has examined the current situation of urban and rural differences in CBE using more recent 
Australian data, although evidence for a rural disadvantage in breast cancer survival after diagnosis 
has been observed more recently [6, 7, 53]. Therefore, existing research is inconclusive as to 
whether the rural disadvantage in breast cancer survival after diagnosis can be explained by the lack 
of CBE. 
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Table 8. Literature review on studies comparing the prevalence of clinical breast examinations between the rural and urban population 
Study Author(s),  
Year [ref] 
Country Age Data year Outcome measure 
of CBE 
Control variables Conclusion 
Bryant et al., 1992 
[103] 
Canada, 
Alberta  
40-74 1991 1) Ever 
2) Past 1 year 
- 1) U>R 
2) *U>R 
Coughlin et al., 2002 
[106] 
US ≥40 1998–1999 Past 2 years Year, age, race, marital status, 
education, household, employment 
status, smoking, physician consultation, 
and health insurance 
*U>R 
Inoue et al., 2009 
[97] 
US ≥40 1999–2002 Past 1 year - U=R 
Larson et al., 2006 
[112] 
US ≥40 2000 Past 1 and 2 years Age, marital status, race, income, health 
status, usual source of care, physicians 
per capita, education, and insurance 
*U>R 
Michielutte et al. 
1999 [99] 
US ≥60  Unclear Ever Age, race, education, marital status, 
insurance, knowledge of breast cancer 
and screening, medical factors, attitudes 
towards screening, and transport and 
costs barriers.  
U=R 
Siahpush et al., 2002 
[75] 
Australia ≥40  1995 1) Ever 
2) Regular 
Doctor consultation, age, marital status, 
country of birth, area level socio-
economic status, and education 
1) *U>R 
2) *U>R 
*p < 0.05, U>R: urban prevalence greater than rural prevalence. R > U: rural prevalence greater than urban prevalence. 
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Breast self-examination involves the awareness of signs of breast cancer and self-checking of the 
breasts for unusual breast changes [23]. Signs to look for include breast lumps, skin changes, pain, 
changes in shape or size, and discharge from a nipple. Given that BSE can be conducted within the 
home, there should be minimal rural disadvantage in BSE. However, the rural population is likely to 
have lower levels of exposure to health promotion messages on BSE. This is because the 
availability and density of health promotion messages are generally greater in urban areas. 
Therefore, it is possible that the rural population would be less likely to conduct BSE than the urban 
population.  
 
Similarly, a literature review conducted as part of this thesis confirmed that epidemiological 
research on the comparison of BSE across rural and urban areas is under-researched (see Table 9). 
There were five existing studies that compared the rate of BSE between rural and urban women [97, 
99, 103, 122, 133]. Mixed findings (some supporting that BSE are more common in rural 
populations and some supporting no differences) were observed across the studies from Canada, the 
United States, Zambia, and Australia [97, 99, 103, 122, 133]. Of interest to this thesis is the 
Australian study, which found that women living in rural areas were significantly more likely to 
have conducted BSE [75]. This is the same Australian study that observed that women living in 
rural areas were less likely to have clinical breast examinations (CBE). There is currently no 
evidence to support BSE as an effective breast screening method for the reduction of breast cancer 
mortality rates [134]. Therefore, it may not be ideal if the rural women living in rural areas are only 
conducting BSE rather than CBE or mammography. However, as the Australian study did not 
examine how the women engaged in the different breast screening methods in combination, it 
remains unclear whether the women living in rural areas conducting BSE were also attending 
mammography screening. 
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Table 9. Literature review on studies comparing the prevalence of breast self-examinations between the rural and urban population 
Study Author(s),  
Year [ref] 
Country Age Data year 
Outcome 
measure of BSE 
Control variables Conclusion 
Bryant et al., 1992 
[103] 
Canada, 
Alberta  
40–74 1991 1) Ever  
2) 9–15 
times/year 
- 1) *R>U  
2) R=U 
Inoue et al., 2009 
[97] 
US ≥40 1999–2002 At least once a 
month 
- *R>U 
Michielutte et al. 
1999 [99] 
US ≥60  Unclear Ever Age, race, education, marital status, 
insurance, knowledge of breast cancer 
and screening, medical factors, attitudes 
towards screening, and transport and 
costs barriers.  
R=U 
Mukupo et al, 2007 
[133] 
Zambia 15–49 Unclear Unclear - R=U 
Siahpush et al., 2002 
[75] 
Australia ≥40  1995 Unclear Doctor consultation, age, marital status, 
country of birth, area level socio-
economic status, and education 
*R>U  
*p<0.05, U>R: urban prevalence greater than rural prevalence. R>U: rural prevalence greater than urban prevalence. 
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Chapter 4 has shown that the use of mammography services is lower among the rural 
population in several countries around the world. However, most of the studies included in this 
review were conducted in the United States (US). The extent to which findings can be generalised is 
thus limited given the implications of rural residence are likely to be different from one national 
context to another. Various reasons might lead to a contrasting rural-urban screening geography in 
different countries. The social health care system in Australia, might enable better access to 
screening mammography than the more privatised system found in the US. The socio-demographics 
found in rural areas may also differ with implications for take-up of screening services. The 
differing health service provision internationally means that findings from the US cannot be 
generalized to other countries such as Australia. Further, no study has used longitudinal data to 
examine the rural and urban differences in mammography use in the long-term. Other breast 
screening procedures include CBE and BSE. However, no existing studies have examined how 
women engage in the three screening behaviours in combination. No existing study has examined 
whether there are rural disadvantages in breast screening taking into consideration the three 
methods of breast screening. Therefore, to address this literature gap, the aim of the study in this 
Chapter is to examine the longitudinal patterns of breast screening in Australian women living in 
urban and rural areas, including mammography, CBE, and BSE. The research questions of this 
study are:  
1) What are the long-term breast screening patterns of women in terms of their combined 
use of mammography screening, clinical examination, and breast self-examination? 
2) Is there a rural disadvantage in all three types of breast screening and has this changed 
over-time? 
3) What are the socio-demographic and individual characteristics that can affect a woman’s 
breast screening behaviour? 
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5.2. Publication 
Leung J, McKenzie S, Martin J, Dobson A, and McLaughlin D. Longitudinal patterns of breast 
cancer screening: mammography, clinical, and breast self-examinations in a rural and urban setting. 
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Abstract 
Background: We identified breast screening patterns over time and patterns among women 
residing in rural and urban areas by socio-demographic factors.  
 
Methods: This study employs a longitudinal design over 9 years from 2001 on 11,200 women aged 
50-55 from the Australian Longitudinal Study on Women’s Health. Area of residence was defined 
in accordance with the accessibility remoteness index of Australia Plus (ARIA+). Breast screening 
measures included mammography utilization, clinical breast examinations (CBE), and breast self-
examinations (BSE).  
 
Findings: Most women had a mammogram in the past 2 years in combination with CBE or BSE or 
both. Despite poorer access to mammography services, women residing in rural areas had similar 
mammography screening rates than their urban counterparts. Women residing in rural areas were 
less likely to have clinical breast examinations, but more likely to conduct breast self-examinations. 
The breast screening behaviors were generally consistent over time.  
 
Conclusions: The poorer breast cancer survival among rural women is unlikely to be explained by 
differences in mammography service use. A substantial proportion of the population may be 
experiencing over-screening by conducting all three types of breast screening.  
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Background 
Breast cancer is the most prevalent cancer in women in the world and it is one of the few cancers 
for which population screening technologies are available [31]. Breast screening aims to detect 
diseases at an early stage in symptom-free populations. The most widely used method for breast 
cancer screening is mammography. Additional forms of breast cancer screening are clinical breast 
examinations (CBE) and breast self-examination (BSE). CBE involves a physical examination of 
the breasts by a doctor or a nurse to check for signs of abnormality, such as lumps. BSE is the 
physical examination of the breasts that women can conduct on themselves. Most developed 
countries, such as the United States and Australia, have population breast cancer screening 
programs targeting women over 50 years of age who are encouraged to have mammograms every 
two years. Public health organizations and physicians suggest CBE to be conducted annually and 
BSE monthly [123]. 
 
Breast cancer mortality rates have been found to be higher in women residing in rural areas 
compared to women in urban areas, despite the higher incidence observed in urban areas [7, 53, 61, 
84, 135, 136]. As screening contributes to early detection of cancer can lead to a better chance of 
survival [130], a plausible hypothesis for the higher breast cancer mortality rate in rural populations 
is that women residing in rural areas may be less likely to use breast screening services. Some 
studies have shown that the use of both mammography and clinical breast examination services are 
lower among the rural population [7, 58, 75, 96, 100, 106, 109, 114, 115, 117], although a 
longitudinal study examining all three screening practices of mammography, CBE and BSE has not 
been undertaken. 
 
In Australia, the recommended breast screening guidelines for women aged 50 to 69 years of age 
include mammogram screening every two years, CBE every year, and BSE every month [20, 137]. 
Correspondingly, a national mammography program is available cost-free and targeted to all 
Australian women in this age group via fixed and mobile screening units. Participation rate since 
1997 has been steady at about 55% nationwide, 54% in major cities, 57% in inner regional, 58% in 
outer regional, 54% in remote, and 47% in very remote areas of Australia [138]. Health promotion 
messages exist to encourage women to conduct CBE and BSE, however the responsibility to 
conduct these means of screening lie first with the individual women.  
 
Recommendations for breast screening methods differ by country. While women in Australia are 
encouraged to use mammograms, BSE, and CBE, different recommendations exist in other 
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countries such as the United States. In the United States, women are recommended to have 
mammography, but not BSE or CBE [139]. As different programs and policies exist by country, 
country specific studies are required for research relating to breast screening behaviors in women.  
 
Given the recommendations of various methods of breast screening, it is unclear how women utilize 
the different screening techniques, and if the use is likely to change over time. Furthermore, most 
studies rely on a simple urban-rural dichotomy which may mask differences in rural screening 
behaviors. This is especially relevant in Australia where the term ‘rural’ can incorporate areas with 
widely diverse accessibility to health screening services [38]. The aim of the current study is to 
describe longitudinal patterns of mammogram service use, CBE and BSE, and how these change 
over time. A further aim is to examine whether these behaviors differ by geographical area of 
residence.  
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Methods 
Study design and setting  
Data were drawn from The Australian Longitudinal Study on Women’s Health, which is a 
prospective study of factors affecting the health and well-being of three cohorts of women, aged 18 
to 23 years (1973 to 1978 cohort), aged 45 to 50 years (1946 to1951 cohort) and aged 70 to 75 years 
(1921 to 1926 cohort) at the time of Survey 1 in 1996. Women were selected from the Australian 
national health insurance database (Medicare), which includes all citizens and permanent residents. 
Stratified random sampling was used with intentional over-sampling of women from rural and 
remote areas. In terms of response rates, an estimated 41 to 42% of the younger women (n = 14 
247), 53 to 56% of the mid-age women (n = 13 716), and 37 to 40% of the older women (n = 12 
432) agreed to participate in the longitudinal study [86]. The sample is a representative sample of 
women in the Australian population. 
 
The project uses mailed questionnaires to collect self-report data on health and related variables 
every three years. The methods of recruitment and response rates have been described elsewhere 
[87]. The ethics committees of The University of Queensland and the University of Newcastle 
approved the research protocol at every stage.  
 
Participants 
Participants were 11,200 women from the 1946 to51 birth cohort who responded to survey 3 in 
2001 (50 to 55 years of age), survey 4 in 2004 (53 to 58 years of age), survey 5 in 2007 (56 to 61 
years of age), and survey 6 in 2010 (59 to 64 years of age). These surveys were chosen because at 
those times the women fell within the targeted age range for the free population mammogram 
program in Australia [32]. All women in the current sample were eligible for the cost-free national 
breast-screening program, which was available throughout the study period. The sample size of 
women included in the analyses was 11,153 in 2001, 10,105 in 2004, 9,783 in 2007, and 9103 in 
2010. Attrition did not differ by area of residence, and follow-up rates were very high, ranging from 
81% to 91%. 
 
Measures 
The main outcome measures were three self-reported breast-screening variables: mammography, 
CBE and BSE. We measured whether the women had ever had a mammogram, and up-to-date 
mammography was defined as having a mammogram in the last 2 years [140]. CBE was defined as 
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a breast examination by a doctor or nurse in the past three years. BSE was defined as regular 
monthly breast self-examinations over the past three years. In addition, mammography access was 
measured by participants indicating their ease of obtaining a mammogram (‘excellent or very good’ 
and ‘good, fair, or poor’). 
 
Area of residence was based on the Accessibility/Remoteness Index of Australia Plus (ARIA+) 
[141], a component of the Australian Standard Geographic Classification. Areas are classified for 
remoteness based on road distance to the closest service centre, which in turn is categorized on 
population size as major cities of Australia, inner regional Australia, outer regional Australia, 
remote Australia, and very remote Australia. For these analyses the categories of remote Australia 
and very remote Australia, which are based on access to service centres with populations of 5,000 to 
<18,000 and 1,000 to <5,000 respectively, were combined and labelled as 'remote' due to small 
numbers of participants [43].  
 
Other individual characteristics variables examined included country of birth, marital status, body 
mass index (BMI), financial status, education, feeling pressured for time, and depression. Country 
of birth categories were ‘Australia’, ‘other English speaking countries’, and ‘other non-English 
speaking countries’. Marital status categories were ‘partnered’ (married or living with a partner) and 
‘not partnered’ (separated, divorced, never married, or widowed). BMI was calculated from self-
reported height and weight (kg/m
2
) and categorized according to World Health Organization 
recommendations as ‘underweight’ (<18.5), ‘normal’ (18.5 to <25), ‘overweight’ (25 to <30) and 
‘obese’ (≥30). Financial status was measured by asking how the women managed on available 
income (impossible, difficult all the time, or difficult sometimes were categorized as ‘poor’, not too 
bad or easy were categorized as ‘good’). Level of education was categorized as ‘lower’ (no formal), 
‘middle’ (high school), and ‘higher’ (trade / certificate / degree). Pressure for time was measured by 
a question, which asked how often the women felt rushed, pressured, or too busy (‘daily or weekly’ 
or ‘monthly or never’). Depressive symptoms in the past month were measured using the 10-item 
Center for Epidemiologic Studies Depression Scale (CESD-10), with the women categorized as 
depressed if they scored 10 or higher [142].  
 
Data Analysis 
Statistical analyses were conducted using the SAS 9.1.2 software. To examine the cross-sectional 
association of mammogram access and each of the three breast screening variables by area of 
residence, chi-squared tests (unadjusted) were conducted at each time. Missing data were excluded 
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pairwise. Sensitivity analyses were conducted with separate chi-squared tests for each of the eight 
states within Australia to examine whether results were consistent across states.  
 
Longitudinal analyses using generalized estimating equations were conducted to estimate the effects 
of area of residence on the breast screening variables. Generalized estimating equation models are 
used to estimate the odds ratio of an event in longitudinal data that involves multiple time-points. 
Using longitudinal data from all surveys, we estimated the parameters of logistic regressions. 
Separate analyses were conducted for each of the four outcomes, which included mammogram 
access, ever had a mammogram, up-to-date mammography, CBE, and BSE. We tested for 
differences in the outcome variables by area of residence (between-subject factor), by time from 
2001 to 2010 (survey year as repeated factor), and by whether the differences in the outcome 
variables over time differed by area of residence (interaction). 
 
Patterns of breast screening service use and behaviour across all times were extracted using latent 
class analysis, using the MPlus 5.01 software. Latent class analysis is a statistical technique that 
classifies participants into groups based on the similarity of their responses across several outcome 
variables. The entered variables included the three observed breast-screening variables (up-to-date 
mammography, CBE or BSE) over the four time-points. From these observed responses, the latent 
class analysis identified subgroups of women who responded in a similar way. The model 
parameters were class membership probabilities and class-specific probabilities of endorsement. 
Assignment of each woman to the classes was made based on a probabilistic method [143]. Good 
model fit is indicated by low likelihood statistics, low Akaike information criterion, low Bayesian 
Information Criterion, low sample size adjusted Bayesian information criterion, and low Lo-
Mendell-Rubin adjusted likelihood ratio test value with a significant p-value. From the identified 
patterns, logistic regression analyses were conducted to examine whether the patterns can be 
predicted by area of residence and the individual characteristics variables.  
 
Results 
Sample characteristics 
The distribution of the participants at baseline by area of residence was 34% urban, 41% inner 
regional, 21% outer regional, and 4% remote (see Table 10). This was similar across surveys. A 
very high prevalence of women (90%) reported that they had at least one mammogram, and the 
prevalence of an up-to-date mammogram (77%) was higher than the national average (68%) [32]. 
Consistent with the national average, CBE (71%) was also common, with lower prevalence of BSE 
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(55%). Most women were born in Australia (78%), partnered (81%), had good financial status 
(61%), and reported feeling pressured for time daily or weekly (75%). Underweight was rare (1%), 
15% had higher education, and 22% were categorised by the CESD as depressed. 
Table 10. Baseline characteristics of Australian women aged 50-55 years in 2001 
Baseline variables n % 
Area of residence 
  
 
Urban 3807 34.13% 
 
Inner regional 4539 40.70% 
 
Outer regional 2322 20.82% 
 
Remote 485 4.35% 
Breast screening 
  
 
Ever had a mammogram 10006 90.22% 
 
Mammogram in last 2 years 8584 77.40% 
 
Clinical breast examinations 7862 70.69% 
 
Breast self-examinations 6073 54.60% 
Ease of obtaining a mammogram 
  
 
Excellent or very good 7619 72.67% 
 
Good, fair, or poor 2866 27.33% 
Country of birth 
  
 
Australia 8551 77.56% 
 
Other English speaking 1486 13.48% 
 
Other 988 8.96% 
Marital status 
  
 
Partnered 9039 81.48% 
 
Not partnered 2055 18.52% 
Body mass index 
  
 
Underweight 153 1.47% 
 
Normal 4442 42.75% 
 
Overweight 3382 32.55% 
 
Obese 2413 23.22% 
Financial status 
  
 
Poor 4231 38.40% 
 
Good 6780 60.80% 
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Baseline variables n % 
Education 
  
 
Lower 5376 48.58% 
 
Middle 4057 36.66% 
 
Higher 1634 14.76% 
Felt pressured for time 
  
 
Daily or weekly 8137 74.50% 
 
Monthly or never 2789 25.50% 
Depression 
  
 
Not depressed 8347 78.38% 
 Depressed 2302 21.62% 
 
 
Cross-sectional relationships 
Ease of obtaining mammography significantly differed by area of residence at each time from 2001 
to 2010, with poorer access associated with increasing remoteness (see Table 11). However, area of 
residence did not affect whether the women had utilized mammography services. Women residing 
in rural areas were as likely to ever had a mammogram, as well as having a timely mammogram, 
then women residing in urban areas. The use of CBE was observed to be much lower in regional 
and remote areas. BSE was less common among women in urban areas. These results were 
consistent across every state. 
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Table 11. Cross-sectional prevalence of breast screening service access, use, and behaviour by 
area of residence from 2001 to 2010 
      Area of residence 
  
Urban 
Inner 
regional 
Outer 
regional 
Rural 
    n % n % n % n % 
Excellent or very good ease of obtaining a mammogram 
 
2001* 2867 80% 3175 74% 1371 63% 206 44% 
 
2004* 2877 81% 2666 71% 1155 62% 156 44% 
 
2007* 2734 79% 2617 72% 1126 62% 182 51% 
 
2010* 2548 80% 2491 72% 967 64% 116 47% 
Ever had a mammogram 
 
2001 3419 90% 4055 90% 2092 91% 440 91% 
 
2004 3536 95% 3681 95% 1845 95% 351 95% 
 
2007 3455 95% 3651 96% 1825 96% 355 97% 
 
2010 3211 96% 3497 96% 1542 96% 246 97% 
Mammogram in the last 2 years 
 
2001 2907 77% 3468 77% 1821 79% 388 80% 
 
2004 3033 81% 3196 82% 1581 81% 311 85% 
 
2007 2995 83% 3216 85% 1597 84% 307 84% 
 
2010 2767 83% 3048 84% 1355 84% 220 87% 
Clinical breast examination 
 
2001* 2828 75% 3180 70% 1540 67% 314 65% 
 
2004* 2626 69% 2482 63% 1157 59% 212 57% 
 
2007* 2523 70% 2520 66% 1247 65% 212 58% 
 
2010* 2189 65% 2193 60% 925 57% 125 49% 
Breast self-examination 
 
2001* 1945 51% 2528 56% 1317 57% 283 58% 
 
2004* 1729 46% 2001 51% 1026 52% 179 48% 
 
2007* 1846 51% 2177 57% 1149 60% 204 56% 
  2010* 1722 51% 2036 56% 960 59% 135 53% 
*p < 0.001, chi-squared tests 
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Longitudinal relationships 
The generalized estimating equation results showed a significant overall effect of time, with an 
increase in the use of mammography services (p < 0.001), and a decrease in CBE (p < 0.001) over 
time. The ease of mammography access (p = 0.574) and practice of BSE (p = 0.057) did not change 
over time. There was no significant time by area of residence interactions, indicating that the 
changes in breast screening over time were consistent across the areas.  
 
The logit results showed that the effects of area of residence followed a dose-response trend. 
Compared to women in urban areas, women residing in more remote areas had lower odds of 
experiencing excellent or very good access to mammography services (inner regional OR=0. 61, 
95%CI=0.53-0.70, outer regional OR=0.43, 95%CI=0.37-0.51, remote OR=0. 27, 95%CI=0.19-
0.36; see Figure 10). In separate analyses, results showed that no significant differences in whether 
the women had ever had a mammogram were observed across area of residence. However, women 
residing in inner regional (OR=1.25, 95%CI=1.05-1.49) and remote areas (OR=1.63, 95%CI=1.02-
2.61) had slightly higher odds of having a mammogram in the last 2 years. Women residing in 
remote areas (OR=0.56, 95%CI=0.41-0.75) had much lower odds of having CBE, while women in 
inner regional (OR=1.16, 95%CI=1.05-1.46) and outer regional (OR=1.28, 95%CI=1.12-1.46) areas 
had higher odds of BSE.  
  
Chapter 5 – Breast screening patterns 
100 
 
 
Figure 10. Generalized estimating equation results showing odds ratios of breast screening 
service access, use and behaviour by area of residence (urban as referent category) from 2001 
to 2010 in Australian women. *p<0.05, ***p<0.001 
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Breast screening patterns over time 
Fit statistics of the latent class analysis were examined (see Table 12). The 6 class solution was 
selected because there was a large decrease in Akaike Information Criterion (AIC), Bayesian 
Information Criterion (BIC), and sample size adjusted Bayesian Information Criterion (SSABIC), 
with no great improvement with more classes. The estimated probabilities of women in each of the 
6 classes on the breast screening variables from 2001 to 2010 are shown in Figure 11. Classes were 
labelled according to the probability characteristics of the breast screening behaviours.  
 
Table 12. Fit statistics of latent class analysis on the three breast screening variables over four 
time-points from 2001 to 2010 (N = 11153) 
Classes Likelihood df AIC BIC SSABIC LRT p 
2 -70064.34 25 140178.68 140364.07 140284.63 13125.37 < .001 
3 -66355.34 38 132786.68 133068.48 132947.72 7357.89 <.001 
4 -65023.01 51 130148.01 130526.22 130364.15 2643.07 <.001 
5 -63937.72 64 128003.44 128478.06 128274.68 2152.98 <.001 
6 -63336.23 77 126826.46 127397.49 127152.79 1193.23 <.001 
7 -63102.17 90 126384.34 127051.77 126765.76 464.33 <.001 
8 -62956.25 103 126118.49 126882.33 126555.00 289.48 0.017 
9 -62838.82 116 125909.64 126769.88 126401.24 232.95 0.008 
10 -62735.54 129 125729.08 126685.73 126275.78 204.88 <.001 
LRT, Lo–Mendell–Rubin adjusted likelihood ratio test value, AIC, Akaike information 
criterion, BIC, Bayesian Information Criterion, SSABIC, sample size adjusted Bayesian 
information criterion. The three breast screening variables were mammography service 
use in the past 2 years, clinical breast examinations, and breast self-examinations. 
 
 
Latent class 1 (BSE only screeners) was characterized by a low probability of mammography 
service use, a low to moderate probability of CBE, and a high probability of BSE. Latent class 2 
(non-screeners) was characterized by a low probability of all three breast screening variables. Latent 
class 3 (mammogram only screeners) was characterized by a high probability of mammography 
service use, but low probability of CBE and BSE. Latent class 4 (mammogram and CBE screeners) 
was characterized by a high probability of mammography service use and CBE, but low probability 
of BSE. Latent class 5 (mammogram and BSE screeners) was characterized by a high probability of 
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mammography and BSE, but low probability of CBE. Lastly, latent class 6 (all methods screeners) 
was characterized by a high probability of all three breast screening variables.  
 
As shown in Figure 11, the probabilities of breast screening across time were relatively stable in 
each of the groups. For example, in latent class 6, all methods screeners, the probability of 
mammography service use were above .80 across all four time-points of 2001, 2004, 2007, and 
2010. The approximately flat line across time within each breast screening variable indicated that 
the women were likely to be consistent with the same variable over time. All methods screeners 
were most common (30%), followed by mammogram and CBE screeners (25%), mammogram only 
screeners (15%), and mammogram and BSE screeners (14%). There were low proportions of BSE 
only screeners (9%), and non-screeners were the least common (7%).  
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Figure 11. Pattern plot from the latent class analysis results showing the six breast screening 
service use and behaviour patterns overtime from 2001-2010 in Australian women 
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Individual characteristics associated with breast screening patterns 
Logistic regression results showed that compared to non-screeners, BSE only screeners were more 
likely to be obese and not depressed (see Table 13). Mammogram only screeners were characterized 
by residing in outer regional areas, having better mammogram access, not born in a non-English 
speaking country, and being partnered. The mammogram and CBE screeners were characterized by 
better mammogram access, not born in a non-English speaking country, being partnered, not having 
poor financial status, feeling less pressured for time, and not being depressed. The mammogram and 
BSE screeners were characterized by residing in regional and remote areas, having better 
mammogram access, being partnered, not underweight but obese, not having poor financial status, 
having lower or middle education, and not being depressed. Lastly, the all methods screeners were 
characterized by having better mammogram access, not being born in a non-English speaking 
country, being partnered, not having poor financial status, having a lower or middle level of 
education, and not being depressed. 
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Table 13. Characteristic profiles of breast screening patterns from 2001 to 2010 by area of residence and baseline individual characteristics 
(class 2: non-screeners as referent category) 
    
BSE only 
screeners 
Mammogram only 
screeners 
Mammogram and 
CBE screeners 
Mammogram and 
BSE screeners 
All methods 
screeners 
Baseline variables OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
Area of residence                     
 
Urban  1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
 
Inner regional 1.18 (0.89-1.56) 1.19 (0.92-1.54) 0.95 (0.74-1.20) 1.79 (1.37-2.32) 1.20 (0.95-1.53) 
 
Outer regional 1.13 (0.80-1.61) 1.46 (1.06-2.01) 1.02 (0.75-1.37) 2.23 (1.62-3.07) 1.30 (0.96-1.75) 
 
Remote 1.07 (0.56-2.06) 1.60 (0.88-2.89) 1.07 (0.60-1.89) 2.95 (1.65-5.29) 1.57 (0.89-2.74) 
Ease of obtaining a mammogram 
          
 
Excellent or very good 0.85 (0.66-1.10) 1.64 (1.29-2.07) 2.05 (1.64-2.56) 2.47 (1.94-3.14) 2.39 (1.92-2.99) 
 
Good, fair, or poor 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 Country of birth 
          
 
Australia 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
 
Other English speaking 1.16 (0.81-1.66) 1.08 (0.78-1.50) 1.05 (0.77-1.44) 0.93 (0.66-1.31) 0.98 (0.71-1.34) 
 
Other 0.80 (0.55-1.18) 0.55 (0.38-0.79) 0.54 (0.39-0.75) 0.79 (0.55-1.12) 0.65 (0.47-0.90) 
Marital status 
          
 
Partnered 1.05 (0.79-1.39) 1.42 (1.09-1.85) 1.43 (1.12-1.82) 1.64 (1.25-2.15) 1.71 (1.33-2.19) 
 
Not partnered 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
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BSE only 
screeners 
Mammogram only 
screeners 
Mammogram and 
CBE screeners 
Mammogram and 
BSE screeners 
All methods 
screeners 
Baseline variables OR 95%CI OR 95%CI OR 95%CI OR 95%CI OR 95%CI 
Body mass index 
 
Underweight 1.35 (0.61-3.01) 0.86 (0.39-1.89) 0.66 (0.31-1.37) 0.31 (0.11-0.87) 0.74 (0.35-1.55) 
 
Normal 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
 
Overweight 1.06 (0.79-1.41) 1.08 (0.83-1.40) 0.99 (0.77-1.26) 1.22 (0.94-1.59) 1.19 (0.93-1.51) 
 
Obese 1.42 (1.04-1.93) 1.16 (0.87-1.55) 0.83 (0.63-1.09) 1.53 (1.15-2.04) 1.10 (0.84-1.44) 
Financial status 
          
 
Poor 0.84 (0.65-1.09) 0.83 (0.66-1.05) 0.73 (0.58-0.91) 0.74 (0.59-0.94) 0.72 (0.58-0.90) 
 
Good 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 Education 
          
 
Lower 1.44 (1.00-2.08) 1.19 (0.86-1.65) 0.87 (0.64-1.17) 2.16 (1.54-3.02) 1.86 (1.37-2.54) 
 
Middle 1.31 (0.91-1.88) 1.07 (0.78-1.48) 0.86 (0.64-1.16) 1.41 (1.01-1.98) 1.59 (1.17-2.16) 
 
Higher 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 Felt pressured for time 
          
 
Daily or weekly 1.00 
 
1.00 
 
1.00 
 
1.00 
 
1.00 
 
 
Monthly or never 1.10 (0.83-1.45) 1.28 (0.99-1.65) 1.30 (1.02-1.65) 1.16 (0.90-1.50) 1.25 (0.99-1.59) 
Depression 
          
 
Not depressed 1.52 (1.15-2.02) 1.17 (0.91-1.50) 1.34 (1.06-1.70) 1.71 (1.31-2.22) 1.77 (1.39-2.26) 
 Depressed 1.00   1.00   1.00   1.00   1.00   
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Discussion 
This is the first study to examine how women use the different breast screening methods in 
combination. Our findings are interesting because we have found that the women were likely to use 
a combination of breast screening methods, rather than just one method. The results of our analyses 
indicate that although Australian women living in more remote areas reported poorer access to 
mammograms, they were as likely to obtain mammograms as the women living in urban areas. 
However the women living in more remote areas were less likely to have mammograms in 
combination with CBE. A possible explanation is that in Australia, the national cost-free 
mammogram screening mobile services are delivered to rural areas. However, no such services are 
delivered for the purpose of CBE, which generally requires access to physicians or nurses through 
general medical practices. These services are less available in rural than in urban areas in Australia, 
which contributes to the healthcare disparities by area of residence [144]. As these women had 
higher rates of BSE, it is possible that lower access to CBE in rural areas results in higher practice 
of BSE. Another key finding of the current study is that generally both the breast screening patterns 
and the rural and urban differences were consistent over time.  
 
Our findings suggest that the increased death rates of rural women with breast cancer may not be 
due to lack of mammography services. It is the first study to investigate rural and urban differences 
in breast screening including all screening methods together. This is important to examine as 
women with poor access to mammography could attempt to compensate the lack of screening 
mammography by having BSE and CBE. Further, the longitudinal nature of this study is relevant 
for resource allocation decisions as findings from cross-sectional analyses may not capture the 
effects of changes in screening behaviors.  
 
Consistent with previous studies from the US, Canada, and Australia, we found that lower CBE but 
higher BSE rates among the rural population [75, 97, 103, 106, 112]. However, our findings were 
inconsistent with the majority of previous studies that found that mammography service use was 
lower among the rural population [75, 106, 110, 114, 115, 117, 118]. Though some studies found 
that rates of mammogram use did not differ by area of residence, these are in the minority [99, 116]. 
It is likely that analyses based on different times, cohorts, and countries may yield inconsistent 
results. A possible explanation is that the breast screening program in Australia was effective in 
enabling equality of service use across rural and urban areas. Another possible explanation is that a 
substantial proportion of rural residents are of Aboriginal and Torres Strait Islander descent, and 
this ethnic minority group is less likely to use mammography screening services [145]. However, 
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our sample included a very low proportion of Aboriginal and Torres Strait Islander women (<1%). 
Therefore, our results may not have captured the rural health service use disadvantages in this group. 
 
A finding of interest is that women born in non-English speaking countries were less likely to 
conduct breast screening activities. This category included women who were born in a broad range 
of non-English speaking countries, including Europe, Asia, or other countries. Unfortunately, due to 
insufficient sample size, we were not able to split the women from non-English speaking countries 
into further subgroups for analysis. It is likely that breast screening patterns as well as breast 
screening attitudes differ across cultural backgrounds and ethnic groups [146]. However, we did not 
have information on the women’s attitudes towards breast screening. Given that these women were 
living in Australia, and have the same eligibility to access breast screening programs and services as 
those women who were born in Australia, our results imply that the differences in breast screening 
by country of birth is likely to be due to cultural differences rather than the availability of breast 
screening programs.  
 
A strength of the study is that a valid and standard classification of remoteness to define area of 
residence was used. Further, a description of the classification has been provided to enable our 
findings to be compared with other studies. Our study also has the merit of using data from a large 
population-based longitudinal study, enabling sufficient sample size to allow for comparisons 
across different levels of remoteness with adequate power (>.80). In addition, we were able to 
include in the analyses a range of relevant variables that were available in the dataset.  
 
Our study has several limitations. The current sample included a very low proportion of Indigenous 
Australians, [87], therefore our results may not have captured the disparities in mammography 
service use in the rural Indigenous population. The study relied on self-report data, and it is possible 
that the women may be over-reporting their mammogram service use [147]. However, there is no 
evidence that this self-report bias differs by area of residence. Thus, it is unlikely to confound our 
key findings on the comparison of rural-urban differences in mammography service use. Another 
limitation is that in Australia, mammography service is managed and delivered by each state 
independently. Hence, the provision of these services may differ between states. However, we have 
conducted sensitivity analysis stratified by state, which showed consistent results, enabling 
generalizability. Our data were limited in that we were not able to examine follow-up and 
management of breast screening findings.  
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There are recent criticisms of mammograms, stating they result in both over-diagnosis and over-
treatment [148-150]. Over-diagnosis of breast cancer has a high social cost, including costs to the 
public health system, as well as individual financial costs and psychological distress. This is 
especially likely to impact women residing in rural areas who bear the increased travel and 
accommodation costs as well as stress of leaving the home and the family [36]. However, 
mammography is the still the best population screening tool for early detection of breast cancer [3, 
31, 151-153]. 
 
In conclusion, the majority of women were having mammograms in combination with CBE and/or 
BSE, and this behavior was consistent over time. Australian women living in more rural areas are 
not disadvantaged in mammography service use. Therefore, the breast cancer survival disadvantage 
in the rural population may be unlikely to be explained by differences in the use of these screening 
services. Further research is required to examine other factors that can explain the breast cancer 
mortality discrepancies. 
 
Although we found that rural women were disadvantaged in obtaining CBE, there is currently no 
evidence that CBE in addition to mammography is helpful in the early detection of cancer or to 
improve survival [154]. It is therefore unlikely that the rural disadvantage in CBE can explain the 
higher breast cancer mortality rate among the rural population in Australia. Further, our finding that 
about 70% of women conducting mammograms were also doing CBE and/or BSE suggest that the 
majority of women may be having unnecessary additional breast screening. Our results suggest that 
the women were not using CBE and BSE to compensate for poor mammography access; rather they 
were conducting CBE and BSE in addition to mammography. The promotion of CBE and BSE in 
women who were already accessing mammogram could be de-emphasized to reduce health care and 
health promotion costs. Such resources redistributed to the improvement of treatments may 
potentially help in improving the survival rate of breast cancer.  
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5.3. Chapter summary 
This chapter aimed to examine the long-term breast screening patterns of women residing in rural 
and urban Australia using data from 2001 to 2010 drawn from the Australian Longitudinal Study on 
Women’s Health. This original research is the first epidemiological study on rural and urban 
differences in breast screening patterns that employed a longitudinal design, and takes into 
consideration the combined use of mammography, clinical breast examination (CBE), and breast 
self-examination (BSE).  
 
Firstly, this study examined the long-term breast screening patterns of women in terms of their 
combined use of mammogram service use, clinical examination, and breast self-examination. 
Findings from a latent class analysis indicated that from the 84% of women who had mammograms 
in the past two years, 82% had at least one additional breast screening method. This included 36% 
who had a mammogram with CBE, 20% who had a mammogram with BSE, and 43% who had a 
mammogram with both a CBE and BSE. Ten percent of women only conducted BSE. Only 7% of 
women did not use any of these breast-screening methods. The latent class analysis did not identify 
a group of women who only had CBE, indicating that the proportion of women who only had CBE 
alone is likely to be very rare. The findings from this study suggest that the majority of Australian 
women had mammography, as well as a CBE, a BSE, or both together.  
 
Secondly, this study examined whether there was a rural disadvantage in breast screening, and if so, 
had this changed over time. Generalised estimating equation results revealed a rurality effect on 
mammography access, where the ease of obtaining a mammogram was reported to be worse with 
increasing rurality. However, results support that compared to women living in urban areas, women 
who were living in rural areas were more likely to have had a mammogram in the past two years. 
Women living in rural areas were less likely to have a CBE, but more likely to have a BSE, 
compared to women living in urban areas. Findings showed that these patterns were observed 
consistently with no change from 2001 to 2010.  
 
Thirdly, the study examined the socio-demographic and individual characteristics factors that can 
affect a woman’s breast screening behaviour. In terms of urban–rural differences, compared to 
women living in urban areas, women living in rural areas were more likely to be only conducting 
mammography without CBE or BSE, or conducting mammography with BSE but not CBE. Several 
other socio-demographic and individual characteristics were observed to be associated with specific 
screening behaviours. As expected, women who were less likely to had mammography were those 
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with poorer access. In addition to access, intrinsic characteristics associated with not having a 
mammography included a non-English speaking country of birth, not partnered marital status, poor 
financial status, and depression. Findings showed that women who were obese were more likely to 
only conduct BSE. These results provide a profile of women who are unlikely to use mammography 
breast screening services. With this information, public health interventions to achieve health-care 
equality in mammography uptake can be targeted accordingly.  
 
In conclusion, findings from this chapter indicated that the majority of women were having 
mammograms in combination with CBE and/or BSE, and this behaviour was consistent over time. 
Australian women living in rural areas are as likely to use mammography services compared to 
their urban counterparts. Therefore, the higher breast cancer mortality rates observed in the rural 
population is unlikely to be explained by differences in the use of breast-screening services. If the 
rural population is no longer disadvantaged in terms of their use of breast-screening services, it 
poses a question as to whether a later stage of disease presentation in rural breast cancer patients 
remains. The next chapter examines rural and urban differences in stage of breast cancer at 
diagnosis. 
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 Study 3 – Rurality and a late stage of breast cancer diagnosis Chapter 6.
Following on from the breast screening study, the current chapter focuses on rural and urban 
differences in stage of breast cancer at diagnosis. This chapter presents a systematic review study 
examining existing international evidence on the stage of breast cancer at diagnosis between the 
rural and urban populations. This study has been published in a peer-reviewed journal (Citation 3). 
In addition, findings were disseminated through an interview. A brief introduction and conclusion 
in relation to the research questions of this chapter are included to bracket the publication. 
 
6.1. Chapter aims 
In the previous chapter, an original study drawing on data from the Australian Longitudinal Study 
on Women’s Health revealed no rural disadvantage in mammography service use. Despite not 
having lower uptake of mammography, it does not necessarily mean that the rural women with 
breast cancer would have equal stage of breast cancer at diagnosis than urban women with breast 
cancer. The reason is that after breast cancer has been identified by screening mammography, 
additional follow-up tests, such as a diagnostic mammography, biopsy, chest x-ray, CT scan, bone 
scan, or PET scan, are required to be carried out to determine the stage of the cancer based on the 
size and spread of the disease [12]. Access to health-care services is generally lacking in the rural 
population [39, 41, 155, 156]. Therefore, it is possible that these additional tests used to follow up 
any suspicious results from screening mammography are lacking in rural areas. A delay in or lack 
of these additional follow-up tests may lead to the cancer having developed into a more advanced 
stage. Thus, the focus of this chapter is rural and urban disparities in stage of breast cancer at 
diagnosis.  
 
In general, existing research on risk factors for a late stage of breast cancer focuses on urban 
populations, with little research comparing urban and rural differences. While there are a number of 
existing studies that have examined the urban–rural disparities in diagnostic stage, findings have 
been mixed. Therefore, it is apparent that there is a need to evaluate this existing evidence in a 
systematic manner in order to determine whether public health resources are required to target rural 
areas. The aim of the current systematic review and meta-analysis was to compare and to quantify 
the effects of rurality on the stage of disease at breast cancer diagnosis. The research questions of 
the current chapter are: 
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1) Are women with breast cancer residing in rural areas more likely to be diagnosed at a 
later stage than those residing in urban areas? If yes, is this observed on an international 
level or is this country specific? 
2) If there is a discrepancy of stage at breast cancer diagnosis between the rural and urban 
population, has this changed over time? 
3) What are the limitations of existing evidence on research that examined rural and urban 
comparisons on stage at breast cancer diagnosis in the Australian setting?  
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6.2. Publication 
Nguyen-Pham S, Leung J, and McLaughlin D. Disparities in breast cancer stage at diagnosis in 
urban and rural adult women: a systematic review and meta-analysis. Annals of Epidemiology. 
2014. 24 (3): p. 228-235 
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Abstract 
Purpose: Survival from breast cancer is dependent on stage at diagnosis and some evidence 
suggests that rural women are more likely than urban women to be diagnosed with advanced stage 
disease. This systematic review and meta-analysis compared stage of breast cancer at diagnosis 
between women residing in urban and rural areas.  
 
Methods: Pubmed (1951-2012), Embase (1966-2012), CINAHL (1982-2012), RURAL (1966-2012) 
and Sociological abstracts (1952-2012) were systematically searched in November 2012 for 
relevant peer reviewed studies. Studies on adult women were included if they reported quantitative 
comparisons of rural and urban differences in staging of breast cancer at diagnosis.  
 
Results: Twenty-four studies were included in the systematic review and twenty-one studies had 
sufficient information for inclusion in the meta-analysis (N = 879,660). Evidence indicated that 
patients residing in rural areas were more likely to be diagnosed with more advanced breast cancer. 
Using a random effects model, the results of the meta-analysis showed that rural breast cancer 
patients had 1.19 higher odds (95% confidence interval= 1.12-1.27) of late stage breast cancer 
compared to urban breast cancer patients.  
 
Conclusions: Evidence indicated that there are inequalities associated with area of residence in 
stage at diagnosis of breast cancer in a number of developed countries across the world. Breast 
cancer patients residing in rural areas were diagnosed with more advanced cancer. Screening 
programs made available in rural areas may help reduce this discrepancy. 
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Background 
Despite breast cancer in women being an extensively researched topic, the majority of published 
studies focus on urban populations of women, whereas those who live rurally are generally under-
represented. While the incidence of breast cancer has been observed to be lower in women residing 
in rural areas, death rates are higher in rural women who are diagnosed compared to urban women 
[157, 158]. 
 
There is evidence that women residing in rural areas are disadvantaged in access to breast screening 
[151]. Women who resided in rural areas were less likely to have received a mammogram or 
clinical breast examination than women who resided in urban areas [7, 58, 75, 96, 100, 109, 114, 
115, 117]. Breast screening facilitates the early detection of cancer. Therefore, disadvantages 
experienced by rural women in accessing mammography screening may increase their risk of being 
diagnosed at a later stage. This is problematic because breast cancers that are detected at earlier 
stages have higher rates of successful treatments. Survival rates are highly dependent on the stage of 
breast cancer at diagnosis [1], with five-year survival ranging from 15% in women diagnosed at 
stage IV breast cancer to 88% in women diagnosed at stage I breast cancer [22]. Therefore, the 
early detection of breast cancer, that is, breast cancer diagnosed at an earlier stage, is related to a 
better 5-year prognosis. Previous research using cancer registry data has reported that people living 
in rural areas are likely to have more advanced disease at diagnosis than people living in urban 
areas [159].  
 
While a number of previous studies have examined possible urban-rural disparities in diagnostic 
stage, findings have been mixed. The aim of the current systematic review and meta-analysis was to 
compare and to quantify the effects of residing in rural areas on the stage of disease at breast cancer 
diagnosis among women residing in rural and urban areas.  
 
Methods 
Search terms and databases  
We searched across Pubmed (1951-2012), Embase (1966-2012), CINAHL (1982-2012), RURAL 
(1966-2012) and Sociological abstracts (1952-2012) with the following keywords: breast cancer or 
breast neoplasms or breast tumour and rural or rural urban differences or rural populations or rural 
health or rural area and diagnosis or detection or delayed diagnosis. The databases were searched 
between 21 to 25 November 2012. In addition, secondary references were retrieved within the 
reference lists of publications that were included for review.  
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Eligibility criteria and study selection 
Studies were eligible if they were in English, included adult women, were peer reviewed original 
research articles, included quantitative comparisons, analysed rural and urban differences, and 
compared staging of breast cancer at diagnosis. Studies were removed during initial screening if 
they failed to meet any of these criteria. All returned citations across the searched databases were 
initially screened for duplicates, then for relevance by title and abstract. Following this the full text 
of the remaining citations were screened by two independent reviewers with 98% agreement. 
Disagreements were resolved by clarifying through discussion and the involvement of a third 
reviewer. Studies were included in the meta-analysis if required statistics were presented. 
 
Quality assessment 
Quality and risk of bias of each study were assessed by adapting the Newcastle-Ottawa Scale (NOS) 
for quality assessment of non-randomized studies in meta-analyses [160]. The development of the 
NOS involved panel review and critical review by experts. The NOS has strong face validity and is 
endorsed by the Cochrane Collaboration. A dichotomous scale was used to rate whether the studies 
meet the criteria. The assessment tool relates to  the selection of study groups, comparability of 
groups, and the assessment of outcomes. The study scored a 1 if they had met the criteria, and 0 if 
they had not met the criteria. The eight criteria assessed in the current systematic review included:  
1) Representativeness of the rural sample;  
2) Selection of the urban sample;  
3) Ascertainment and definition of the rural and urban assessment;  
4) Stage of disease measured at first diagnosis of breast cancer, not recurrent cancer;  
5) Study controlled for breast screening history;  
6) Study controlled for possible confounds, such as age and socio-economic factors;  
7) Clearly reported the definition of advanced stage; and  
8) Quality of the assessment used to define disease stage.  
 
The total quality scores were summed to obtain a score from 0 to 8. The summed scores were 
divided by eight to calculate a percentage score that ranged from 0% to 100%. The use of a 
percentage score enables the ease of interpretation of the quality of the studies regardless of the 
number of quality assessment items in the scale employed. Higher scores were indicative of higher 
quality. Studies that scored 60% or more are included in the current review, in accordance with 
Cochrane recommendations.  
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Data extraction and analysis 
The PRISMA guidelines were referred to in writing our report. Data collection was conducted 
independently by the reviewers. Data extraction parameters included country, sample size, age of 
the sample, year of data, data source, assessment of area of residence, assessment of outcome for 
stage at diagnosis, and conclusion of the paper. For the meta-analysis, data extracted included the 
number of patients diagnosed with an advanced stage of breast cancer in the rural and the urban 
sample out of the total number of participants in both samples. The total number of participants 
included the number of patients diagnosed with an advanced stage of breast cancer and the number 
of patients diagnosed with a not advanced stage of breast cancer. In studies that stratified rurality of 
area with more than two categories, data on the most urban and most rural area were extracted and 
analysed. Where required information was not presented in the article, the authors were contacted in 
an attempt to obtain the data. 
 
In a meta-analyses, the overall effects of rural residence on an advanced breast cancer diagnosis 
from the studies were pooled and estimated using the Cochrane Collaboration Review Manager 
software, RevMan 4.1. The Mantel-Haenszel method was employed. Heterogeneity of studies was 
assessed by calculation of the χ2 and I2 statistics. A random effects model was used if the test of 
heterogeneity was significant. Results were presented as odds ratios (OR) and 95% confidence 
intervals (CI). Sub-analyses were conducted stratified by definition of the stage at breast cancer 
diagnosis, and by only including studies of women aged 40 years or above. This is so that I can 
examine whether the results were consistent across definition of stage at breast cancer at diagnosis, 
and whether the results differ by age.  
 
Risk of publication bias across studies was assessed by examination of funnel plots. The funnel plot 
is used to check for asymmetry in the distribution results in a meta-analysis. It presents a scatter plot 
of data used in the meta-analysis. A plot that is not symmetrical, for example if all data plots are 
clustered to the left side of the plot, is indicative of publication bias.  
Results 
Study selection 
A total of 1076 studies were found across Pubmed, CINAHL, Embase, Sociological abstracts and 
RURAL databases, and three additional records were identified through other sources. 809 of these 
remained after removing duplicates. After screening the abstracts for relevance, 690 records were 
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removed. Full text screening of the remaining 119 studies were conducted by two independent 
readers using the inclusion criteria. A final 24 studies were included in the systematic review, which 
included 1,917,691 observations. 21 studies were included in the meta-analysis, which included 
960,971 observations with 879,660 urban and 81,311 rural observations (see Figure 12).  
 
Figure 12. Flowchart of study inclusion for the systematic review on rural and urban 
differences in a late stage of breast cancer at diagnosis 
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Study characteristics 
Characteristics of studies are presented in Table 14. There were 13 studies from the United States 
[77, 159, 161-171], which is over half of all included studies. There were two studies from Australia 
[172, 173], two from New Zealand [174, 175], and one study each from Canada [176], Denmark 
[78], Egypt [136], Italy [177], Norway [178], Poland [179], and South Africa [180]. Sample sizes in 
the studies ranged from 485 to 796,611, with the studies that covered larger areas having higher 
sample sizes. Patients of all ages were included in 14 of the studies [77, 136, 159, 161, 164-166, 
169, 170, 173-176, 179], which was over half of the included studies. Other age groups studied 
included 15 or over [171], 25 or over [163], 40 or over [162, 168], 55 or over [180], under 70 [78], 
19-89 [177], 30-62 [178], 30-79 [172], and 50-74 [167] years of age. Year of data analysed ranged 
from 1964-1992 to 2004-2006. There were 22 studies that included multiple years of data. One 
study collected the data using questionnaires [180], while all other studies utilized existing data 
sources such as cancer registry and census data. The funnel plot of studies included in the meta-
analysis is presented in Figure 13, which indicated publication bias for a rural effect for a late stage 
of diagnosis.  
 
 
Figure 13. Funnel plot of studies included in the meta-analysis 
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There are some variations of the definitions of breast cancer stage at diagnosis. While there are 
studies that clearly stated that they used a standard cancer staging system, such as the TNM, the 
classification of cancer stage was unclear in other studies. Some studies defined early stage as TNM 
0-I and late stage as stage II-IV [162, 170, 177], while other studies defined early stage as 0-II and 
late stage as III-IV [171, 176]. Three studies excluded breast cancer patients with stage 0 cancers 
from their analyses [136, 172, 180]. One study compared mean TNM stage in the analysis [164]. 
There was general consistency among studies for localized cancers to be categorized as early stage 
and distant/metastasis to be categorized as late stage. In five studies, cases of in situ  (stage 0) 
cancer were excluded because this was defined as a pre-cancer stage [173-175, 178, 179], while 
other studies included this as early stage breast cancer [77, 159, 161, 165-169]. For regional cancer, 
there were inconsistencies with some studies classifying this as early stage [162, 173], while other 
studies classified regional as late stage [77, 159, 161, 165-169, 174, 175, 178, 179]. One study 
defined early stage as tumour ≤20mm, corresponding to stage I of the TNM or localized cancer [78]. 
Most studies have dichotomized stage of breast cancer at diagnosis, rather than conducting analyses 
against each of the stages, to allow for sufficient sample sizes in the comparison groups, especially 
in the rural sample.  
 
There was a general lack of detail reported by the studies regarding the basis for the staging system 
used. Many referenced the TNM staging system, but failed to detail whether they used the clinical 
or pathological type [136, 164, 170-172, 176, 180]. Several studies did not mention any particular 
staging system [78, 178]. The two main types of staging are clinical staging and pathological 
staging. Clinical staging is an estimate of the stage of the cancer based on physical examines, 
imaging tests, and biopsies. Pathological staging, also known as the surgical stage, is only for if 
surgery was conducted, and it is based on the clinical staging and additional information found out 
from the surgery. The SEER summary staging system, which uses both clinical and pathologic 
information depending on what is available in medical records, was also commonly referenced.[161, 
163, 165, 168, 169, 173]. 
 
Variations were also apparent in the definition of urban or rural residence. Some studies defined 
urban and rural areas based on population size or density [170, 174, 176]. Other studies used a 
standard system of rural and urban classification, such as the Rural Urban Commuting Area Codes 
[162, 168, 171], Census classifications [159, 163, 164], and the Accessibility/Remoteness Index of 
Australia [172, 173]. One study defined urban areas as areas without food production [178]. Some 
studies did not give detailed information on the basis of their rural and urban classification [77, 78, 
169, 180].  
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The quality of all included studies ranged from 63% to 100%. The studies generally had reliable 
and objective data sources, such as cancer registries, which contributed to higher quality. A number 
of studies had reduced quality scores because they did not included control variables (such as 
mammography and socio-demographic factors) in the analysis. Other studies were assessed as 
lower quality due to the use of an unclear or non-standard classification for breast cancer stage or 
rural/urban definition. 
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Table 14. Characteristics for studies included in the systematic review of rural and urban differences in breast cancer stage at diagnosis 
Study [ref] Country Sample 
size 
Age Data years Data source Stage definition Rural-urban definition Quality 
Amey et al. 
(1997) [77] 
USA 79946 All 
ages 
1981-1989 Florida Cancer 
Data System 
Cancer Registry 
Early: in situ or local; 
Late: more advanced 
stage 
Metro or non-metro 
counties 
81 
Armstrong & 
Borman 
(1996) [174] 
NZ 20090 All 
ages 
1978-1992 National Cancer 
Registry 
Early: localized; Late: 
regional/nodal, 
metastasis 
Population >30000 as urban 63 
Baade et al. 
(2011) [172] 
Australia 19544 30-79 1997-2006 Queensland 
Cancer Registry 
Early: TNM stage I; 
Late: stage II, III, IV 
Accessibility/Remoteness 
Index of Australia 
classification 
75 
Bennett et al. 
(2007) [175] 
NZ 11340 All 
ages 
1998-2002 New Zealand 
Cancer Registry 
Early: localized disease 
with no nodal 
involvement; Late: 
regional/remote disease  
Statistics New Zealand 
classification: main urban, 
secondary urban, minor 
urban/rural 
69 
Blair et al. 
(2006) [161] 
USA 59615 All 
ages 
1988-2003 California 
Cancer Registry 
Early: SEER in 
situ/localized; Late: 
regional/distant disease 
California Rural Health 
Commission definition: 
population density ≤ 
250/mile as rural 
69 
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Study [ref] Country Sample 
size 
Age Data years Data source Stage definition Rural-urban definition Quality 
Celaya et al. 
(2010) [162] 
USA 5966 ≥40 1998-2004 New Hampshire 
State Cancer 
Registry  
Early: TNM stage 0-I, 
Late: stage II-IV  
Rural Urban Commuting 
Area (RUCA) classification 
scheme: urban, large rural, 
small rural 
100 
Clegg et al. 
(2009) [163] 
USA 2565 ≥25 1973 to 2001 Surveillance, 
Epidemiology, 
and End Results 
data (SEER) 
Early: SEER not distant 
stage; Late: distant stage 
Census rural urban 
classification 
81 
Dalton et al. 
(2006) [78] 
Denmark 28765 <70 1983-1999 Danish Breast 
Cancer 
Cooperative 
Group 
Early: tumour ≤20mm Capital areas, suburbs, 
provincial cities, rural areas 
63 
Dey et al. 
(2010) [136] 
Egypt 3673 All 
ages 
2001-2006 Gharbiah 
population-
based cancer 
registry 
Early: TNM stage I; 
Late: stage II, III, IV 
Central Agency for Public 
Mobilization and Statistics 
urban and rural coding 
69 
Elliott (2004) 
[164] 
USA 831 All 
ages 
1993-1997 Lake Superior 
Rural Cancer 
Care Project 
Records 
Mean TNM stage US Census Bureau rural 
and urban classification 
63 
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Study [ref] Country Sample 
size 
Age Data years Data source Stage definition Rural-urban definition Quality 
Friedell 
(2003) [165] 
USA 18205 All 
ages 
1995-2000 Kentucky 
Cancer Registry 
Early: SEER in 
situ/local; Late: 
regional/distant 
Beale code classification of 
counties 
75 
Hall et al. 
(2005) [166] 
USA 27989 All 
ages 
1995-1999 North Carolina 
Central Cancer 
Registry 
Early: in situ; Late: 
localized, regional, 
distant stage 
Urban Influence Code: 
metropolitan, non-
metropolitan adjacent, non-
metropolitan non-adjacent 
75 
Hausauer et 
al. (2009) 
[167] 
USA 796611 50-74 1997-2004 North American 
Association of 
Central Cancer 
Registries 
resource 
Early: in situ; Late: 
invasive according to 
International 
Classification of Disease 
for Oncology 3rd Edition  
2003 US Department of 
Agriculture: urban, 
suburban, rural 
69 
Henry et al. 
(2011) [168] 
USA 161619 ≥40 2004-2006 Arkansas, 
California, Iowa, 
Idaho, 
Kentucky, North 
Carolina, New 
Hampshire, New 
Jersey, New 
York, Oregon 
state registries 
Early: SEER in 
situ/localized; Late: 
regional/distant 
Rural Urban Commuting 
Area Codes on population 
size: urban > 50000, small 
town 10000-49000, small 
rural town <10000 
94 
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Study [ref] Country Sample 
size 
Age Data years Data source Stage definition Rural-urban definition Quality 
Higginbotham 
et al. (2001) 
[169] 
USA 1135 All 
ages 
1978-1985 Georgia Center 
for Cancer 
Statistics 
Early: in situ/localized; 
Late: regional 
Unclear 69 
Hoffman et al. 
(2001) [180] 
South Africa 485 ≤55 1994-1997 Questionnaire Early: TNM stage I/II; 
Late: stage III-IV 
Unclear 63 
Howe et al. 
(1992) [170] 
USA 717 All 
ages 
1986-1987 Illinois State 
Cancer Registry 
Early: TNM stage 0-I; 
Late: stage II-IV 
Population density 
<100/mile as rural 
75 
Krzyzak et al. 
(2010) [179] 
Poland 696 All 
ages 
2001-2002 Cancer Registry Early: localized; Late: 
regional/metastatic 
according to European 
Network of Cancer 
Registries classification 
National Official register of 
Territorial Division of the 
Country rural urban 
classification 
69 
Liff et al. 
(1991) [159] 
USA 1302 All 
ages 
1996 Mississippi State 
Department of 
Health Central 
Cancer Registry 
Early: in situ/localized; 
Late: regional 
US Census Bureau rural 
and urban classification 
69 
Markossian & 
Hines (2012) 
[171] 
USA 23500 ≥15 1992-2007  Atlanta & Rural 
Georgia Cancer 
Registries 
Early: TNM stage 0-II; 
Late: stage III-IV 
Rural Urban Commuting 
Area Codes 
75 
Montella et al. 
(1995) [177] 
Italy 976 19-89 1991-1993 National Cancer 
Institute (Italy) 
hospital tumor 
Early: TNM stage 0-I; 
Late: stage II-IV 
Italian Central Institute of 
Statistics classification of 
urban and rural 
63 
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Study [ref] Country Sample 
size 
Age Data years Data source Stage definition Rural-urban definition Quality 
registry 
Olson et al. 
(2012) [176] 
Canada 2869 All 
ages 
2002 BC Cancer 
Registry 
Early: TNM stage 0-II; 
Late: stage III-IV 
Population size, urban was 
if 95% residents live in 
community >100000, rural 
was if >50% residents live 
in community <10 000 
63 
Robsahm & 
Tretli (2005) 
[178] 
Norway 589521 30-62 1964-1992 Cancer registry 
of Norway 
Early: localized; Late: 
regional/ distant 
Urban was without food 
production area in 1968 
63 
Tracey et al. 
(2008) [173] 
Australia 59731 All 
ages 
1980-2003 New South 
Wales Central 
Cancer Registry 
Early: SEER local; Late: 
distant 
Accessibility/Remoteness 
Index of Australia 
75 
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Systematic review 
Of the 24 included studies, 16 reported later stage at diagnosis in rural breast cancer patients [77, 78, 
136, 159, 164-167, 169, 170, 172, 173, 176, 177, 179, 180], and eight studies found no rural and 
urban differences [161, 162, 168, 171, 174, 175, 178] (see Table 15). The differences in findings 
were not due to the breast cancer staging definition, sample sizes, whether the analyses controlled 
for confounding variables, year of data, or the age of the included sample, as no clear patterns were 
observed across these factors. Both studies from New Zealand and the study from Norway found no 
rural and urban differences [174, 175, 178]. On the other hand, both studies from Australia [172, 
173], and the studies from Egypt [136], Italy [177], Canada [176], Poland [179], South Africa [180], 
and Denmark [180] found that rural patients were more likely to be diagnosed at a later stage. 
Discrepancies in findings were observed in the United States studies with five showing no 
differences [161-163, 168, 171], and eight studies reporting that rural patients were diagnosed later 
[77, 159, 164-167, 169, 170].  
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Table 15. Study findings of rural and urban differences in breast cancer stage at diagnosis 
Study [ref] Control variables Rural vs Urban findings 
Amey et al. (1997) [77] Age, marital status, race, 
smoking, poverty, 
education, medical 
personnel/population, labor 
force employment 
Rural black diagnosed later 
Armstrong & Borman 
(1996) [174] 
- No rural/urban differences 
Baade et al. (2011) [172] Age, marital status, area 
level socio-economic 
status, year of diagnosis, 
indigenous status, 
occupation 
Rural more likely to be 
advanced 
Bennett et al. (2007) [175] - No rural/urban differences 
Blair et al. (2006) [161] - No rural/urban differences 
Celaya et al. (2010) [162] - No rural/urban differences 
Clegg et al. (2009) [163] Age, year of diagnosis, 
registry 
No rural/urban differences 
Dalton et al. (2006) [78] Mammography screening, 
age, education, occupation, 
income, living 
arrangements 
Rural more likely to have 
advanced breast cancer 
Dey et al. (2010) [136] - Rural higher proportion of 
later stage 
Elliott (2004) [164] Age, oncology consultation Rural higher mean stage 
Friedell (2003) [165] Age  Rural had higher ratio of late 
stage 
Hall et al. (2005) [166] Age, race Rural higher proportion of 
invasive 
Hausauer et al. (2009) 
[167] 
- Rural higher proportion of 
invasive 
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Study [ref] Control variables Rural vs Urban findings 
Henry et al. (2011) [168] Age, race, poverty, 
insurance, driving time to 
diagnosis facility, driving 
time to mammography 
No rural/urban differences 
Higginbotham et al. 
(2001) [169] 
- Rural more likely to be 
advanced 
Hoffman et al. (2001) 
[180] 
Age, race (no whites), 
educational, medical aid 
membership, place of 
residence, family history, 
breast self-examination 
Rural more likely to be 
advanced 
Howe et al. (1992) [170] Race Rural more likely to be 
advanced 
Krzyzak et al. (2010) 
[179] 
- Rural more likely to be 
advanced 
Liff et al. (1991) [159] - Rural higher proportion of 
later stage 
Markossian & Hines 
(2012) [171] 
Age, race, county No rural/urban differences 
Montella et al. (1995) 
[177] 
Education Rural higher proportion of 
later stage 
Olson et al. (2012) [176] - Rural more likely to be 
advanced 
Robsahm & Tretli (2005) 
[178] 
- No rural/urban differences 
Tracey et al. (2008) [173] - Rural higher proportion of 
later stage 
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Meta-analysis  
Data were available from 21 studies with 81,311 rural and 879,600 urban observations for the meta-
analysis comparing late breast cancer stage between the rural and urban population (see Figure 14). 
The studies were heterogeneous (Tau
2 = 0.01, χ2 (20) = 141.95, p <0.001, I2 = 86%), indicating that 
a random effects model was appropriate. Pooled effects results showed that the rural population had 
significantly higher odds of having a late stage of breast cancer at diagnosis when compared to the 
urban population, (odds ratio (OR) = 1.19, 95%confidence interval (CI) = 1.12-1.27).  
Figure 14. Meta-analysis results: studies comparing the odds of having a more advanced stage 
at diagnosis in rural breast cancer patients compared to urban patients 
 
Due to the variations in the definition of a late stage breast cancer, sensitivity analyses were 
conducted by including studies with matching stage definition methods. We analyzed the eight 
studies that classified late stage as regional or distant. These studies were less heterogeneous (Tau
2 
<0.01, χ2 (7) = 16.25, p = 0.02, I2 = 57%), however pooled effects results showed that the rural 
patients had 1.07 higher odds (95%CI = 1.04-1.10) of being diagnosed with regional or distant 
breast cancer compared to the urban patients. Consistent results were found in the analysis of the 
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five studies that classified late stage as TNM II-IV, which showed a low level of heterogeneity 
(Tau
2 = 0.01, χ2 (4) = 5.80, p = 0.21, I2 = 31%). The effect was slightly stronger in these studies, 
with rural patients having 1.17 higher odds (95%CI = 1.07-1.28) of being diagnosed with TNM 
stage II-IV. Sensitivity meta-analysis on studies that sampled women aged 40 or over was not 
possible because this included only two studies. However, age did not appear to affect the results 
based on the findings of the systematic review.  
 
Discussion 
Overall, this review suggests that rural breast cancer patients are diagnosed at a later stage of 
disease than their urban counterparts, in particular the effect size was weak when late stage was 
defined ‘regional’ or ‘distant’ stage, and the effect size was slightly stronger when late stage was 
defined as TNM II-IV. The systematic review identified 16 of 24 studies in which rural patients had 
a later stage at diagnosis than urban patients. The results of the meta-analysis provide further 
evidence of a rural disadvantage, which remained even when further sensitivity analyses were 
conducted in sub-samples with matching definitions of breast cancer stage. However, it should be 
noted that differences across geographic locations were observed and reported.  
 
The current review is the only known systematic review and meta-analysis investigating rural-urban 
differences in stage at diagnosis for breast cancer. Breast cancer is the most prevalent cancer in 
women and it is one of the few cancers for which population screening technologies are available
 
[171]
. Most of the countries represented in this review have a national-level program for two-yearly 
breast cancer screening, with about half recommending screening commence at 40 or 45 years and 
the remainder recommending that screening start at age 50 [181]. Mammography is likely to detect 
early stage tumours and the differences in diagnostic stage between women living in rural and urban 
areas have been attributed to the lower take-up of screening services among rural women
 
[75, 106]. 
Our results indicate that rural women are diagnosed with later stage breast cancer and this may be 
reflective of difficulty accessing cancer screening services in rural areas. However, it may also 
indicate decreased awareness of the importance of regular breast screening or the significance of 
attending to early symptoms. 
 
There are a number of limitations that should be considered when interpreting the findings of this 
paper. Our search strategy was limited to English language publications thus we may have 
overlooked studies which were indexed in other languages, or which appeared in electronic 
databases that were not accessed. However, this thesis is based in an Australian setting; therefore 
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non-English literature is likely to be irrelevant to the thesis. That is, excluding non-English 
language publications is unlikely to bias the results in the context of the thesis. The possibility of 
publication bias needs to be considered because studies which have null results tend not to be 
published. This may have resulted in an overestimation of the association between stage at 
diagnosis and area of residence. Quality of the studies may also affect the results. However, we 
found no patterns of results according to the quality of the studies, and we have excluded studies 
that were of poorer quality. Therefore, our observed results are unlikely to be biased due to the 
quality of the studies. There was a large variation in the definition of rurality and urbanity across 
different studies, which may also impact on the comparability of findings among studies. This 
variability in definitions is common in studies which examine rural variations across a number of 
health conditions and many studies rely on a simple rural-urban dichotomy that may conceal 
variations in health across rural areas [182]. However, the consistency of the findings suggests that 
the results were unlikely to be affected by differences in rural-urban definitions. As the control 
variables used in the multivariate analyses of the included studies differed, we were unable to 
conduct a meta-analysis using matching adjusted estimates across studies. Nevertheless, where 
control variables were present, we were able to review these results in the systematic review to 
draw conclusions. Studies from the United States represented 13 of the 24 studies reviewed and the 
remaining studies were drawn from Australia (2 studies), New Zealand (2), Denmark (1), Canada 
(1), South Africa (1), Egypt (1), Italy (1), Norway (1) and Poland (1) and this limits the 
generalizability of our conclusions. This is because rural-urban differences could be largely affected 
by the policy setting as well as the geographical construct of a particular location. Therefore, 
findings of rural and urban differences in breast cancer stage may differ across different states or 
areas within each country. Hence, generalization of overall findings from one place onto other 
countries or geographic locations is not recommended. There are a number of other factors which 
may modify the association between area of residence and stage at diagnosis, such as demographic 
and cultural variables. The incidence of early diagnosis of breast cancer, that is breast cancer 
diagnosed at an early stage, is generally higher in more developed countries than those which are 
less developed [3]. This may reflect the better access of early detection interventions in the 
developed countries. Or this may reflect the cultural differences in attitudes towards breast 
screening. Cultural variations may influence public awareness of breast cancer and the availability 
of screening services and appropriate treatment.  
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Conclusion 
In conclusion, evidence indicated that there are inequalities associated with area of residence in 
stage at diagnosis of breast cancer in a number of developed countries across the world. Breast 
cancer patients residing in rural areas were diagnosed with more advanced cancer. This may be 
related to rural disadvantage in accessing breast screening services. Early detection of breast cancer 
enables better response to treatment and interventions which are more likely to ensure a higher 
survival rate. Ensuring the access of breast screening programs in rural areas, may help reduce the 
rural-urban health discrepancy. Rural healthcare providers should be encouraged to 
opportunistically discuss breast cancer screening when seeing eligible female patients.  
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6.3. Chapter summary 
This chapter aimed to review existing literature on the stage of breast cancer at diagnosis between 
the rural and urban populations. A systematic review and meta-analysis study was conducted to 
address the research questions of this chapter. Firstly, this study examined whether there is a rural 
disadvantage in stage at breast cancer diagnosis, and if yes whether this is observed on an 
international level. The findings indicated that there was a rural disadvantage in stage at breast 
cancer diagnosis, with women from rural areas more likely to be diagnosed with a later stage of 
breast cancer than women from urban areas. While a later stage of breast cancer at diagnosis in the 
rural population was consistently observed across a number of studies internationally, over half of 
the studies were from the United States. It was apparent that epidemiological research comparing 
urban and rural differences in countries outside of the United States is lacking.  
 
Secondly, this study examined if a discrepancy of stage at breast cancer diagnosis between the rural 
and urban populations changed over time. Findings suggested that the rural and urban difference in 
stage at diagnosis has not changed over time, with studies showing consistent results after 
stratifying the findings by year of data examined. The later presentation of breast cancer in women 
living in rural areas remains an unresolved public health issue.  
 
Thirdly, this study examined limitations of existing research on rural and urban comparisons on 
stage at breast cancer diagnosis in Australia. The systematic review study revealed that there are 
two existing Australian studies that compared the rural–urban discrepancy in a late stage of breast 
cancer diagnosis. However, unanswered questions on the cause of the rural disadvantage in breast 
cancer stage at diagnosis remained. Firstly, the studies were state-specific, therefore further research 
using a nation-wide data source can help strengthen the evidence-base and potentially establish this 
rural disadvantage as an Australian-wide public health issue. More importantly, due to the absence 
of individual risk factors in the dataset used in the studies, it is unclear whether the rural 
disadvantage in stage of breast cancer diagnosis is caused by rurality of residence alone, or whether 
there are individual risk factors that are responsible. 
 
The current chapter showed that a rural disadvantage in a late presentation of breast cancer has been 
observed in several developed countries around the world. While the rural population presented 
breast cancer at a later stage at diagnosis, it remains an unresolved issue as to how much of this 
rural–urban disparity can be attributed to rurality of residence or individual risk factors. To answer 
these research questions, a data linkage study is needed to draw together information on the patients’ 
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area of residence, individual risk factors, and cancer characteristics. The next chapter compares 
rural and urban differences in the stage at breast cancer diagnosis using the ALSWH data linked 
with cancer registry data.  
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 Study 4 – Advanced breast cancer in rural and urban Australia  Chapter 7.
This chapter presents a research study examining the risk factors of women presenting with an 
advanced stage of breast cancer at diagnosis in rural and urban Australia. This is a data linkage 
study using data from 1996 to 2010 drawn from the Australian Longitudinal Study on Women’s 
Health with linked cancer registry data. This study is under review in a peer-reviewed journal 
(Citation 4). In addition, findings were disseminated through a conference presentation, and an 
article published in a rural health magazine.  
 
7.1. Chapter aims 
As previously identified in Chapter 2, breast cancer outcomes are highly dependent on early 
detection [1], with five-year survival ranging from 88% in women diagnosed at the earliest stage, to 
15% in women diagnosed at the latest stage [22]. Findings from the previous chapter indicated that 
breast cancer patients living in rural areas present at a later stage. However, epidemiological 
research is lacking to examine potential causal factors for this discrepancy. 
 
In a recent Australian study that used cross-sectional Queensland cancer registry data between 1997 
and 2006, it was found that having advanced breast cancer at diagnosis was associated with living 
in more rural areas, after adjusting for individual level variables including age, year of diagnosis, 
indigenous status, occupation, and marital status [172]. This was the first Australian study to show 
that women living in rural areas were more likely to be diagnosed with later and more advanced 
breast cancer after adjusting for individual socio-demographic variables. However, due to the 
limited range of individual-specific variables available in the dataset, some previously identified 
individual risk factors for an advanced breast cancer at diagnosis were unexamined. Obesity, 
menopausal status, and smoking behaviour are individual factors associated with advanced breast 
cancer at diagnosis, and are more common among the rural Australian population [69, 77, 78, 183-
186]. These additional individual-level risk factors are not available in cancer registry datasets. 
Therefore, research that examines area of residence as a risk factor for a late stage of breast cancer 
at diagnosis incorporating these additional individual-level risk factors is warranted. A data linkage 
study would enable this research.  
 
The aim of this chapter was to conduct a data linkage study to examine risk factors for an advanced 
stage of breast cancer at diagnosis. The research used data from the Australian Longitudinal Study 
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on Women’s Health (ALSWH) with linked data from Australian cancer registries. The research 
questions of this chapter are: 
1) Are breast cancer patients from rural areas at higher risk of an advanced breast cancer at 
diagnosis, after adjusting for individual socio-demographic and lifestyle variables? 
2) What is the strongest predictor of an advanced stage of breast cancer at diagnosis, 
taking into consideration individual socio-economic factors, lifestyle factors, and 
rurality of residence? 
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7.2. Publication 
Leung J, Martin J, McLaughlin D. Rural-urban disparities in stage of breast cancer at diagnosis in 
Australian women. Under review in Australian Journal of Rural Health 2015. 
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Abstract 
Background: Early detection of breast cancer reduces mortality associated with the disease. This 
study aims to examine risk factors for a late stage of breast cancer at diagnosis in a population of 
Australian women residing in urban and rural areas.  
 
Methods: Data were drawn from the Australian Longitudinal Study on Women’s Health 1946-1951 
cohort (N = 13,715), linked with cancer registry data from New South Wales (New South Wales 
Cancer Registry linked by the Centre for Health Record Linkage [CHeReL]), Queensland 
(Queensland Cancer Registry), and Victoria (The Cancer Council Victoria). The sample included 
195 women identified from the linked cancer registry data with a breast cancer diagnosis.  
 
Results: A late stage of breast cancer diagnosis was observed in 36% of women residing in urban 
areas and 40% of women residing in rural areas (not statistically significant). However, we found 
that obesity was the strongest risk factor of a late stage at diagnosis, after adjusting for individual 
and socio-demographic variables including survey year, menopausal status, country of birth, 
education, marital status, and urban or rural residence.  
 
Conclusions: Obesity was associated with a higher risk of advanced stage of disease at breast 
cancer diagnosis after socio-demographic factors were considered. Given that women are becoming 
increasingly obese, this paper provides further evidence for targeting interventions for obesity as a 
public health priority.  
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Background 
Globally, breast cancer is the most common type of cancer in women [1]. At diagnosis, the stage of 
disease is described by tumor size and spread within the body. The stage of cancer at diagnosis 
highly affects the prognosis – time to relapse and overall mortality. In Australia, five-year breast 
cancer survival ranges from 55% to 90% when the cancer is 20mm or larger, compared to 89% to 
98% when the cancer is smaller than 20mm . Degree of spread also affects five-year survival, which 
ranges from 80% to 83% when the cancer has spread to the nodes, compared to 94% to 98% when 
the cancer has not spread to the nodes [54]. 
 
Previously identified risk factors for an advanced stage of breast cancer diagnosis include low 
socio-economic status, birth in a non-English speaking country, residing in rural areas, menopausal 
status, and poor lifestyle behaviors, such as smoking [163, 172, 173, 183, 187]. While population-
based cancer registries can provide objective information on key breast cancer characteristics and 
basic socio-demographic information, data on contextual variables such as lifestyle characteristics 
likely to be related to breast cancer services and uptake are not available in these datasets. 
Consequently, existing Australian-based research, which relies solely on cancer registry data, is 
limited in its ability to provide a comprehensive profile of the factors associated with an advanced 
stage at diagnosis.  
 
The linking of both cancer registry data and data drawn from population-based epidemiological 
studies can thus provide a comprehensive profile of women who are diagnosed with a late stage of 
breast cancer. The aim of the current study is to use data from the Australian Longitudinal Study on 
Women’s Health and linked data from Australian State-based cancer registries to examine risk 
factors for a late stage of breast cancer at diagnosis.  
 
Methods 
Participants  
Participants in the current study were drawn from the ALSWH 1946-1951 cohort. Diagnosis of 
breast cancer was obtained from cancer registry data from New South Wales (New South Wales 
Cancer Registry linked by the Centre for Health Record Linkage [CHeReL]), Queensland 
(Queensland Cancer Registry), and Victoria (The Cancer Council Victoria) for the period 1997 to 
2011. Participants were identified as breast cancer cases if they had an International Classification 
of Diseases (ICD-10) diagnosis of breast cancer (C50) in the cancer registry datasets. Additional 
breast cancer data (e.g. date of diagnosis, stage at diagnosis) were also drawn from cancer registry 
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datasets. To date, six surveys of the ALSWH data have been collected from this cohort (surveyed in 
1996, 1998, 2001, 2004, 2007, and 2010). The ALSWH data used in analyses were drawn from 
surveys preceding the date of diagnosis recorded in the cancer registry.  
 
The flowchart of participant inclusion is shown in Figure 15. From the 13,715 women who 
responded to survey 1 of the ALSWH, 313 women were identified from the linked cancer registry 
data as having a breast cancer diagnosis. The incidence of breast cancer was estimated to be 203.3 
per 100,000 women in this study, which is comparable to the incidence in the Australian population 
(184.3-334.9 per 100,000 women aged 45-64 years) [188]. From these identified breast cancer cases, 
women with missing or unknown stage in the cancer registry data were excluded, resulting in 272 
women with information on stage at diagnosis. Of these, 219 women (81%) had responded to the 
ALSWH surveys preceding their breast cancer diagnosis. The final sample included 195 women 
with complete data across all variables of interest (see Figure 15). Table 16 presents the 
characteristics of participants who were included or excluded. Women who smoked were less likely 
to be included, which was consistent with previous observations in the full ALSWH sample [89]. 
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Australian Longitudinal 
Study on Women’s Health 
(ALSWH) 1946-51 cohort
N = 13715
Not identified with breast 
cancer 
N = 13402 (98%)Identified with breast 
cancer in 1997-2011 in the 
NSW, QLD, and VIC 
cancer registries
N = 313 (2%)
Valid data on stage
N = 272 (87%)
Responded to ALSWH 
survey before breast 
cancer diagnosis
N = 219 (81%)
No valid data on stage
N = 41 (13%)
 Missing n = 9
 Unknown n = 32
Did not respond to ALSWH 
survey before breast 
cancer diagnosis 
N = 53 (19%)
Final sample
Complete data across 
variables of interest
N= 195 (89%)
Missing data across 
variables of interest
N = 24 (11%)
 
Figure 15. Flowchart of participant inclusion for the examination of risk factors for advanced 
stage of breast cancer 
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Measures 
Breast cancer stage at diagnosis was the outcome variable. It was defined using internationally 
recognized TNM Classification of Malignant Tumors, based on tumor size (T), lymph node 
involvement (N) and metastases (M)[22]. Breast cancer stage at diagnosis was categorized by 
defining stage I as ‘early’ (localized; tumor size 20mm or smaller without positive nodes), and stage 
II, III, or IV as ‘late’. In situ (stage 0; cancer has not formed) cases were excluded. This 
categorisation method is consistent with previously published research in order to enable 
comparison of results [172].  
 
The women provided information on their country of birth, which because of small numbers was 
categorized as ‘Australia’, ‘other English speaking countries’, and ‘non-English speaking countries’; 
highest educational qualification completed ‘school certificate’, ‘higher school, trade, certificate, or 
diploma’, and ‘university or higher’; marital status ‘partnered’ (married or living with a partner) and 
‘not partnered’ (separated, divorced, never married, or widowed). For these analyses, area of 
residence was dichotomized into ‘urban’ (major cities) and ‘rural’(inner regional Australia, outer 
regional Australia, and remote or very remote Australia), based on the Accessibility/Remoteness 
Index of Australia Plus (ARIA+) [141]. Body mass index (BMI) was calculated from self-reported 
height and weight (kg/m
2) and categorized as ‘underweight or normal’ (<25), ‘overweight’ (25 to 
<30) and ‘obese’ (≥30). Smoking status categories were ‘never’, ‘ex-smoker’, or ‘current smoker’. 
Menopausal status was categorized as ‘surgical menopause’, ‘hormone replacement therapy or oral 
contraceptive pill use (HRT or OCP)’, ‘Pre’, ‘Peri’, and ‘Post’ menopausal. Women were grouped 
into the surgical menopause category if they had a hysterectomy, bilateral oophorectomy, or both. 
From the remaining women, those whose menopause status could not be defined because of the use 
of HRT or OCP were classified separately. Then, in the remaining sample, women were classified 
as: pre-menopausal if they had menstruated in the last 3 months and reported no change in 
menstrual frequency in the last 12 months; peri-menopausal if they reported changes in menstrual 
frequency or 3-11 months of amenorrhea (absence of menses); and post-menopausal (natural) if 
they reported amenorrhea for 12 consecutive months or more. Response at earlier surveys was used 
to determine menopausal status at later surveys. Once the women were defined as post-menopausal 
or had surgical menopause, they remained in that category regardless of later HRT or OCP use.  
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Statistical analysis 
The percentages, and 95% confidence intervals (95%CI), of women with a late stage of breast 
cancer at diagnosis were estimated by country of birth, education, marital status, area of residence, 
body mass index, smoking, and menopause status. Secondly, a binary logistic regression analysis 
was conducted to estimate the adjusted odds ratio (OR) of a late stage of breast cancer at diagnosis, 
compared to an early stage as the reference category. A binary logistic regression analysis is 
appropriate because the outcome variable (stage of breast cancer) is a categorical variable with two 
groups. Explanatory variables in the adjusted model included country of birth, education, marital 
status, area of residence, BMI, smoking status, and menopause status before diagnosis. Year of 
diagnosis and year of birth were entered as control variables. All analyses were conducted using 
SPSS 18.0.  
 
Results 
Characteristics of participants pre-diagnosis are shown in Table 16. Thirty-nine percent of women 
had an advanced stage of breast cancer at diagnosis. This was lower than the 53% previously 
observed in a Queensland study on women with breast cancer aged 30-79 years [172].The majority 
of women were born in Australia and were partnered. Forty-four percent of women had a normal 
BMI, 29% were overweight, and 27% were obese. Half of the women had never smoked and over 
half of the women were post-menopausal. 
 
A late stage of breast cancer at diagnosis was more common in women who were overweight (42%) 
or obese (47%), compared to women who were normal weight (31%; see Table 17). A late stage of 
breast cancer at diagnosis was more common in the surgical menopause group (54%), and least 
common in the HRT and OCP use group (23%) and the post-menopausal group (27%). Higher 
levels of education were associated with a late stage of breast cancer at diagnosis (48% with 
university or higher education, 39% with higher school, trade, certificate, or diploma, and 34% with 
school certificate). In rural areas, 40% of women with breast cancer were diagnosed at a late stage, 
compared to 36% in women residing in urban areas, though this difference did not reach statistical 
significance. After adjusting for covariates, results of the logistic regression showed that women 
who were obese (odds ratio (OR) = 2.70, 95% confidence intervals (CI) = 1.18-6.17) and women 
who were in the surgical menopausal group (OR = 2.82, 95%CI = 1.14-6.99) had significantly 
higher odds of being diagnosed with a late stage of breast cancer.  
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Table 16. Pre-diagnosis characteristics of participants (N = 195) 
    n % 
Stage at diagnosis     
 
Not advanced 120 61.5 
 
Advanced 75 38.5 
Area of residence   
 Urban 72 36.9 
 Rural 123 63.1 
Country of birth  
  
 
Australia 142 72.8 
 
Other English speaking countries 29 14.9 
 
Non-English speaking countries 24 12.3 
Education 
  
 
School certificate 77 39.5 
 
Higher school, trade, certificate, or diploma 89 45.6 
 
University or higher 29 14.9 
Marital status 
  
 
Not partnered 43 22.1 
 
Partnered 152 77.9 
Body mass index 
  
 
Underweight or normal (<25) 85 43.6 
 
Overweight (25 to <30) 57 29.2 
 
Obese (≥30) 53 27.2 
Smoking status 
  
 
Never 98 50.3 
 
Ex-smoker 70 35.9 
 
Current 27 13.8 
Menopause status 
  
 
Surgical menopause 54 27.7 
 
HRT or OCP use 35 17.9 
 
Pre 24 12.3 
 
Peri 23 11.8 
  Post 59 30.3 
HRT or OCP: hormone replacement therapy or oral contraceptive pill 
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Table 17. Advanced stage of breast cancer diagnosis by predictor variables 
    Row percentage   
Adjusted odds of 
advanced stage 
    
Not 
advanced 
stage 
Advanced 
stage 
  OR 95%CI 
Area of residence    
  
 
Urban 63.9% 36.1%  1.00 
 
 
Rural 60.2% 39.8%  1.08 (0.53-2.23) 
Country of birth            
 
Australia 62.7% 37.3%  1.00 
 
 
Other English speaking  58.6% 41.4%  1.05 (0.42-2.67) 
 
Non-English speaking 58.3% 41.7%  1.42 (0.51-3.97) 
Education    
  
 
Lower 66.2% 33.8%  1.00 
 
 
Middle 60.7% 39.3%  1.71 (0.83-3.53) 
 
Higher 51.7% 48.3%  2.20 (0.80-6.03) 
Marital status    
  
 
Not partnered 62.8% 37.2%  1.00 
 
 
Partnered 61.2% 38.8%  1.20 (0.54-2.67) 
Body mass index    
  
 
Normal 69.4% 30.6% * 1.00 
 
 
Overweight 57.9% 42.1%  1.42 (0.65-3.11) 
 
Obese 52.8% 47.2%  2.70 (1.18-6.17) 
Smoking    
  
 
Never 59.2% 40.8%  1.00 
 
 
Ex-smoker 65.7% 34.3%  0.68 (0.33-1.39) 
 
Current 59.3% 40.7%  0.80 (0.30-2.17) 
Menopause status    
  
 
Surgical menopause 46.3% 53.7%  2.82 (1.14-6.99) 
 
HRT use 77.1% 22.9%  0.73 (0.24-2.20) 
 
Pre 54.2% 45.8%  1.86 (0.54-6.40) 
 
Peri 52.2% 47.8%  2.24 (0.71-7.11) 
  Post 72.9% 27.1%   1.00   
*p < 0.05 chi-squared test. Variables in the adjusted logistic regression model included 
date of diagnosis, year of birth, country of birth, education, marital status, area of 
residence, body mass index, smoking, and menopause status 
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From the observation that obesity was a stronger risk factor for an advanced stage of breast cancer 
at diagnosis than area of residence, post-hoc analyses were conducted to further examine how 
obesity affected stage of breast cancer at diagnosis across area of residence. Figure 16 presents the 
percentage of women with breast cancer diagnosed at an advanced stage according to their body 
mass index, stratified by area of residence in urban and rural areas. Findings indicated that women 
who were obese were at greater risk of having an advanced stage of breast cancer at diagnosis in 
both the urban and rural sample.  
 
 
Figure 16. Percentage of women living in urban and rural areas with advanced stage of breast 
cancer at diagnosis by body mass index  
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Discussion 
The current study is the first Australian study that utilizes survey data linked with cancer registry 
data to investigate factors associated with a late stage of breast cancer at diagnosis in urban and 
rural women. The findings highlight the role of obesity, rather than the commonly assumed rurality, 
as a more important contributor to advanced stage of breast cancer at diagnosis. No differences 
were found in stage of breast cancer at diagnosis by country of birth, marital status, and smoking 
status. It was observed that the percentage of breast cancer patients with an advanced stage of breast 
cancer at diagnosis was higher in rural areas compared to urban areas. However, after adjusting for 
all other predictors, the effect size, as indicated by the odds ratio, was small and the study was 
unable to detect a significant difference by rurality of residence.  
 
The findings of this study are consistent with previous studies on a predominantly urban sample that 
have observed that women who were obese were more likely to be diagnosed with an advanced 
stage of breast cancer [79-81]. Obesity has also been identified as a risk factor for breast cancer 
mortality after diagnosis [70], which suggests that breast cancer may be more aggressive in obese 
patients. While the rate of obesity is generally higher in rural areas [69], no previous studies 
comparing urban and rural differences in stages of breast cancer at diagnosis have adjusted for 
obesity [189]. The current study highlighted that obesity, which is more common in the rural 
population [69], is a more important predictor of an advanced stage of breast cancer at diagnosis 
than area of residence.  
 
Previous research has shown that prolonged use of combination HRT (estrogen and progesterone) 
increases the risk of breast cancer, as well as the risk of being diagnosed with advanced disease 
[185, 186]. Findings from the current study indicated that breast cancer patients who reported HRT 
or OCP use before breast cancer diagnosis were less likely to be diagnosed at an advanced stage of 
disease. However, the evidence was weak because the sample size of women using HRT or OCP 
was small. Also, details of HRT type, dosage and length of use were not available. In contrast, 
breast cancer patients who reported a surgical menopause were more likely to be diagnosed at an 
advanced stage of disease. There is evidence that menopause status can affect the stage of breast 
cancer at diagnosis differently for women with different body mass index [190]. It is possible 
therefore, that obesity was a confounding factor for the observed association between menopause 
status and stage at breast cancer diagnosis in this study. However, due to the small sample size, the 
interaction effects of menopausal status and body mass index on the stage of breast cancer at 
diagnosis could not be examined. 
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A surprise finding was the increased risk of a diagnosis of advanced stage breast cancer associated 
with higher levels of education, although results were not statistically significant. A lower level of 
education is generally regarded as an indicator of lower socio-economic status, which is a widely 
established risk factor for an advanced stage breast cancer [191]. However, in previous research on 
breast cancer screening behaviours in the 1946-51 ALSWH cohort, women with higher levels of 
education were less likely to have regular mammograms [128]. Further research is required to 
explain these findings and to examine the breast cancer prognosis of these educated women with 
advanced stage breast cancer.  
 
A number of limitations to this study should be considered when interpreting the results. Previous 
research has found that women with high BMI were at higher risk of an advanced stage of breast 
cancer only when the disease was self-detected [81]. The absence of information on breast 
screening and the method of diagnosis in our dataset is a limitation. However, in a previous study 
from the Australian Longitudinal Study on Women’s Health, from which the current sample was 
drawn, women with BMI in the obese range were more likely to conduct breast self-examinations 
with combination with mammography when compared to women with normal BMI [128]. 
Therefore, the relationship between obesity and a later stage of breast cancer diagnosis is unlikely to 
be explained by a lack of mammography.  
 
Another limitation of the study was that BMI was self-reported rather than objectively measured. 
Weight is likely to be under-reported, while height is likely to be over-reported, resulting in BMI 
being likely to be underestimated [192]. Therefore, in this study, some women in the overweight 
and obese range were likely to be misclassified into the normal BMI range. For these reasons, our 
reported effect of obesity on a late stage of breast cancer diagnosis is likely to be underestimated.  
Despite being the most common type of female cancer, the sample of women with breast cancer 
within the Australian Longitudinal Study on Women’s Health was small. The small sample size 
with wide confidence intervals limited the power to detect differences for some analyses. Therefore, 
results should be interpreted with caution. Nonetheless, the relationship between obesity and an 
advanced stage breast cancer at diagnosis was evident, and observed to be much stronger than the 
effects of rurality of residence. Future studies based on a larger sample size could provide 
opportunities for more sub-group analyses of interest. This would need to be achieved by focusing 
on a breast cancer sample, rather than identifying breast cancer cases from a general population 
sample.  
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Research on attrition within the ALSWH has found that non-responders were more likely to be 
women with poorer health [89]. Hence, this study is likely to have an under-representation of 
women with advanced breast cancer and effect sizes may be underestimated. Previous research has 
found that ethnic minorities are more likely to be diagnosed with an advanced stage of breast cancer 
[193]. We found no differences in stage of breast cancer at diagnosis by country of birth. However, 
our sample was derived from a mostly white Australian population. Indigenous women represent 
only about 1% of the ALSWH sample [87]. Therefore, our findings cannot be generalised to 
Indigenous Australian women living in rural areas, who are likely have higher risk of advanced 
breast cancer at diagnosis [194, 195]. That is, separate research focusing on Indigenous samples are 
required to understand the risk of advanced breast cancer in that special population.  
 
Of note are the missing data from the cancer registry datasets. Within the current study, 87% of 
cases had data on breast cancer stage, while 13% of the cases were missing stage of diagnosis or 
were marked as ‘unknown’. The range of variables available, as well as coding of variables, 
differed slightly across the cancer registries. Linked cancer registry data were sought from each 
state separately as part of a wider project to also obtain hospital administration and perinatal data 
from each state. At the time of the study, linked cancer registry data had been obtained from New 
South Wales, Victoria, and Queensland, and therefore the study used cancer registry data from these 
three states. Linked cancer registry data from Western Australia were also obtained. However, the 
linked Western Australia cancer registry data were not able to be used in this study because stage of 
breast cancer at diagnosis was not available in the dataset. As the best treatment for breast cancer 
depends on determining stage of breast cancer at diagnosis [54], the availability of high quality 
records and documentation is important for policy decisions. Further, an increased range of cancer-
related variables collected on a national level, which require initiation by the Australian Institute of 
Health and Welfare and the National Cancer Database, as well as the cooperation of the cancer 
registries of each state, may help to facilitate more consistent information collection that can enable 
improved nation-wide cancer data source for research.  
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Conclusion 
Despite an expectation that later stage at diagnosis would be associated with living in rural areas, 
we found that this was not the case in an Australian population. However, we did find that obesity 
was associated with a higher risk of advanced stage of disease at breast cancer diagnosis, which 
persisted after socio-demographic and individual risk factors were considered. Socio-demographic 
disadvantages, such as country of birth, lower education, and rural residency were not associated 
with breast cancer stage at diagnosis. Given that women are becoming increasingly obese [196], this 
work suggest there is another reason to target interventions for obesity as a public health priority.  
 
Acknowledgements 
The research on which this paper is based was conducted as part of the Australian Longitudinal 
Study on Women’s Health, the University of Newcastle and the University of Queensland. We are 
grateful to the Australian Government Department of Health and Ageing for funding and to the 
women who provided the survey data. The authors thank the NSW Ministry of Health, the NSW 
Central Cancer Registry and staff at the Centre for Health Record Linkage (CHeReL). The authors 
wish to thank the staff and the data custodians of the Queensland Cancer Registry. The authors 
thank staff at The Cancer Council Victoria. The funding source had no role in the design, conduct, 
and reporting of the study. We thank Annette Dobson for her comments on the study design, 
analysis and interpretation of data, and reporting of results. 
  
Chapter 7 – Advanced breast cancer 
153 
 
 
7.3. Chapter summary 
The aim of this chapter was to conduct a data linkage study to examine risk factors for advanced 
breast cancer at diagnosis. The current study is the first Australian study that utilises survey data 
linked with cancer registry data to investigate an advanced stage of breast cancer in a sample of 
women residing in rural and urban settings.  
 
Firstly, this study examined whether women with breast cancer who lived in rural areas were at a 
higher risk of an advanced breast cancer at diagnosis. It was observed that the percentage of breast 
cancer patients with an advanced stage of breast cancer at diagnosis was higher in rural areas 
compared to urban areas. However, after adjusting for all other predictors, the effect size was small 
and the study was unable to detect a significant difference by rurality of residence. This indicated 
that rurality of residence was not the main factor that is responsible for a late stage of breast cancer 
diagnosis.  
 
Secondly, this study aimed to identify the strongest predictor of an advanced stage of breast cancer 
at diagnosis, taking into consideration individual socio-economic factors, physical factors, clinical 
factors, and rurality of residence. The findings clearly highlight that obesity was the most important 
contributor to advanced stage of breast cancer at diagnosis in the study. In the current sample, the 
prevalence of obesity was higher in rural areas (18% obese in urban areas, compared to 32% obese 
in rural areas). Indeed, when stratified by urban or rural residence, obesity was a strong risk factor 
for an advanced stage of breast cancer at diagnosis in both the urban and rural sample. This study is 
the first study examining rural and urban differences in breast cancer stage at presentation to take 
into consideration the patients’ body mass.  
 
In conclusion, this chapter showed that obesity was associated with a higher risk of advanced stage 
of disease at breast cancer diagnosis in both the rural and urban populations, after socio-
demographic and individual physical risk factors were considered. Given that that women living in 
rural areas are more likely to be obese [69], this study provides further evidence for targeting 
interventions for reducing obesity in the rural population as a public health priority. Reducing rates 
of obesity, a modifiable individual risk factor, may be a possible method to alleviate the rural 
disadvantage in breast cancer prognosis. This chapter highlighted the role of obesity with poorer 
breast cancer outcomes in terms of a more advanced stage of disease at diagnosis. Apart from  
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considering breast cancer outcomes in terms of later stage of disease at diagnosis resulting in lower 
survival rates, health-related quality of life in survivors is also an important outcome to consider, 
especially because breast cancer has a high survival rate. The next chapter examines risk factors 
associated with poorer breast cancer outcomes in terms of health-related quality of life.  
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 Study 5 – Breast cancer, social support and quality of life Chapter 8.
This chapter presents a study examining the impact of breast cancer on women’s social support. In 
addition, the study examined how social support can affect the health-related quality of life of 
women living with breast cancer. Specifically, the study examined whether social support can act as 
a promoting factor for health-related quality of life (HRQOL) in women living with breast cancer. 
This was a secondary analysis study using data from women with breast cancer between 1998 and 
2007 identified from the Australian Longitudinal Study on Women’s Health. This study has been 
published in a peer-reviewed journal (Citation 5). In addition, findings were disseminated through a 
conference presentation. A brief introduction and conclusion in relation to the research questions of 
this chapter are included to bracket the publication.  
 
8.1. Chapter aims 
In previous chapters, risk factors for poor health service use and outcomes in breast cancer were 
considered for breast screening and stage at diagnosis, which have implications for breast cancer 
survival. As breast cancer survival rates are very high [30], health-related quality of life in breast 
cancer survivors is an important outcome for consideration.  
 
Health-related quality of life refers to the impact of health on a person’s quality of life, including 
physical, mental, emotional, and social functioning [197]. Compared to the general population, 
breast cancer survivors have reduced quality of life, especially if there were complications resulting 
from surgery [55]. Existing evidence has indicated that HRQOL in urban breast cancer survivors 
was higher than that in non-urban breast cancer survivors one year after diagnosis [55]. However, 
HRQOL before breast cancer diagnosis was not measured. In addition, the risk factors responsible 
for the poorer HRQOL among rural breast cancer patients have not yet been investigated.  
 
Having an adequate level of social support can help alleviate the negative effects of declining health 
on functioning [198]. Social support is a possible protective factor for HRQOL in women with 
breast cancer. Breast cancer patients may experience lack of social support due to their illness, 
which may be especially problematic for women living in rural areas where breast cancer may be 
stigmatised by the rural culture, as well as having to face physical isolation due to residing a greater 
distance away from formal support [36]. However, there is currently insufficient evidence regarding 
need for, and accessibility to, social support by women living in rural areas to assess whether rural 
women with breast cancer experience lower levels of social support than their urban counterparts.  
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This aim of this study is to examine the impact of a breast cancer diagnosis on social support and 
health-related quality of life over time in women living in rural and urban areas. Additionally, this 
paper will examine the role of social support as a protective factor for health-related quality of life 
in women living with breast cancer. The research questions of this chapter are: 
1) How does a breast cancer diagnosis affect a woman’s social support and HRQOL? 
2) Do breast cancer patients living in rural areas have less social support and lower 
HRQOL than breast cancer patients living in urban areas? 
3) Can social support improve HRQOL in breast cancer patients? 
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Abstract 
Objectives: A breast cancer diagnosis is a distressing event which impacts on physical and 
psychological functioning. This study examined the longitudinal relationships among a diagnosis of 
breast cancer, social support and health-related quality of life (HRQOL).  
 
Methods: Participants were 412 women from the 1946-1951 birth cohort of the Australian 
Longitudinal Study on Women’s Health who self-reported a new diagnosis of breast cancer 
between 1998 and 2007. The three surveys of longitudinal data analyzed included data three years 
before diagnosis, at diagnosis (baseline), and three years after diagnosis (follow-up). Social support 
was measured using the 19-item Medical Outcomes Study Social Support Survey; HRQOL was 
measured using the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36).  
 
Results: Compared to pre-diagnosis HRQOL, women newly diagnosed with breast cancer reported 
significantly poorer HRQOL in subscales related to pain, physical functioning and health and 
vitality. At three-year follow-up, HRQOL had improved in most domains to levels consistent with 
pre-diagnosis. Levels of social support remained stable across time. The structural equation model 
showed that social support was positively predictive of better physical and mental HRQOL at three-
year follow-up. 
 
Conclusions: Longitudinal analyses indicate that social support appears to be an important 
predictor of health related quality of life in women diagnosed with breast cancer. In particular, 
positive emotional and informational support that may normally be provided by a partner is 
important in maintaining HRQOL. Identification of those lacking social support, especially patients 
without partners, will enable them to be guided to appropriate support networks and programs.  
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Background 
Breast cancer is the most prevalent cancer among women and is one of the leading causes of death 
in women worldwide [1]. Despite this, advances in screening and diagnostic procedures mean that 
most breast cancers can be diagnosed at an early stage, leading to effective treatments and improved 
survival rates [199]. Nonetheless, a diagnosis of breast cancer is a distressing event which affects 
physical and psychological functioning and impacts on lifestyle and relationships with family and 
friends [200-202]. Breast cancer treatments, such as adjuvant therapy, lead to long-term worsened 
quality of life in breast cancer survivors [202]. Furthermore, treatment-related changes to women’s 
physical appearance may affect self-image and other effects of treatment, including fatigue, nausea 
and pain, may decrease opportunities for social interactions, and limit the ability of women with 
breast cancer to continue their normal lifestyle and social activities [203]. This in turn curtails their 
opportunities to maintain supportive social networks and to receive appropriate emotional and 
instrumental support. 
 
Social support has been identified as being protective for health and in particular for reducing 
cancer-related distress [204-206]. Studies have found that social support is associated with better 
adjustment to disease and better quality of life, however the subjective appropriateness of the 
support offered is important[207, 208]. Not all social relationships are sources of support; while 
women possess extensive and robust social networks, these can come at a price (such as 
maintaining the networks and managing expectations of providing support to others) [207, 209]. 
The stress-buffering model, a well-establish model in the social support research discipline, of 
social support focuses on the perceived availability, quality and appropriateness of support [210]. In 
particular, this model suggests that when confronted with a situation of high stress, the availability 
of appropriate levels of subjective support is more important than the number of contacts in the 
social network. Perceived social support in health-related contexts has been categorized as (a) 
emotional/informational support, (b) tangible support, (c) affectionate support, and (d) positive 
social interaction [211]. The provision of satisfactory emotional and informational support has been 
associated with better health and lower symptom intensity in women with breast cancer [212]. Both 
tangible support, in the form of a psycho-educational program, and affectionate support from family 
and friends, have been associated with better well-being and improved health-related quality of life 
(HRQOL) among breast cancer patients [213-215] 
 
While previous studies have reported that positive social support can enhance adjustment to breast 
cancer and improve HRQOL [215-217], these studies are largely cross-sectional. Little evidence has 
been presented that examines either the longitudinal impact of social support on HRQOL in women 
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with breast cancer, or changes over time in social support and HRQOL throughout the course of the 
disease. A small number of previous studies which have reported on patterns of social support 
associated with breast cancer have found that levels of social support fluctuated over time [218, 
219]. However, these studies did not have information on pre-diagnosis levels of social support and 
analyses were based on short follow-up times (up to 6 months). Given the increasing incidence and 
lower breast cancer mortality rate from breast cancer in recent years [14], a focus on factors 
associated with HRQOL, especially from a longitudinal perspective, can provide valuable insight to 
inform the development of strategies to support women during this distressing experience.  
 
The aim of this study is to examine the impact of a breast cancer diagnosis on social support and 
quality of life over time. Additionally, this paper will examine the role of social support as a 
predictor of better HRQOL in women newly diagnosed with breast cancer. Consistent with 
previously reported cross-sectional research, it is expected that women with high levels of social 
support will report higher HRQOL scores. 
Method 
Participants 
The Australian Longitudinal Study on Women’s Health (ALSWH) is a prospective study of the 
health and well-being of three cohorts of women who were aged 18-23 years (1973 to 1978 birth 
cohort), 45-50 years (1946 to1951 birth cohort) and 70-75 years (1921 to 1926 birth cohort) when 
recruited in 1996. The study sample was selected randomly from the Medicare Australia database 
(which covers all citizens and permanent residents of Australia, including refugees and immigrants), 
with intentional over-sampling of women living in rural and remote areas in order to achieve an 
adequate sample-size in this population. The project uses mailed questionnaires to collect self-
report data on health and related variables every three years. Details of the ALSWH recruitment and 
study design have been fully described elsewhere [87] and details of the study can be found at 
www.alswh.org.au. Participation is voluntary and the ALSWH is approved by the University of 
Newcastle and University of Queensland Human Research Ethics Committees.  
 
Data for these analyses are drawn from surveys 1 to 6 (1996 to 2010) of the 1946 to1951 birth 
cohort. Because of uncertainties about the accuracy of the Medicare Australia database, response 
rates to the initial invitation cannot be exactly specified. However, it has been estimated that 53%-
56% of women in this birth cohort responded with 14,072 women responding to survey 1 [86]. Of 
the total eligible women at each survey, responses to subsequent surveys were 12,338 (90.7%) at 
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survey 2 (1998), 11,226 (84.3%) at survey 3 (2001), 10,905 (84.0%) at survey 4 (2004), 10,638 
(83.8%) at survey 5 (2007) and 10,011 (83.3%) at survey 6 (2010). 
 
Participants were women who responded ‘yes’ to the following question in survey 2 (1998), survey 
4 (2004) or survey 5 (2007), “In the past three years, have you been diagnosed or treated for breast 
cancer”. These surveys (when women responded yes) were defined as the ‘baseline’ surveys in this 
study. This self-report item has been validated against Cancer Registry data with 93% sensitivity 
and 98% specificity [220]. Pre-diagnosis data were drawn from the survey immediately preceding 
the baseline (breast cancer diagnosis in past three years) survey, and follow-up data were drawn 
from the survey immediately after the baseline survey. There were 519 women who reported a new 
diagnosis of breast cancer in the past three years between 1998 and 2007: 82 in 1998, 199 in 2004 
and 238 in 2007. There were 433 women (83%) who completed the follow-up survey, in which 21 
(5%) had missing data. The final sample included 412 women newly diagnosed with breast cancer 
in the past three years who had complete data. Missing data were excluded pairwise for statistical 
analyses. 
 
Measures 
Social support was measured by the 19-item Medical Outcomes Study Social Support Survey [211], 
with a stem question that asks, “How often is each of the following kinds of support available to 
you if you need it?” Each item was answered on a 5-point scale, ranging from none of the time to 
all of the time. Scores were from 1 to 5 with higher scores indicating greater levels of social support. 
The original 4 functional support subscales included: 1) emotional/informational support (8 items); 
2) tangible support (4 items); 3) affectionate support (3 items); and 4) positive social interaction (3 
items), and an additional item [211].  
 
Emotional support is the expression of positive affect, empathic understanding, the encouragement 
of expressions of feelings (e.g. “Share your most private worries and fears with”). Informational 
support is the offering of advice, information, guidance or feedback that can provide a solution to a 
problem (e.g. “Turn to for suggestions about how to deal with a personal problem”). Positive social 
interaction is companionship or the availability of other persons to share leisure and recreational 
activities (e.g. “Have a good time with”). Affectionate support is expressions of love and affection 
(e.g. “Love and make you feel wanted”). Lastly, tangible support is the offering of material aid or 
behavioural assistance (e.g. “Take you to the doctor if you need it”).  
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Psychometric testing and scale validation in the current sample was previously conducted [221]. 
Factor analysis and parallel analysis in the current sample revealed three factors (Cronbach’s 
alphas .90 to .96), supporting the combination of the affectionate support and positive social 
interaction subscales, and the inclusion of the additional item in the emotional/informational 
support subscale [221]. Consequently, in our sample, the three subscales of social support that can 
be measured separately included mean emotional/informational support (EMI), mean affectionate 
support/positive social interaction (AFF), and mean tangible support (TAN).  
 
Health related quality of life (HRQOL) was measured using the Medical Outcomes Study 36-item 
Short-Form Health Survey (SF-36) [222]. The SF-36 assesses general physical and psychological 
health and well-being over the preceding four weeks. The survey covers eight dimensions of 
physical and mental health: physical functioning, role limitations due to physical or emotional 
problems, bodily pain, general health perceptions, vitality, social functioning and emotional well-
being or mental health. The responses to items within each dimension are summed and transformed 
to a comparable scale out of 100, to produce scores ranging from 0 to 100 with higher scores 
indicating better health.  
 
Socio-demographic characteristics examined included marital status (single/ divorced/ widowed, 
and married/cohabiting), education (no formal, high school, and trade/ certificate/ degree), country 
of birth (Australia, other English speaking countries, and non-English speaking countries), and area 
of residence (major cities, inner regional, outer regional/remote/ or very remote).  
 
Statistical analysis 
Statistical analyses were conducted using SPSS 19. The women’s social support was compared over 
time, from the survey before diagnosis of breast cancer (pre-diagnosis), to the survey at which 
breast cancer was diagnosed (baseline), and at 3 years follow-up. Repeated measures ANOVAs 
were conducted to compare levels of social support over time. Within-subject contrasts were 
conducted to compare pre-diagnosis social support with baseline social support, and baseline social 
support with social support reported at follow-up. Similarly, repeated measures ANOVAs were 
conducted to compare HRQOL over time.  
 
One-way between-subject ANOVAs were conducted to compare social support and HRQOL by 
socio-demographics (marital status, education, country of birth, and area of residence) at baseline. 
ANOVAs are appropriate because the independent variables were categorical variables, and the 
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outcome variables were continuous variables. The bi-variate associations between baseline social 
support and follow-up HRQOL were estimated using Pearson’s correlation. Pearson’s correlation is 
appropriate because both of the variables of interest were continuous variables. Partial correlation 
was used to estimate the association between social support and HRQOL adjusting for socio-
demographic characteristics found to be significantly associated with both social support and 
HRQOL. By estimating partial correlations, it was possible to provide results after considering 
potential confounds.  
 
Structural equation modelling in Amos 17 was used to model the effects of social support on both 
physical and mental HRQOL outcome in the same model. Social support and HRQOL variables 
were standardized into z-scores to facilitate comparability. Paths were entered between latent 
variables from baseline social support to physical and mental HRQOL. The observations on bodily 
pain, general health, physical functioning, and role physical were loaded onto the latent variable 
physical HRQOL. The observations on mental health, role emotional, social functioning, and 
vitality were loaded onto the latent variable mental HRQOL. The three social support subscales, 
EMI, AFF, and TAN, were loaded onto the latent variable social support. Covariance paths were 
entered between the three social support subscales. Socio-demographic characteristics were 
controlled for by entering the observed characteristics with paths to latent social support, physical, 
and mental HRQOL. A good model fit is indicated by a root mean square error of approximation 
(RMSEA) <=0.05, and normed-fit index (NFI) and comparative fit index (CFI) >0.90.  
Results 
Social support and quality of life over time 
Women newly diagnosed with breast cancer had moderately high levels of EMI, AFF, and TAN 
social support overall, indicated by a mean of 3.97-4.16 out of a 5-point scale at baseline (see Table 
18). Repeated measures ANOVA results showed that there was no change in social support pre-
diagnosis, at baseline, and after breast cancer diagnosis. 
 
Compared with pre-diagnosis HRQOL, women newly diagnosed with breast cancer had 
significantly worse quality of life on the subscales of bodily pain, general health, physical 
functioning, role physical, and vitality. However, compared to when they were newly diagnosed, at 
follow-up the women had increased scores in some domains of HRQOL. Specifically, significant 
improvements were observed in their general health, role physical, role emotional, social 
functioning, and vitality (see Table 18).  
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Table 18. Social support and health-related quality of life at pre- diagnosis, at newly diagnosed baseline, and at 3-year follow-up after breast 
cancer diagnosis 
    Before diagnosis   Baseline   Follow-up   Repeated ANOVA 
    M (95%CI) (1) M (95%CI)   M (95%CI) (2) F   
Partial 
eta-
squared 
Social support (N = 124) 
            
 
EMI 3.98 (3.80-4.16) 
 
3.97 (3.79-4.16) 
 
4.00 (3.82-4.18) 
 
0.06 
 
<.01 
 
AFF 4.20 (4.03-4.37) 
 
4.16 (3.98-4.34) 
 
4.16 (3.99-4.32) 
 
0.30 
 
<.01 
 
TAN 4.01 (3.80-4.22) 
 
4.10 (3.90-4.29) 
 
4.01 (3.81-4.22) 
 
0.66 
 
.01 
Health-related quality of 
life (N = 345)             
 
Bodily pain 68.08 (65.40-70.76) * 65.12 (62.38-67.85) 
 
67.24 (64.61-69.88) 
 
2.73 
 
.01 
 
General health 69.74 (67.42-72.06) *** 63.70 (61.21-66.18) 
 
67.22 (64.70-69.74) ** 15.84 *** .05 
 
Physical functioning 80.84 (78.70-82.98) ** 77.80 (75.49-80.11) 
 
78.48 (76.15-80.82) 
 
5.86 ** .02 
 
Role physical 73.90 (69.97-77.83) ** 65.18 (60.61-69.74) 
 
72.73 (68.61-76.84) ** 7.59 ** .02 
 
Mental health 73.42 (71.46-75.37) 
 
72.60 (70.49-74.70) 
 
74.05 (72.07-76.03) 
 
1.37 
 
<.01 
 
Role emotional 77.38 (73.49-81.28) 
 
73.80 (69.63-77.96) 
 
79.99 (76.20-83.78) ** 4.07 * .01 
 
Social functioning 79.45 (76.81-82.08) 
 
77.04 (74.15-79.93) 
 
82.14 (79.60-84.68) ** 6.07 ** .02 
  Vitality 57.89 (55.56-60.22) * 55.86 (53.30-58.41)   58.55 (56.14-60.96) * 3.44 * .01 
Repeated within-subject contrasts were (1) before diagnosis vs baseline, and (2) baseline vs follow-up; EMI, Emotional / informational support; AFF, 
affectionate / positive social interaction support; TAN, tangible support; M, mean. *p < 0.05, **p < 0.01, ***p < 0.001
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Social support by socio-demographic characteristics 
ANOVA results showed no significant difference in social support scores by area of residence (see 
Table 19). HRQOL scores were observed to be slightly higher in women living in outer regional or 
more rural areas, though results were not statistically significant.  
 
Table 19. Social support at recent diagnosis and health-related quality of life at follow-up by 
area of residence at baseline 
    
Major cities Inner regional 
Outer regional or 
more rural 
    M (95%CI) M (95%CI) M (95%CI) 
Social support (N = 412)           
 
EMI 3.98 (3.83-4.13) 3.91 (3.73-4.08) 3.89 (3.71-4.08) 
 
AFF 4.14 (3.99-4.29) 4.02 (3.85-4.19) 4.11 (3.93-4.29) 
 
TAN 3.94 (3.79-4.10) 3.99 (3.81-4.17) 3.90 (3.69-4.11) 
Health-related quality of life (N = 358) 
 
Bodily pain 68.37 (64.21-72.52) 64.08 (59.64-68.53) 69.96 (65.19-74.72) 
 
General health 67.16 (63.13-71.19) 67.52 (63.39-71.66) 67.74 (63.65-71.84) 
 
Physical 
functioning 71.87 (68.68-75.05) 74.31 (71.12-77.49) 76.52 (73.02-80.02) 
 
Role physical 78.96 (75.22-82.70) 77.76 (73.74-81.78) 79.17 (75.41-82.93) 
 
Mental health 77.24 (70.90-83.58) 79.60 (73.73-85.47) 84.85 (78.18-91.52) 
 
Role emotional 71.43 (64.63-78.23) 68.28 (61.59-74.97) 80.00 (72.81-87.19) 
 
Social 
functioning 80.50 (76.24-84.76) 80.04 (75.75-84.33) 86.39 (82.30-90.48) 
 Vitality 57.92 (53.98-61.86) 57.71 (53.79-61.63) 60.93 (56.71-65.14) 
EMI, Emotional / informational support; AFF, affectionate / positive social interaction 
support; TAN, tangible support; M, mean; no significant differences by area of residence in 
table  
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ANOVA results by socio-demographic characteristics showed that at baseline, women who were 
married/cohabiting reported higher EMI, AFF and TAN support scores and had better HRQOL 
scores (see Table 20). Therefore, marital status was included as a control variable in the analysis 
between social support and HRQOL. There were no significant differences in social support scores 
by education, country of birth.  
 
Table 20. Social support at baseline and health-related quality of life at follow-up by marital 
status at baseline 
    
Single /divorced 
/widowed 
Married/  
cohabiting p-value 
    M (95%CI) M (95%CI) 
Social support (N = 412)         
 
EMI 3.51 (3.28,3.73) 4.06 (3.96,4.16) *** 
 
AFF 3.43 (3.20,3.65) 4.28 (4.18,4.38) *** 
 
TAN 3.25 (3.01,3.49) 4.16 (4.05,4.26) *** 
Health-related quality of life (N = 358) 
   
 
Bodily pain 62.27 (56.10,68.44) 68.06 (65.22,70.91) 
 
 
General health 61.11 (55.55,66.66) 69.01 (66.36,71.66) ** 
 
Physical 
functioning 
70.38 (65.94,74.82) 74.76 (72.62,76.90) 
 
 
Role physical 72.57 (67.19,77.96) 79.91 (77.41,82.40) * 
 
Mental health 69.33 (60.00,78.66) 82.73 (78.80,86.66) ** 
 
Role emotional 62.33 (52.49,72.18) 74.73 (70.32,79.14) * 
 
Social functioning 75.17 (68.87,81.47) 83.42 (80.72,86.13) ** 
  Vitality 52.13 (46.57,57.70) 60.00 (57.44,62.56) ** 
EMI, Emotional / informational support; AFF, affectionate / positive social interaction support; 
TAN, tangible support. *p < 0.05, **p < 0.01, ***p < 0.001 for one-way ANOVA 
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Correlation between social support and quality of life 
 Unadjusted Pearson’s correlation results showed that the social support subscales were 
highly correlated (see Table 21). Therefore, the combined effects of the three social support 
subscales were examined in the multivariate analysis. Higher baseline social support scores were 
associated with higher physical and mental HRQOL scores at follow-up. This indicated that better 
social support was associated with better quality of life. The effects of EMI and AFF support 
appeared to be slightly stronger than the effect of TAN support at predicting HRQOL at follow-up. 
Partial correlation results were consistent after controlling for marital status (data not shown).  
Table 21. Correlation between social support at baseline at breast cancer diagnosis in the past 
three years and health-related quality of life at 3-year follow-up 
    Baseline social support 
    EMI AFF TAN 
Baseline social support 
   
 
EMI - 
  
 
AFF 0.85** - 
 
 
TAN 0.72** 0.71** - 
Follow-up health-related 
quality of life 
   
 
Bodily pain 0.27** 0.25** 0.18** 
 
General health 0.24** 0.23** 0.18** 
 
Physical functioning 0.20** 0.19** 0.13* 
 
Role physical 0.22** 0.23** 0.18** 
 
Mental health 0.27** 0.29** 0.21** 
 
Role emotional 0.18** 0.24** 0.19** 
 
Social functioning 0.22** 0.28** 0.18** 
 Vitality 0.25** 0.25** 0.19** 
EMI, Emotional / informational support; AFF, affectionate / positive social interaction support; 
TAN, tangible support. *p < 0.05, **p < 0.01 
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Structural equation model  
The structural equation model results showed a good model fit (RMSEA = 0.02, NFI = 0.92, CFI = 
0.93). In women with newly diagnosed breast cancer at baseline, more social support overall was 
predictive of better HRQOL, both physical and mental, at follow-up (see Figure 17). The effect was 
slightly stronger for mental HRQOL.  
 
 
Figure 17. Structural equation model of social support at baseline predicting health-related 
quality of life at 3-year follow-up. Standardized estimates for significant paths at p < 0.001 are 
presented 
 
Discussion 
Findings from this study indicate that, over time, a diagnosis of breast cancer impacted negatively 
on HRQOL, but not on perceived social support, which remained stable. The aspects of HRQOL 
that were most likely to be impaired by a breast cancer diagnosis were those that were most 
susceptible to treatment effects (bodily pain, general health, physical functioning and vitality). The 
correlational results suggested that emotional/informational support and affectionate 
support/positive social interaction, rather than tangible support, were more important in improving 
quality of life after diagnosis. Better social support at time of recent diagnosis predicted better 
physical and mental HRQOL at subsequent follow-up.  
 
A diagnosis of breast cancer, while no doubt a stressful and distressing event, did not impact on 
existing levels of social support in the women in this study over time. The women had moderately 
high levels on all three aspects of social support prior to diagnosis and there was little variation at 
the two subsequent measurement points. The stability of social support in the current analyses is 
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inconsistent with the results from previous studies which showed levels of social support which 
either decreased within six months [218] or increased in the first 12 weeks of a social support 
intervention and then decreased [219]. Neither of these studies had pre-diagnosis measures, 
however, and their measurement timeframe was relatively short. The current study is the first to 
examine the long-term effects of a breast cancer diagnosis on women’s social support and HRQOL 
employing a 6-year longitudinal design. Consistent with these results, was the stability over time of 
the women’s mental health. Prior research has shown that poor mental health is associated with 
lower levels of social support, possibly either through withdrawal from existing networks or 
resistance to approaches from within the network [206, 223]. However, the impact of diagnosis was 
clearly evident on HRQOL. The effects were strongest in those areas of quality of life functioning 
that would be most affected by treatment side-effects (pain, general health and vitality). Despite 
this, by three years post-diagnosis, the women had returned to pre-diagnosis functioning on most 
aspects of HRQOL.  
 
The positive effect of social support on HRQOL is consistent with previous cross-sectional studies 
(17-19) and with the stress-buffering model of social support (12). Our findings indicate that certain 
aspects of social support such as the provision of emotional, affectionate and informational support 
were more influential on HRQOL than the provision of instrumental support. When confronted with 
a high stress situation, such as a diagnosis of breast cancer, the stress-buffering model suggests that 
the receipt of subjectively appropriate support optimizes outcomes. For women who are managing a 
distressing diagnosis and concomitant treatment, the most appropriate subjective support may be 
emotionally focused and most likely provided by husbands or other intimate partners [217].  
 
The importance of spousal support for women with breast cancer was highlighted in our findings. 
Married or partnered women had higher levels of social support on the three measured dimensions 
and better HRQOL. This is consistent with previous research among women with breast cancer 
which has shown that spousal support is associated with improved emotional and physical well-
being and better quality of life [217]. 
 
Our findings raise a number of issues relating to the treatment and support provided to women 
diagnosed with breast cancer. Women who face diagnosis and subsequent treatment without a 
partner, or other adequate support provider, are at clear risk of impaired HRQOL. Treatments which 
focus wholly on the physical aspects of breast cancer and which exclude psychological and social 
aspects leave patients vulnerable to continuing distress. This is an important ethical issue which 
needs to be addressed when health professionals and their patients are discussing treatment options 
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and available support and counselling programs. Further, access to breast cancer support groups and 
other assistance-providing agencies may be affected by a range of factors including area of 
residence, mobility and financial constraints. Women experiencing these additional barriers may be 
doubly disadvantaged if their available social support is inadequate. 
 
There are a number of limitations in our study. Other possible variables that may be associated with 
both social support and HRQOL, such as stage of breast cancer at diagnosis and timing and efficacy 
of treatment, were not available in the dataset. We did not have a cancer-specific measure of 
HRQOL (e.g. Functional Assessment of Cancer Therapy, FACT) available in our dataset, and rather 
have used a generic instrument (SF-36) to examine HRQOL, which should be taken into 
consideration in the interpretation of our findings. Our results reflect overall effects of social 
support, rather than specific effects of social support for women with different stages of cancer and 
with varying responses to their treatments. We did not have information on the women’s subjective 
feelings about the social support they were receiving. Previous research in breast cancer patients has 
shown that unwanted support can have adverse psychological effects [224]. The women who 
provided data for this paper generally reported good mental health at the three time points and 
women with poor psychological health may be under-represented. As negative affect can result in 
poorer self-assessment and lower social support, the results may reflect this possible bias. The 
majority of participants in the current study were Australian born; as the need for social support 
after breast cancer treatment differs by cultural background [225], our results may be not be 
generalizable to women of other cultural background. However, our oversampling of women 
residing in rural areas has provided an adequate sample size in this group, so our results can be 
generalized to women with breast cancer living in both urban and rural areas of Australia.  
 
Health care support staff should enquire about the levels of social support available to women 
diagnosed with breast cancer. Although tangible support in the form of assistance with activities 
such as transportation to medical appointments is a useful and perhaps obvious form of social 
support for women diagnosed with breast cancer, our data suggest that emotional/informational 
support and affectionate/positive social interaction was as important, if not more important, to 
quality of life. Thus encouragement of activities and behaviors to promote companionship and 
quality time with those who can provide these types of support should be stressed, particularly for 
those patients who do not have partners. In this way the negative effects of a diagnosis of breast 
cancer on quality of life post-diagnosis can be ameliorated. 
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8.3. Chapter summary 
This chapter aimed to examine longitudinal changes on social support and health-related quality of 
life (HRQOL) after a diagnosis of breast cancer in women living in rural and urban Australia. 
Firstly, this study examined the effects of a breast cancer diagnosis on a woman’s social support 
and HRQOL. Findings from repeated measures analyses indicated that a diagnosis of breast cancer 
did not affect social support over a nine-year follow-up period. Levels of emotional/informational 
support, affectionate/positive social interaction support, and tangible support were consistent from 
before diagnosis, at recent diagnosis, and post-diagnosis. In addition, findings indicated that a breast 
cancer diagnosis resulted in poorer HRQOL. These findings indicated that despite the poorer health 
of women after a diagnosis of breast cancer, the disease was unlikely to lead to the loss of social 
support networks and social isolation. 
 
Secondly, this study examined the association between HRQOL and area of residence. Findings 
indicated no rural and urban differences in social support or HRQOL. After a breast cancer 
diagnosis, women who resided in rural areas received the same level of social support compared to 
their urban counterparts. In addition, HRQOL also did not differ by area of residence. These 
findings indicated that women with breast cancer living in rural areas were not disadvantaged in 
levels of social support or HRQOL. 
 
Thirdly, the study examined the effects of social support on HRQOL in breast cancer patients. 
Findings from a structural equation model revealed that women with breast cancer who received 
higher levels of social support reported better HRQOL. While any type of support were helpful in 
increasing HRQOL, social support in terms of emotional support was more important than 
instrumental support in promoting HRQOL. From this, it can be concluded that social support, 
especially emotional support, can help protect HRQOL in women with breast cancer. Of interest is 
that women who without partners were lacking social support and reported poorer HRQOL. It is 
possible that breast cancer patients without partners are at risk of poorer HRQOL due to the lack of 
partner support.  
 
In conclusion, this chapter highlighted social support as an important factor for the maintenance of 
health-related quality of life for breast cancer patients living in rural and urban areas of Australia. 
Breast cancer patients living in rural areas were not receiving less social support than breast cancer 
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patients living in urban areas. Similarly, HRQOL were consistent between breast cancer patients 
living in rural and urban areas. It was concluded that there was no rural disadvantage in the access 
of social support and consequently no rural disadvantage in HRQOL in women living with breast 
cancer post-diagnosis.
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 Thesis discussion Chapter 9.
This chapter summarises the contribution of the five studies (Chapters 4–8) to the epidemiological 
understanding of rural–urban differences in breast cancer screening, stage at diagnosis, and quality 
of life among survivors. It discusses the implications of the current research findings for health-care 
policy planning and practice, strengths and limitations of the studies, including sources of potential 
bias, and future research directions. 
 
9.1. Summary of key findings 
This thesis presented five research studies on rural and urban differences in health-service use and 
individual risk factors for breast cancer outcomes. The first study (Chapter 4) involved a systematic 
review of the literature on rural and urban differences in the use of screening-mammography 
services in adult women worldwide. The review found a rural disadvantage in the use of screening-
mammography services. It also highlighted the need for monitoring changes in health service use 
over time within the population so that long-term comparisons can be made. Such comparisons 
would allow evaluation of the effectiveness of changes in public health policy in improving health-
service access in the targeted population.  
 
The second study (Chapter 5) examined rural and urban differences in breast screening patterns 
using data drawn from the Australian Longitudinal Study on Women’s Health (ALSWH). Results 
showed that women living in urban areas were more likely to have mammography in combination 
with clinical breast examination (CBE), whereas women living in rural areas were more likely to 
have mammography in combination with breast self-examination (BSE). As CBE is usually 
obtained from general practices or private clinics, the lower CBE rates in the rural population could 
be a reflection of their poorer access to these private health-care services. Nevertheless, it was 
concluded that there was no rural disadvantage in mammography service use.  
 
The third study (Chapter 6) used a systematic review framework to evaluate evidence on rural and 
urban disparities in the stage of breast cancer at diagnosis. It was found that the rural breast cancer 
population presented with a later stage of disease at breast cancer diagnosis than their urban 
counterparts. The study identified a need for further research on rural-urban differences in stage at 
breast cancer in Australia, because existing studies were mostly based on data from the US or 
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Canada. Furthermore, existing studies did not consider potential individual-level factors that could 
be associated with both living in rural areas as well as a late stage of diagnosis. The reason is 
because individual-level factors are not readily available in cancer registry records, which these 
existing studies used for their analyses. Therefore, a data linkage study that pulls together a 
comprehensive profile of breast cancer patients with cancer registry data was needed. Such a study 
would enable research to better account for individual risk factors contributing to a late presentation 
of breast cancer.  
 
The fourth study (Chapter 7) consisted of such a data-linkage study. Data were drawn from the 
ALSWH linked with data for breast cancer cases registered in the cancer registries. The study 
compared rural and urban differences in stages of breast cancer diagnosis, and combined this with 
an examination of various individual socio-demographic and lifestyle characteristics as possible 
explanatory factors. The study found some evidence for a rural disadvantage for being diagnosed at 
a later stage than breast cancer patients in urban areas, but highlighted obesity as a stronger risk 
factor for an advanced stage at diagnosis.  
 
The fifth study (Chapter 8) examined health-related quality of life (HRQOL) in breast cancer 
survivors as a breast cancer outcome. The study investigated whether social support would be 
associated with better HRQOL in women living with breast cancer. Findings indicated no rural 
disadvantage in HRQOL in breast cancer survivors. That is, the rural breast cancer survivors did not 
have worse HRQOL than the urban breast cancer survivors. The study did however identify social 
support as a protective factor for HRQOL decline, which were observed in both the rural and urban 
breast cancer survivors. Further, findings indicated that women without partners were lacking social 
support, and they also reported poorer HRQOL. In sum, there were no rural disadvantage in 
HRQOL among breast cancer survivors, but it was found that breast cancer survivors without 
partners, regardless of whether they lived in rural or urban areas, were experiencing poor HRQOL.  
 
Overall, the thesis showed that women living in rural Australia were not lacking in mammography 
service use, or presenting at a later stage at diagnosis, compared to those living in urban Australia. 
In addition, women with breast cancer living in rural areas were also not susceptible to poorer 
HRQOL post-diagnosis than those living in urban areas. However, the higher rates of obesity in the 
rural population indicate a health inequality in the rural population that is associated with poorer 
breast cancer outcomes. This inequality needs to be addressed by evaluating public health policies 
that target these risk factors in the rural population.  
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9.2. Implications for practice and policy 
The increased death rates of rural women with breast cancer have been previously identified as a 
public health concern [7, 53]. Findings of this thesis suggested that the rural disadvantage in breast 
cancer mortality is unlikely to be due to lack of mammography services. Contrary to expectations, 
the rural population (77%-87%) were as likely to have an up-to-date mammogram as the urban 
population (77%-83%). It is reasonable to conclude that the introduction of the breast-screening 
program in Australia was effective in improving access across the rural and urban population. It 
should be noted that the rural sample in this thesis consisted mostly of women from inner regional, 
outer regional and remote areas, with a small sample size in the very remote group (1%). Therefore, 
our results may not be able to be generalised to women living in very remote areas, because they are 
under-represented in the sample. Indeed, in the BreastScreen Australia monitoring report 2010-2011, 
it was reported that the percentage of mammography uptake among women living in very remote 
areas was almost 10% lower than the rest of Australia. The report indicated that women living in 
very remote areas remained disadvantaged in the access and uptake of mammography breast 
screening [226]. Nevertheless, the findings of this thesis can be used to conclude that the mobile 
screening mammography services are effective in delivering breast screening service to inner 
regional, outer regional and remote areas, which comprise the majority of the Australian rural 
population.  
 
The efficacy of screening mammograms has recently been the subject of some debate [148, 150, 
227]. Mammography screening can result in false positives and over-diagnosis, which can lead to 
unnecessary psychological distress and over-treatment [150, 228, 229]. This may explain the 
observation in the thesis that women with higher levels of education were less likely to have 
mammograms, although the uptake rate was still high overall [128]. The lower mammography rate 
among women with higher education may reflect their ability to consider up-to-date research 
evidence on the benefits and costs of mammography. It is possible that they have made an informed 
choice not to undergo mammography. Another possible explanation is the women with higher 
education may have had clinical breast-examinations. Consequently, they may not feel the need to 
conduct mammography. Since 1991, which was before the collection of data for the studies of this 
thesis, The National Program for Early Detection of Breast Cancer established by the Australian 
Government has made available a vast amount of public health information to promote the benefits 
of mammography for breast screening [23]. However, information on the negative aspects of 
mammography is less widely promoted. This could result in an unrealistic acceptance of 
mammography as unconditionally beneficial. Public health messages promoting mammography 
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breast screening, accompanied with information that outlines both benefits and risks, would be 
helpful in ensuring that women can make informed choices on participation in mammography.  
 
Although the rural population in our sample was not less likely to have mammography breast 
screening, they were less likely to have clinical breast-examination (CBE) than their urban 
counterparts. This result suggested that the rural population have poorer access to certain health 
services. In Australia, the federal government provides cost-free mammography services across 
rural and urban areas [20]. On the other hand, CBE is mostly conducted by general practitioners or 
nurses in private clinics. Therefore, a possible explanation for the result that the rural population are 
less likely to have CBE than the urban population could be due to the lack of access to private 
health care services. The lack of health-care professionals in rural Australia has previously been 
identified as a public health issue that needs urgent attention [11]. Therefore, the lower rate of CBE 
among the rural population is likely to be a reflection of the lack of health-care professionals and 
private health clinics in rural Australia. The provision of mammography services across urban and 
rural areas is likely to have compensated for the lack of private health clinics in rural areas for 
conducting CBE. However, the lack of health-care professionals and private health clinics in rural 
areas has wider implications for a range of other health outcomes that require primary care beyond 
screening for breast cancer. In the past decade, various initiatives have been put in place to increase 
the number of health-care professionals in rural areas [230]. For example, scholarships, recruitment, 
and retention schemes have become available to encourage doctors to work in rural areas. In 
addition, a significant proportion of vocational training positions for medical school graduates have 
shifted to rural areas. The increased number of health-care professionals, especially medical school 
graduates, working in rural Australia is a good start to reduce the health-care access gap between 
the rural and urban population [231]. However, access to primary health-care professionals in rural 
areas persists as a public health concern. Of particular concern is that primary health-care 
professionals are unlikely to stay long-term. Common barriers for retaining rural health-care 
professions include poor access to professional development, professional isolation, and insufficient 
supervision [232]. Inferior facilities and equipment in rural hospitals pose as further barriers [233]. 
Access to experienced health-care professionals is also an issue in rural areas. Women with breast 
cancer living in rural areas are less likely to be treated by high caseload surgeons than those living 
in urban areas [7]. Stronger public health efforts to increase and retain health professionals in rural 
areas, combined with outreach programs, and updated equipment and facilities, are required to 
ensure health-care access equality across urban and rural Australia.  
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The thesis found that there were more women with advanced stage of breast cancer at diagnosis 
among rural patients; however, the effect size was small. Further, the effect of rurality of residence 
on this later detection was minimised after adjusting for obesity, which was a much stronger 
explanatory factor. Given that the rate of obesity is higher in the rural population [69], the findings 
suggest that public health interventions to target obesity in the general population may help to 
improve breast cancer outcomes across the rural population, as well as reduce the rural–urban 
disparities in breast cancer outcomes. Obesity is an increasing public health problem worldwide and 
is a major risk factor for a wide spectrum of chronic diseases [234]. Targeting obesity will not only 
provide benefits for improving breast cancer outcomes, but also those benefits could be applied to 
the reduction of a wide range of chronic diseases. In Australia, obesity rates have doubled over the 
last 30 years [235]. In 2008, 37% of adults were overweight, and 24% of adults were obese [236]. A 
potential population-based strategy to reduce obesity rates may be to improve access to healthier 
foods across Australia. Unfortunately, in Australia, the price increases for healthy foods have grown 
at a higher rate than price increases for less healthy foods [237]. The higher price of healthy foods 
poses as a barrier for healthy foods access across the population [237]. In particular, these cost 
discrepancies have increased the rural disadvantage in access to healthy foods. Food prices, and the 
increase in food prices, have been higher in rural Australia than urban Australia [238]. Specifically, 
food prices in rural areas are up to 56% higher than those in urban areas [239]. The higher costs of 
foods in rural areas are largely due to the additional transport costs of fresh foods. An option would 
be for the government to subsidise the transport of fresh foods to rural areas, which could both 
reduce food costs and the food price gap in rural areas. Public health initiatives aimed at improving 
access to healthy foods across the population could also have a positive effect on reducing obesity 
rates in both urban and rural areas. Public health policies that aim to reduce obesity in the 
population are urgently needed [239]. Addressing obesity in the population can reduce its burden on 
breast cancer as well as a wide range of other chronic diseases, such as diabetes and cardiovascular 
diseases [240].  
 
The findings of this thesis have provided no support for a rural disadvantage in physical and mental 
health-related quality of life (HRQOL) in Australian women aged 45-65 years. In addition, the 
analyses found no rural disadvantage in social support. The findings did, however, highlight that 
HRQOL, as well as social support, were lacking in women who were single, divorced, separated, or 
widowed. Therefore, when a breast cancer patient without a partner presents for care, the patient 
should be encouraged to access other means of social support. Although breast cancer patients’ 
HRQOL, in addition to physical health, is increasingly recognised as an important component of 
health, a focus on the potential benefits of social support is currently lacking. It could be useful to 
Chapter 9 – Thesis discussion 
179 
 
include the checking of breast cancer patients’ social support as part of the health-care guidelines. 
In terms of rural-specific recommendations, public health-care programs to support women from 
rural areas to travel to urban areas for treatment could also consider travel support for partners, as a 
way of maintaining HRQOL. Given that women living with breast cancer without partners were 
likely to be disadvantaged in social support and HRQOL, it is likely that older women would be 
more disadvantaged. Older women are more likely to be without partners due to widowhood, as life 
expectancy is higher in women than men [241]. It has been previously observed that older women 
without partners report poorer HRQOL, poorer self-rated health, and higher levels of stress about 
their health [242]. Women with breast cancer without partners may need assistance and 
encouragement in seeking alternative sources of support, such as from family and friends.  
 
9.3. Strengths and limitations 
Strengths 
A strength of the studies in this thesis are that they used a standard classification of remoteness to 
define area of residence [43]. This approach was taken because of criticisms surrounding the 
inconsistent definition of rurality used in other previous research [42]. The use of a standard 
classification of rurality means that findings from this thesis can be compared with those from other 
studies that employ a consistent definition of rurality. In addition, as the definition used is 
consistent with that adopted by the Australian Government, it is suitable for capturing access to 
health-care services, meaning that the research findings can be used directly for the evaluation and 
planning of health-care services.  
 
The longitudinal design of the studies is strength of this thesis. This design made it possible to 
examine changes in behaviours and risk factors associated with breast cancer outcomes between 
women living in rural areas and those living in urban areas. It thus allowed for the identification of 
causal relationships and temporal effects between the risk factors and outcomes.  
 
The use of linked data is a further strength of this thesis. This thesis is the first Australian study to 
compare rural-urban differences in stage of breast cancer at diagnosis using linked data from cancer 
registries with data from a large longitudinal survey that includes detailed individual-level 
characteristics of the patients. Such a linkage formed an important milestone in the use of 
administrative data sources for research on the topic. Although cancer registry data contain gold-
standard information on breast cancer characteristics, the dataset includes only basic demographic 
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characteristics. Breast cancer stage at diagnosis can be influenced by a multi-dimensional range of 
individual-level (e.g. obesity) as well as area-level (e.g. rurality) factors; thus, studies that focus 
solely on data drawn from the cancer registry are susceptible to possible confounding. Using a data-
linkage design, the thesis was able to provide a comprehensive profile – including risk factors in the 
domains of rurality of residence, individual socio-demographic characteristics, physical 
characteristics, lifestyle factors, and cancer characteristics– to examine how these combined factors 
affect the early detection of breast cancer.  
 
Limitations 
While there were strengths with the use of linked data, there were also limitations due to the 
methods employed in the thesis. The process of obtaining linked data was more difficult than 
expected. It required numerous data application documents, and multiple rounds of reviews with 
lengthy review periods. This is a methodological limitation in this thesis, because a limited 
timeframe in a thesis setting restricts the allowable time available towards waiting for data. A 
difficulty with the method was that the cancer registry data were requested separately by state and 
territory cancer registries. The cancer registries retain ownership of their data. Therefore, additional 
research barriers and administrative process existed because each of the cancer registries needed to 
agree on the conditions of the supply and analysis of their data. Mainly due to the lengthy processes, 
overall, the method of applying for linked data through each state and territory separately was a 
weak approach for this thesis. Although data linkage applications were submitted (and eventually 
approved) with every state within Australia, given the limited time-frame, the thesis was unable to 
wait for data from all states to arrive before commencing in the analyses. Therefore, the data 
linkage analyses were unable to be conducted using data from all states within Australia. 
Nevertheless, at the time of the data linkage analyses, linked data had arrived from NSW, QLD, and 
VIC, which comprised over 70% of the Australian population. Therefore, this data was adequate for 
the analyses in terms of coverage of the Australian population. Accessing cancer data through the 
Australian Cancer Database (ACD), rather than through the cancer registries of each state, could 
have addressed some of these barriers and reduced the administrative process. However, the 
standard list of variables in the ACD is limited. The standard ACD list does not include information 
on the stage of cancer at diagnosis, which was required for the purpose of this thesis. While 
additional variables may be requested for specific projects with the ACD approach, cooperation of 
cancer registries were required, which would result in additional administrative processes. The 
process of requesting additional variables for a data linkage project through the ACD was 
unexplored in this thesis.  
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Another limitation related to the use of linked data was that the missing data in the cancer registry 
reduced the sample size for analysis. In the cancer registry data, over 10% of data on the stage of 
breast cancer was missing or unknown. The range of variables available, as well as coding of 
variables, differed slightly across the cancer registries. For example, stage of breast cancer at 
diagnosis was not available in the linked Western Australia cancer registry data. Rather, grade of 
breast cancer was available, which is not directly comparable to stage. Therefore, even though 
linked cancer registry data from Western Australia were obtained, the data could not be used in the 
thesis to examine stage of breast cancer at diagnosis. The unavailability of consistent data on stage 
at cancer diagnosis across Australia has previously been criticised [243]. It was noted in the 
National Cancer Data Strategy for Australia report in 2008 that the lack of a national approach to 
the collection of data on stage was a fundamental gap in population-based data collection [244]. 
This limitation was apparent across the 1997 to 2011 cancer registry data examined in this thesis. 
Another limitation is that only incidence data and mortality data were available. However, data on 
breast cancer recurrences were not available. Collection of cancer data only at the current 
mandatory data collection points at diagnosis and at death limits the ability to examine recurrence 
rates in cancer survivors.  
 
Response bias is a limitation in the thesis. In this thesis, women with breast cancer had a 5% higher 
dropout rate than women without breast cancer. Even though this was not a large difference, it 
should be noted that women with breast cancer were slightly under-represented in the sample. In 
Australia, the incidence of breast cancer in women between the age of 45-60 years is 184.3-334.9 
per 100,000 females [188]. In this thesis, the incidence among respondents was 203.3-252.3 per 
100,000 females, which was within the range of the Australian female population. Response bias 
would be a major limitation in the study if a significant proportion of women with breast cancer are 
not responding to the survey, which would be indicated by a lower breast cancer incidence observed 
in the sample. This was not the case. The corresponding incidences between the sample in the thesis 
with the Australian population means that women with breast cancer remained to be responding to 
the surveys. For these reasons, it is likely that the thesis included a reasonable representation of 
women with breast cancer in the Australian population.  
 
As with all survey data, self-report bias is a possible limitation in the thesis. Mammography breast 
screening was self-reported, and administrative records of mammography uptake were not available 
for these studies. Therefore, it is possible that there is a risk of self-report bias, which is likely to 
result in an over-report of mammography rates. In addition, the women may have included 
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diagnostic mammography in their self-report as well as screening mammography. Screening 
mammograms are conducted in symptom-free women in the general population routinely. 
Contrastingly, diagnostic mammograms are commonly conducted to follow a suspicious result on 
screening mammograms. The inability to distinguish these two types of mammography is a 
limitation in the thesis. However, the majority of women in the mammography study in the thesis 
did not have breast cancer. Therefore, it is reasonable to assume that the self-reported 
mammography is likely to consist of mainly screening mammograms rather than diagnostic 
mammograms. A revision of the survey question to collect information on type of mammography 
the women have had would address this limitation.  
 
9.4. Directions for future research 
Given that the age distribution in the Australian rural population is older than the urban population, 
older age can possibly explain the rural and urban disparities in breast cancer outcomes observed 
previously [41]. The thesis followed an Australian sample of women from 45-65 years of age, as 
this is the age group with a high prevalence of breast cancer. Further, the rural and urban 
comparison groups in the thesis were the same in this mid-aged range. The thesis was unable to 
detect any disparities in breast cancer outcomes in older women over 65 years of age. Future studies 
that include participants in an older age group can confirm whether the rural disadvantage in breast 
cancer outcomes can be attributed to the older age distribution in the rural population. As the age of 
the population is increasing globally, chronic diseases will become more prevalent. The need for 
epidemiological research on diseases associated with older age will increase. Future research will be 
required to monitor breast cancer outcomes in the ageing population.  
 
While mortality has been traditionally the most important breast cancer outcome to consider, this 
thesis was unable to conduct research on this due to the small number of deaths in the sample (n = 
14). As survival rate is high for breast cancer, the well-being post-cancer is becoming an 
increasingly important breast cancer outcome to consider. It used to be that after a cancer diagnosis, 
patients are provided with palliative care to reduce their suffering until death; however, now, an 
increasing proportion of cancer survivors are returning to work after recovery [245]. Future research 
on factors that support women with breast cancer to return to work is required to understand this 
population trend. Returning to work after cancer could be more difficult for women living in rural 
areas. One reason is that women living in rural Australia are less well educated [246], and 
employment opportunities are better for those with higher education. In addition, women living in 
rural areas are more likely to be working in physically challenging jobs, such as in the agriculture 
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industry[246]. However, working in these jobs is likely to be difficult for women who are living 
with worsened physical health as a result of their breast cancer [247]. Training that will enable 
employment in non-physically intensive industries (e.g. information technology) can possibly 
support women living with breast cancer who choose to return to work. Currently there are few 
services to support cancer survivors in returning to work [248]. The Australian Government has 
legislation in place to protect mature-aged workers against discrimination and has issued guidelines 
to encourage businesses to keep older Australians in the workforce [249]. Given the high breast 
cancer survival rate observed in this thesis, these legislative measures could be expanded to protect 
older employees with chronic diseases. Policies to facilitate working choices and increase flexibility 
in the workplace can help support cancer survivors to keep their employment and return to work 
during cancer treatment. Research is required to identify barriers for returning to work among 
women living with breast cancer. Such research can provide directions for support programs to help 
women with breast cancer return to work.  
 
Further research is required to interrogate the relationship between marital status, social support, 
and HRQOL observed in this thesis. While the thesis observed that breast cancer patients without 
partners were susceptible to both lower social support and HRQOL, the underlying pathway was 
unclear. Social support may be a possible mediator in the relationship between marital status and 
HRQOL. It may be that women with breast cancer without partners were susceptible to a lack of 
social support, which in turn puts them at risk of poorer HRQOL. Given the finding of the thesis 
that emotional support was especially useful in the protection of HRQOL, this mediation hypothesis 
is highly plausible. Such mediation hypotheses could be tested in future studies. 
 
This thesis contributes to the rural health literature on rural and urban disparities on the use of and 
access to breast cancer health-services in a preventive-care perspective before breast cancer is 
diagnosed. Further research is required to compare rural and urban differences in health services in 
a disease-management perspective after breast cancer is diagnosed. The best treatment for breast 
cancer varies among individuals, depending on cancer stage and characteristics, and the patient’s 
characteristics, such as age and health status [12]. Previous research has found that rural women 
were more likely to receive mastectomies, whereas urban women were more likely to receive 
breast-conserving surgeries [36]. In Australia, several studies have examined rural and urban 
differences in treatment procedures for breast cancer [7, 59, 250]. However, a knowledge gap 
remains, because these studies were unable to control for key individual risk factors, such as socio-
economic status and body mass index. Future research is required to recruit a patient sample to 
examine individual-level and area-level factors responsible for the rural and urban disparities in 
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breast cancer treatments after diagnosis. In addition, research is required to examine how the 
different management options are associated with breast cancer recurrence, co-morbid chronic 
diseases, survival, and health-related quality of life after treatment.  
 
Future research on breast cancer treatments should consider drawing on multiple sources of data. 
This thesis planned to use hospital administrative data to examine breast cancer treatments in rural 
and urban patients. However, the hospital administrative data did not provide information on a 
comprehensive range of treatment options for research. Only surgical treatments were included in 
the linked hospital administrative records. No information was available on chemotherapy 
(chemical drug treatment) as a type of breast cancer treatment. This is because the thesis only 
obtained inpatient records. Chemotherapy is commonly delivered on an outpatient basis, but the 
thesis did not obtain this information. The absence of information on chemotherapy posed a 
research shortfall because it is one of the most common treatment options for breast cancer. 
Similarly, information on radiation therapy as a type of breast cancer treatment was also lacking in 
the hospital administrative records. Due to this lack of data on a comprehensive list of treatments, 
this study was unable to complete a planned study that examines rural and urban differences in 
breast cancer treatments. Future studies comparing rural and urban differences in treatment 
procedures need to employ a design that links together different sources of data to collect a 
comprehensive coverage of all treatment options. This research would also require linked data from 
cancer registries to obtain information on the date and stage of disease at diagnosis. In addition, 
linked data with sources that include information on the participants’ individual characteristics, 
such as body mass index, would be useful. Such data linkage studies would enable the 
disentanglement of individual-level versus area-level risk factors associated with different breast 
cancer treatments between the rural and urban population.  
 
In addition to the availability of treatment options, research on patients’ choices of treatment should 
be considered. Treatment options can be influenced by both the availability of health services and 
personal choices or culture [251, 252]. Future research on the reasons for undergoing different 
breast cancer treatments in rural and urban breast cancer patients is required. Similarly, future 
research on cultural and attitudinal reasons on mammography uptake is required. Although this 
thesis did not find a lower mammography uptake rate in the Australian setting, it was identified that 
rural populations had lower rates of screening mammography than urban populations in other 
settings, especially in the United States. Further research is required to examine whether this lower 
rate of screening mammography in the rural population can be attributable to the lack of screening 
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services, or the rural culture in these settings. Such research would provide information on 
underlying reasons for the rural–urban differences in breast cancer services.  
 
Related to breast cancer outcomes after treatment, there is still a lack of information on how rural–
urban differences in breast cancer treatment affect psychosocial outcomes and HRQOL. Research 
that provides information on the unmet needs of women living with breast cancer is lacking. Future 
research is required to examine the possible causal factors that contribute to rural and urban 
differences in breast cancer treatment, and what physiological and psychological outcomes result 
from this rural–urban disparity. The thesis is a step towards understanding how preventive health 
care to reduce breast cancer mortality in rural and urban Australia can affect breast cancer outcomes. 
Further research to extend this research to a post-breast cancer perspective is needed provide a 
complete evaluation of rural and urban disparities in breast cancer outcomes.  
 
While this thesis found no rural disadvantages in a number of breast cancer outcomes, it does not 
provide a comprehensive picture of rural health. Findings cannot be generalised onto other cancers 
or other chronic conditions. In Australia, strong evidence indicate that the rural population is 
disadvantaged in numerous factors, such as socio-economic status and access to health-care services, 
which should not be ignored as these factors can have a great impact on health [10, 38, 39, 253]. 
Breast cancer is a unique topic for rural health research because deliberate public health efforts, 
namely mobile mammography units, are in place to provide cancer screening for the rural 
population. Further rural health research is required to examine other health areas in which a rural 
disadvantage has previously been observed, such as for bowel cancer. Similar to breast cancer, 
screening is available for the early detection of bowel cancer. In Australia, a bowel cancer screening 
program is in place, which involves a mailed test kit sent out for people to collect samples at home 
and sent to a pathologist for analysis. This screening program is relatively new, having commenced 
in 2006. Shortly after the introduction of the program, research showed that participation rates were 
lower in older rural residents, especially in men [254]. Research using data that are more recent is 
required to examine whether this discrepancy remains, and if yes, what are the underlying causal 
factors for the rural disadvantage.  
 
9.5. Conclusion 
These studies form the first epidemiological examination of rural and urban differences in health-
service use and individual characteristics that may affect breast cancer outcomes in Australia. 
Access to detailed longitudinal survey data from a large-scale sample of women living in rural and 
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urban areas made this research possible. Findings showed no rural and urban differences in the use 
of breast-screening services. This suggests that the breast screening service delivery to rural areas is 
successful. However, there was an association between rurality and later stage of presentation. It is 
known that rural women are more likely to be obese, that obesity is a risk factor for advanced breast 
cancer, and that advanced breast cancer is associated with a lower chance of breast cancer survival; 
thus, the worse outcomes for rural women with breast cancer could be due to obesity. Finally, the 
thesis showed that rural women were not disadvantaged in terms of social support received, and 
there was no rural disadvantage in health-related quality of life in breast cancer survivors living in 
rural areas. Public health policies targeting risk factors that are associated with breast cancer as well 
as other major diseases, and shared across geographical locations, such as reducing rates of obesity, 
could help to improve breast cancer outcomes and general health across both the urban and rural 
population.  
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